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Abstract 
Clostridium difficile is the leading cause of hospital-acquired diarrhoea and a 
major burden to healthcare services worldwide.  Endospore production plays a 
pivotal role in infection and disease transmission, but in order to cause disease 
these spores must germinate and return to vegetative cell growth.  Therefore, 
knowledge of spore germination is important and may have direct applications 
in future disease prevention.  Germination has been well studied in Bacillus 
and in some clostridia, but the mechanisms of C. difficile spore germination 
remain unclear.  Apparent homologues of genes important for germination in 
other spore formers have been identified in the C. difficile genome and 
ClosTron technology was used to inactivate homologues of sleC, cspA, cspB 
and cspC (Clostridium perfringens) and cwlJ, sleB and cwlD (Bacillus subtilis) 
in both C. difficile ǻerm and a BI1$3LVRODWHDµK\SHUYLUXOHQW¶W\SH
associated with outbreaks of increased disease severity).  Using a combination 
of several different assays to study these mutants in detail, a number of the 
identified target genes appear to be essential for germination and outgrowth of 
C. difficile spores.  This is the first report of using reverse genetics to study the 
germination of C. difficile spores and the first gene characterisation by 
mutagenesis in a BI/NAP1/027 isolate of C. difficile.  Furthermore, this study 
uncovered evidence of significant variation in the sporulation and germination 
characteristics of different C. difficile strains, but this variation did not appear 
to be type-associated. 
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1.1 Clostridium difficile 
1.1.1 Clostridium difficile: emergence of a significant human pathogen 
The genus Clostridium is comprised of many species of Gram-positive, 
obligate anaerobic, rod shaped, endospore-forming bacteria.  The vast majority 
are entirely benign, and have recently become of importance due to their 
potential beneficial properties, both economical and medical.  For example, 
interest in Clostridium acetobutylicum has grown rapidly, due to its role in bio-
butanol production (Jones and Woods, 1986; Lee, et al., 2008).  Furthermore, a 
significant role in the treatment of cancer has also been described for 
Clostridium sporogenes and Clostridium novyi (Minton, et al., 1995; Theys, et 
al., 2006).  However, the beneficial properties of these species have largely 
been overshadowed by the actions of a few.  Clostridium perfringens is a 
significant cause of gastrointestinal diseases in humans and animals (Collie, et 
al., 1998), and Clostridium botulinum, while widely used in the cosmetics 
industry and of importance for a number of medical applications, has long 
been associated with food poisoning and bio-terrorism concerns due to its 
production of the most potent natural toxin known to man (Schantz and 
Johnson, 1992).  Nevertheless, the most serious headlines in recent times have 
been reserved for the emergence of Clostridium difficile.  
 
C. difficile is capable of residing in the gut of mammals, and is the causative 
agent of C. difficile-associated disease (CDAD).  Originally named Bacillus 
difficilis, C. difficile was first described in 1935 as part of neonatal intestinal 
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microflora (Hall and O'Toole, 1935).  However, its true potential as a human 
pathogen was not known until 1978, when the first confirmed case of CDAD 
was reported (Larson, et al., 1978).  In 1999, clindamycin, the antibiotic of 
choice at the time, was identified as a major risk factor for CDAD following 
the study of a clindamycin-resistant strain of C. difficile at the heart of four 
outbreaks across the United States of America (Johnson, et al., 1999).  In 
recent years, outbreaks of CDAD have led to patient isolation, ward closures, 
and in some cases, hospital closure.  C. difficile has now become recognised as 
the major cause of hospital-acquired diarrhoea and is a huge burden to 
healthcare services across Europe, North America and some parts of Asia. 
 
Surveillance of positive C. difficile laboratory samples in England and Wales 
was introduced in 1990, as part of a voluntary monitoring scheme.  Over the 
following 15 years, the incidence of CDAD rose dramatically (Figure 1.1).  As 
a result, a mandatory reporting scheme was introduced in 2004 which required 
all National Health Service Trusts in England to report cases of CDAD in 
patients aged 65 and over.  Since then, similar mandatory surveillance schemes 
have begun across the United Kingdom, covering every patient aged 2 or over, 
in an attempt to accurately assess the incidence of CDAD.  In 2008, C. difficile 
was the underlying cause of more than 2500 deaths in England and Wales 
alone (Figure 1.2), more than 10 times that of methicillin-resistant 
Staphylococcus aureus (from the website for the Office of National Statistics, 
http://www.statistics.gov.uk). 
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Figure 1.1. Reports of positive C. difficile laboratory samples isolated from 
faecal specimens under the voluntary reporting scheme in England between 
1990 and 2005.  From the website of the Health Protection Agency 
(http://www.hpa.org.uk). 
 
 
Figure 1.2. Number of death certificates mentioning C. difficile in comparison 
to where C. difficile was noted as the underlying cause of death in England and 
Wales between 1999 and 2008.  A mandatory surveillance scheme was 
introduced between 2004 and 2005, which may partly account for the large 
increase in C. difficile incidence in the following years.  From the website for 
the Office of National Statistics (http://www.statistics.gov.uk). 
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1.1.2 C. difficile disease 
C. difficile is commonly isolated from faecal specimens obtained from 
neonates and the elderly.  In many cases carriage is asymptomatic (as is 
especially the case in neonates); however, in susceptible individuals C. difficile 
can cause diarrhoeal diseases ranging from asymptomatic carriage to a 
fulminant, relapsing and potentially fatal pseudomembranous colitis (Poxton, 
et al., 2001).  The major risk groups for CDAD are the elderly and those 
individuals whose normal intestinal microflora has been disrupted following 
antibiotic treatments (Johnson, et al., 1999).  C. difficile subsequently 
capitalises on this disruption of gut flora to colonise the large intestine, causing 
disease symptoms through the action of two large toxins TcdA and TcdB, 
which are commonly referred to as toxin A (enterotoxin) and toxin B 
(cytotoxin) (Poxton, et al., 2001; Voth and Ballard, 2005).  
 
Treatment of CDAD is far from straightforward as C. difficile possesses a large 
number of mobile elements in the genome carrying antibiotic resistance genes 
(Sebaihia, et al., 2006).  As CDAD development is associated with antibiotic 
disruption of the gut flora, mild disease may be treated by withdrawing the 
previously administered antibiotics and providing further supportive therapy 
(Hedge, et al., 2008).  Currently, the only available antibiotics for treating 
CDAD are metronidazole and vancomycin and these antibiotics, when 
combined with patient isolation procedures, remain the principal therapeutic 
option. 
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1.1.3 C. difficile virulence factors 
The mode of action of toxins A and B have been extensively studied and 
shown to be functionally similar.  They are both endocytosed by the host cell 
and target the Ras super family of GTPases for modification via glycosylation.  
This causes disruption of the actin cytoskeleton and tight junctions, ultimately 
resulting in excessive fluid accumulation and destruction of the intestinal 
epithelium (Thelestam and Chaves-Olarte, 2000; Poxton, et al., 2001; Voth 
and Ballard, 2005; Rupnik, et al., 2009).  It has also been shown in the past 
that some C. difficile types also produce an actin-specific ADP-ribosylating 
toxin, a binary toxin encoded by cdtA-cdtB (Carter, et al., 2007; Rupnik, et al., 
2009).  Interestingly, this binary toxin is produced by all emerging C. difficile 
types that have been associated with outbreaks of increased disease severity, 
and it has been suggested that this toxin induces morphological changes in host 
intestinal epithelial cells, which facilitates increased adherence of these C. 
difficile types (Schwan, et al., 2009). 
 
Initially, it was generally accepted that toxin A was the principal virulence 
factor responsible for CDAD.  However, a recent study concluded that toxin B 
is required for disease in Golden Syrian hamsters (Lyras, et al., 2009), and this 
hypothesis is supported by evidence that a significant number of clinically 
relevant C. difficile strains do not produce toxin A, yet remain highly virulent.  
Further research into this area is clearly needed, as data from our laboratory 
would appear to suggest that both toxin A and toxin B alone are sufficient for 
disease in the hamster model (Kuehne, et al., 2010). 
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Whilst the toxins of C. difficile are clearly the principal virulence factors, the 
role of other virulence factors is much more speculative.  The unique surface 
layer proteins of C. difficile vegetative cells are potential virulence factors and 
are thought to be involved in adherence of C. difficile to host cells, and 
eliciting inflammatory and antibody responses (Drudy, et al., 2004; Ausiello, 
et al., 2006; Rupnik, et al., 2009).  In addition, it has been suggested that FliC 
and FliD, key components of the C. difficile flagella, are involved in adherence 
and gut colonisation (Tasteyre, et al., 2001), although data from our laboratory 
suggest that this may not be the case (Soza Baban, Sarah Kuehne and Nigel 
Minton, unpublished results). 
 
1.2 Endospores of C. difficile 
Many bacterial species are able to use specialised differentiated cell types as a 
means of surviving in conditions otherwise detrimental to their vegetative cell 
form.  The primary purpose of endospore production is to ensure survival of 
the organism, but as a consequence the endospore form is now widely 
recognised as a route of infection for transmissible diseases such as CDAD.  
While toxins are the principal virulence factors of C. difficile, the ability of the 
organism to produce endospores is necessary for disease transmission.  
Clostridial spores are extremely resistant to all kinds of chemical and physical 
agents and provide the mechanism by which C. difficile can evade the 
potentially fatal consequences of exposure to heat, oxygen, alcohol and certain 
disinfectants (Setlow, 2007).  Thus, the spores shed in faecal matter are very 
difficult to eradicate and can persist on contaminated surfaces in healthcare 
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facilities for extended periods of time (Setlow, 2007).  This leads to infection 
or re-infection of cohabiting individuals through inadvertent ingestion of 
contaminated material (Riggs, et al., 2007; Gerding, et al., 2008).  Once in the 
anaerobic environment of the gut, spores presumably germinate to form the 
characteristic toxin-producing vegetative cells and, in susceptible individuals, 
diarrhoeal disease. 
  
1.2.1 Sporulation 
Sporulation is the adaptive process by which a bacterial species forms 
metabolically dormant, highly stress resistant endospores.  The most widely 
examined spore-forming organism is Bacillus subtilis, and the mechanisms by 
which it (i) senses a suitable environment for sporulation; and (ii) initiates and 
completes the process have become a useful paradigm for such systems in 
other organisms.   
 
The mechanisms of sporulation initiation in B. subtilis are now understood to 
an exquisite level of detail, beyond the scope of this introduction.  The process 
is driven by a temporally and spatially controlled program of gene expression 
(Sonenshein, 2000; Paredes, et al., 2005), the commencement of which relies 
on the vegetative cell reaching a certain stage of its growth cycle (Grossman, 
1995; Parker, et al., 1996).  Briefly, the main stimulus for sporulation in B. 
subtilis is nutrient-starvation (Schaeffer, et al., 1965; Sonenshein, 2000; Driks, 
2002).  This environmental signal can drive phosphorylation of the master 
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regulator of sporulation, Spo0A, which then functions to repress abrB, a 
repressor of numerous stationary phase genes, a number of which are required 
for sporulation (Weir, et al., 1991).  Upon reaching a threshold of Spo0A-P, 
the sporulation cascade is initiated (Fawcett, et al., 2000; Sonenshein, 2000).  
There are five principal events which follow commitment to sporulation 
(Errington, 2003; Paredes, et al., 2005).  As described in Figure 1.3, these 
stages involve (i) an asymmetrically positioned septum divides the cell into the 
prespore and mother cell compartment; (ii) the prespore is engulfed to form a 
protoplast within a double membrane; (iii) the spore peptidoglycan (PG) cortex 
is formed; (iv) an ordered sequence of gene expression results in spore coat 
formation; and (v) the mature spore is finally released by cell lysis into the 
surrounding environment. 
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Figure 1.3. A simplified diagram of the B. subtilis cell cycle, indicating the 
principal stages of sporulation (Errington, 2003). 
 
Sporulation in organisms such as B. subtilis has been extensively studied.  On 
the other hand, the conditions which lead to sporulation initiation in C. difficile 
are not clear.  Figure 1.4 illustrates the genetic basis of the B. subtilis 
sporulation cascade, with appropriate annotations of proteins of interest that 
have been identified in C. difficile.  It has been shown that Spo0A is required 
for spore formation in C. difficile (Heap, et al., 2007), and that a putative 
sporulation-associated kinase, CD2492, may play a role in phosphorylation of 
Spo0A (Underwood, et al., 2009), but our understanding of this complex 
process in C. difficile remains poor.   
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Figure 1.4. The sporulation cascade in B. subtilis (Paredes, et al., 2005).  
Those labelled in green, pink and yellow represent proteins identified in C. 
difficile, and presumed to play a role in sporulation. 
 
1.2.2 The structure of a bacterial spore 
In spores of B. subtilis, the core containing the spore DNA, RNA, and most 
enzymes, is enclosed within the spore inner membrane.  This membrane has a 
low permeability to small molecules and perhaps even water.  As a result, the 
spore core is protected from DNA-damaging chemicals and has a very low 
water content, presumed to play a role in the heat resistance of the spore 
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(Popham, et al., 1996a; Nicholson, et al., 2000; Cortezzo and Setlow, 2005; 
Setlow, 2006; Setlow, 2007).  Surrounding the spore inner membrane is the 
germ cell wall, a thin layer of PG identical to that of vegetative cell PG, which 
becomes the cell wall on the return to vegetative cell growth.  The germ cell 
wall is itself surrounded by the cortex, a thicker layer of spore-specific PG 
which differs from vegetative cell PG in two major ways (Atrih, et al., 1996; 
Popham, et al., 1996b; Atrih and Foster, 1999; Popham, 2002).  Essentially all 
N-acetylmuramic acid (NAM) residues of germ cell wall and vegetative cell 
PG carry short peptides, but in spore PG only about 25% of NAM residues 
carry these peptides.  Consequently, spore PG is less highly cross-linked than 
vegetative cell PG, which may play a role in spore heat resistance (Atrih and 
Foster, 1999).  Furthermore, approximately every second muramic acid residue 
in spore PG is replaced by muramic-į-lactam (Warth and Strominger, 1969; 
Warth and Strominger, 1972), and, as is discussed below, it has been shown 
WKDWWKHVHį-lactam residues are heavily involved in the germination process.   
 
The cortex is surrounded by an outer membrane, required for sporulation but 
not known to be a permeability barrier in dormant spores (Setlow, 2007).  In 
many species of Bacillus, the outermost layer of the spore is the coat, 
consisting of an ordered assembly of more than 40 different proteins and 
functioning mainly to protect the spore by acting as a barrier to harmful 
molecules (Zheng, et al., 1988; Driks, 1999).  In some, but not all, Bacillus 
VSHFLHV WKH RXWHUPRVW OD\HU LV D ³EDOORRQ-OLNH´ SURWHLQ OD\HU NQRZQ DV WKH
exosporium (Charlton, et al., 1999; Todd, et al., 2003; Redmond, et al., 2004; 
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Setlow, 2007).  The precise function of the exosporium is not known.  As it is 
not present in spores of the non-pathogenic B. subtilis, but is present in spores 
of the pathogenic Bacillus anthracis (Todd, et al., 2003; Redmond, et al., 
2004), it is plausible that the exosporium may play a role in the pathogenesis 
of some spore forming organisms.  This hypothesis is supported by the 
evidence that C. difficile spores possess an exosporium layer (Lawley, et al., 
2009).  However, it is not clear what role the exosporium may play in the 
disease caused by C. difficile. 
 
 
Figure 1.5. Structural diagram of a bacterial spore, adapted from Setlow 
(2003).  The respective layers are not drawn to scale and the large exosporium 
is not present in all species of Bacillus, but has been shown to exist in C. 
difficile spores. 
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1.2.3 Resistance properties of bacterial spores 
Bacterial spores are unified by their ability to resist extreme environments that 
would otherwise be fatal to vegetative cells.  Spores of Bacillus and 
Clostridium can survive exposure to stress conditions such as wet and dry heat, 
UV radiation and many toxic chemicals including ethanol (Nicholson, et al., 
2000; Setlow, 2006; Setlow, 2007).  As described above, the major role of the 
coat and spore inner membrane is likely to protect the spore, presumably acting 
as a barrier against harmful chemicals.  The PG cortex has been strongly linked 
to maintaining spore dormancy and heat resistance (Ellar, 1978; Atrih and 
Foster, 1999), as spores lacking the coat are heat resistant but cannot grow as a 
vegetative cell until the cortex is degraded.   
 
Despite many structural factors contributing to spore resistance, the crucial 
aspect of these properties, and as a result the key to the long-term survival of 
the spore, lies in the mechanisms by which the DNA in the spore core is 
protected and repaired (Setlow, 2007).  7KHVSRUHV¶ODUJHstock of dipicolinic 
acid (DPA), almost certainly existing as a 1:1 chelate with Ca2+ (CaDPA), 
plays a major role in protecting core DNA from damage associated with wet 
and dry heat, desiccation and chemicals such as hydrogen peroxide (Setlow, et 
al., 2006; Setlow, 2007).  Furthermore, arguably the most important 
PHFKDQLVPRIVSRUH'1$SURWHFWLRQ LVSURYLGHGE\ WKHĮȕ-type small, acid-
soluble spore proteins (SASPs), which are synthesised during sporulation and 
saturate spore DNA to prevent potentially fatal DNA-damaging mutations 
(Setlow, 2007).  These Įȕ-type SASPs have been identified in many Bacillus 
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and Clostridium species and are crucial for spore DNA protection, as 
decreased levels of these SASPs render the spore far more susceptible to DNA-
damaging agents (Raju, et al., 2006; Setlow, 2006; Setlow, 2007).  
 
1.3 Spore germination 
1.3.1 Model of bacterial spore germination 
Spore germination is defined as the irreversible loss of spore-specific 
characteristics, is required for conversion of dormant spores to vegetative cells 
and, in pathogenic spore formers, is essential for subsequent disease.  Current 
mechanistic knowledge of spore germination has been principally obtained 
from studying B. subtilis while, in general terms, little is known of the 
mechanisms responsible for germination in clostridia and, in particular, C. 
difficile.   
 
Germination is initiated when a spore senses specific effectors, termed 
germinants.  Spores of B. subtilis can germinate through the binding of 
germinants, either L-alanine or a mixture of asparagine, glucose, fructose and 
potassium ions, to specific receptors located in the spore inner membrane 
(Paidhungat and Setlow, 2000).  The spore is then committed to germination 
and subsequent events include the release of monovalent cations (H+, Na+ and 
K+) and a large depot (~25% of spore dry weight) of CaDPA (Setlow, 2003), a 
process for which SpoVA proteins are required (Vepachedu and Setlow, 2004; 
Vepachedu and Setlow, 2007a; Vepachedu and Setlow, 2007b).  The third 
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major step in germination involves the hydrolysis of the spore PG cortex.  It is 
during this hydrolysis that the previously low water content of the spore is 
returned to that of a vegetative cell and the core is able to expand, in turn 
allowing for enzyme activity, metabolism and, ultimately, vegetative cell 
outgrowth (Moir, 2003; Setlow, 2003; Moir, 2006). 
 
Generally speaking, the germination mechanisms of Clostridium spores have 
been studied in far less detail than Bacillus spores.  A tricistronic gerA operon 
has been identified in C. botulinum and C. sporogenes, and recent work in C. 
perfringens has indicated that monocistronic gerA and gerKB, and a bicistronic 
gerKA-gerKC operon play a role in triggering the germination process 
(Paredes-Sabja, et al., 2008; Paredes-Sabja, et al., 2009a).  However, none of 
these systems are present in C. difficile. 
 
1.4 Spore germination in C. difficile 
Very little is known of the germination mechanisms in C. difficile, and this is 
due in part to a historical absence of genetic tools.  Consequently, studying the 
genetics of C. difficile has been extremely challenging.  In the years preceding 
this thesis, reports of C. difficile germination mechanisms have almost 
exclusively focussed on the interactions of spores with their surrounding 
environment, and the host factors which may influence the behaviour of C. 
difficile spores in vivo. 
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1.4.1 Role of bile salts in C. difficile spore germination 
Bile is produced in the liver and functions to aid digestion and suppress 
significant bacterial colonisation in the small intestine (Ridlon, et al., 2006).  
The two primary bile acids synthesised in the liver are cholate and 
chenodeoxycholate, which are further metabolised via conjugation to glycine 
or taurine.  As bile acids pass through the distal ileum, they are readily 
reabsorbed and recycled into the liver, although a proportion (~5%) of this bile 
avoids active transport and escapes into the cecum (Ridlon, et al., 2006).  A 
number of bacterial species, including C. perfringens, possess bile-salt 
hydrolases (Coleman and Hudson, 1995), which contribute to the removal of 
conjugated amino acids from the bile salt.  These deconjugated cholate and 
chenodeoxycholate derivatives can be further converted, by bacterial species in 
the large intestine, into the secondary bile salts deoxycholate and lithocholate, 
respectively (Ridlon, et al., 2006). 
 
The specific conditions by which C. difficile spores sense a suitable 
environment for germination remain unclear.  However, recent work has 
suggested that bile salts play a pivotal role.  Thus, following on from the 
earlier observation that taurocholate improves the recovery of C. difficile 
spores from environmental surfaces (Wilson, et al., 1982), a  study by Sorg 
and Sonenshein demonstrated that specific bile salts and glycine act as 
cogerminants of C. difficile spores, while the secondary bile salt deoxycholate 
prevented vegetative cell growth (Sorg and Sonenshein, 2008).  They 
hypothesise that, in a healthy host, C. difficile spores can survive passage into 
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the jejunum where they germinate in response to the high concentrations of 
cholate derivatives and glycine.  However, in such individuals, cholate 
derivatives that escape enterohepatic circulation are metabolised into the 
secondary bile salt deoxycholate.  Thus, outgrowth of C. difficile spores is 
prevented.  Conversely, following disruption of intestinal flora, secondary bile 
salts such as deoxycholate are not readily produced.  C. difficile vegetative cell 
growth is therefore not prevented and disease may occur in susceptible 
individuals.  
 
A further study by Sorg and Sonenshein has described the role of the primary 
bile salt chenodeoxycholate in the inhibition of C. difficile spore germination 
(Sorg and Sonenshein, 2009).  This adds an interesting element to their model 
of C. difficile colonisation.  In equal concentrations, both cholate and 
chenodeoxycholate derivatives may compete for binding to putative C. difficile 
germinant receptors.  However, as the rate of absorption by the colon of 
chenodeoxycholate is 10 times that of cholate (Mekhjian, et al., 1979), spores 
reaching the large intestine encounter a higher concentration of cholate 
derivatives.  This suggests that germination may be inhibited until C. difficile 
spores reach the anaerobic environment of the large bowel, where conditions 
are suitable for C. difficile vegetative cell growth.  This model of colonisation 
has been largely supported by a recent study which analysed the kinetics of C. 
difficile germination in response to bile salts and glycine, and proposed that 
taurocholate/glycine receptor complexes are present in C. difficile spores 
(Ramirez, et al., 2010). 
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A recent study has further expanded our knowledge of how C. difficile spores 
may interact with bile salts (Giel, et al., 2010).  The authors described that, 
using an extract from mouse small intestine, a factor produced in vivo 
stimulated colony formation of C. difficile spores.  Treatment of the extract 
with cholestyramine, a bile salt binding resin, reduced the ability of the extract 
to stimulate colony formation, suggesting that the factor is likely a bile salt.  
Furthermore, colony formation was stimulated to greater levels in extracts 
from mice treated with clindamycin, ampicillin or streptomycin, suggesting 
that disruption of normal intestinal flora plays a role in the germination 
frequency of C. difficile spores in vivo.  Indeed, a possible role of antibiotics 
such as fluoroquinolones and clindamycin in inducing C. difficile germination 
has been described, further supporting this hypothesis (Baines, et al., 2009; 
Saxton, et al., 2009). 
 
These studies now suggest that the interaction of C. difficile with bile salts and 
antibiotics, coupled with disruption of normal intestinal flora, plays an 
important role in C. difficile colonisation and subsequent disease.  
Consequently, it now becomes important to understand the detailed mechanism 
of such interactions and this requires knowledge of the genetic basis of C. 
difficile spore germination. 
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1.5 (PHUJHQFHRIµK\SHUYLUXOHQW¶ strains of C. difficile 
1.5.1 BI/NAP1/027 strains of C. difficile 
C. difficile is one of the most intensively typed pathogens, with a wide range of 
systems applied in order to understand its epidemiology.  The emergence of C. 
difficile strains belonging to restriction endonuclease type BI, North American 
pulsed-field type 1 (NAP1) and PCR-ribotype 027 (BI/NAP1/027) has 
contributed to the problem of increased CDAD incidence (Pépin, et al., 2004; 
Kuijper, et al., 2007).  These so-FDOOHG µhypervirulent¶ W\pes of C. difficile 
were in the past isolated infrequently from patients suffering from CDAD, but 
have recently become highly represented among such clinical isolates.  Indeed, 
the BI/NAP1/027 type is now the most commonly isolated C. difficile type in 
England (Figure 1.6).  Across mainland Europe, cases of CDAD associated 
with the BI/NAP1/027 type have been reported in 16 countries (Kuijper, et al., 
2008)  In North America, these strains have largely been associated with the 
over-use of quinolone antibiotics and are responsible for an increase in the 
incidence of nosocomial CDAD, more severe disease, higher relapse rates, 
increased mortality, and greater resistance to fluoroquinolone antibiotics 
(Kuijper, et al., 2006).  Furthermore, the BI/NAP1/027 type has recently been 
linked with the emergence of community-associated CDAD, no longer limiting 
C. difficile to the healthcare environment (Rupnik, et al., 2009). 
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Figure 1.6. Distribution of C. difficile PCR ribotypes in England in 2007-8, 
adapted from Brazier et al. (2008).  The data represent the national distribution 
of PCR ribotypes identified from a study of 677 individual isolates.  The 
incidence of cases due to type 027 strains increased by 15.4% compared to a 
study in 2005, and the percentage of type 001 and type 106 cases fell by 17.3% 
and 6%, respectively (Brazier, et al., 2008). 
 
Unsurprisingly, there is a widespread interest in the field to understand why 
strains such as those of the BI/NAP1/027 type can cause a more severe disease 
than other types, and why incidence and relapse rates appear higher where the 
BI/NAP1/027 type is isolated.  Studies have shown that a number of 
BI/NAP1/027 strains produce higher levels of toxin in the laboratory, although 
the mechanisms for this increased toxin production remain unclear (Warny, et 
al., 2005).  In addition, it has been suggested that strains of the BI/NAP1/027 
type are more prolific in terms of sporulation than non-outbreak strains 
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(Wilcox and Fawley, 2000; Fawley, et al., 2007; Akerlund, et al., 2008), and 
one study has also suggested that BI/NAP1/027 strains may differ in their 
germination characteristics following antibiotic treatment in the patient 
(Saxton, et al., 2009).  However, to-date it is still not clear exactly what causes 
the increased disease incidence and severity associated with BI/NAP1/027 
strains of C. difficile. 
 
1.5.2 Other important C. difficile types 
Whilst BI/NAP1/027 strains of C. difficile have received the most attention, a 
number of other groups of highly virulent C. difficile strains must be 
considered.  Among only a handful of PCR-ribotypes isolated in the UK prior 
to 2003 (Dawson, et al., 2009), PCR-ribotype 106 strains are the most 
commonly isolated non-BI/NAP1/027 C. difficile type in England (Figure 1.6), 
although this type is extremely rarely isolated outside of the United Kingdom 
(Barbut, et al., 2007).  Furthermore, of particular interest are those strains 
belonging to PCR-ribotypes 017 and 078, which have been isolated in parts of 
Asia and Europe (Drudy, et al., 2007; Kim, et al., 2008) and have also been 
associated with severe disease.  In addition, and along with BI/NAP1/027 
strains, these types have also been identified in animals, suggesting a reservoir 
and indeed a possible role of C. difficile as a food-borne pathogen (Songer and 
Anderson, 2006; Gould and Limbago, 2010). 
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1.6 Development of genetic tools to study C. difficile 
The lack of in-depth studies into the genetic basis of C. difficile spore 
germination has been largely attributed to an absence of reliable genetic tools.  
Historically, targeted inactivation of C. difficile genes was limited to single-
crossover mutations through homologous recombination of a replication-
defective plasmid (O'Connor, et al., 2006).  Unfortunately, such integrants are 
unstable and more preferential double-crossover mutants, achieved through 
allelic exchange, had not been described in C. difficile prior to the beginning of 
this work.  However, the ClosTron, a facile directed mutagenesis system, has 
recently been developed (Heap, et al., 2007; Heap, et al., 2010) and allows for 
reverse genetics studies in C. difficile through the creation of stable, insertional 
mutants.   
 
The system is based on a novel way to insertionally inactivate genes using 
group II intron technology (Karberg, et al., 2001).  The mobile intron can be 
specifically targeted to a gene of interest by modification of intron RNA, and 
an intron-encoded protein (required for intron mobility) is provided in trans, 
which allows for its subsequent removal following integration and ensures 
integrant stability.  Nested within the group II intron is an antibiotic resistance 
gene, itself interrupted by a self-splicing group I intron.  This arrangement 
ensures that the antibiotic resistance gene will only be restored following 
integration of the group II intron and self-splicing of the group I intron.  
Therefore, antibiotic resistance is strictly a consequence of the integration 
event.  In terms of studying C. difficile germination, the clear application of the 
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ClosTron is the systematic identification and inactivation of genes encoding 
homologues of proteins important for germination in other spore formers, and 
thus presumed to be important for the germination of C. difficile spores. 
 
When studying the function of a particular gene mutation, complementation 
studies are vital to show that any observed mutant phenotype(s) is a specific 
consequence of target gene inactivation.  This is commonly achieved through 
introduction of an ectopic copy of the gene in question, but such 
complementation has only been briefly reported in C. difficile (O'Connor, et 
al., 2006; Carter, et al., 2007).  A modular system for Clostridium shuttle 
plasmids has now been described, allowing for simple construction and 
modification of plasmids based on a set of standardised components (Heap, et 
al., 2009).  Complementation of C. difficile mutants may, therefore, be easier 
to undertake in the future with such a system. 
 
1.7 This project 
1.7.1 Clinical importance of studying C. difficile spore germination 
C. difficile remains the major cause of hospital-acquired diarrhoea and cases of 
CDAD are now emerging in the community and in animals used for food 
(Songer and Anderson, 2006).  In addition, the emergence of hypervirulent 
types associated with a more severe disease, higher relapse rates, and increased 
mortality has compounded the need to understand this prominent pathogen.  
Vegetative cells of C. difficile cannot survive for extended periods of time in 
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the presence of oxygen.  In order to persist outside the anaerobic environment 
of the large bowel, C. difficile must be in its spore form.  The production of 
spores provides an effective means by which C. difficile can persist on surfaces 
in healthcare facilities.  The considerable resistance properties of these spores 
provide continuous challenges in the search for effective cleaning procedures, 
and the spore form is widely recognised as the principal route of disease 
transmission (Riggs, et al., 2007; Setlow, 2007; Gerding, et al., 2008).  
However, the major virulence factors of C. difficile, the toxins, are produced 
exclusively by vegetative cells.  Thus, in order to cause disease these spores 
must germinate and return to vegetative cell growth.  Therefore, knowledge of 
germination is important, with likely practical implications for routine 
cleaning, outbreak management and potentially in the design of new 
therapeutics. 
 
1.7.2 Aim of this project 
The aim of this project was to gain an understanding of the genetic basis of the 
mechanisms through which C. difficile spores germinate and return to 
vegetative cell growth.  Specifically, target genes in C. difficile were to be 
identified based on their homology to genes important for germination in other 
spore formers, inactivated using ClosTron technology, and the subsequent 
phenotypes analysed. 
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Chapter Two 
 
Materials and Methods 
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2.1 Materials 
Unless indicated otherwise, chemicals and biochemicals were supplied by 
Sigma-Aldrich, enzymes for molecular biology and their buffers were supplied 
by New England Biolabs (NEB) or Promega, and bacterial growth media were 
supplied by Oxoid. 
 
2.2 List of bacterial strains 
Strain Relevant properties Source/reference 
Escherichia coli 
TOP10 
F± mcr$ǻmrr-hsdRMS-mcr%&ĭlac=ǻ0
ǻlacX74 recA1 ara'ǻara leu) 
7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
E. coli CA434 Conjugation donor (Purdy, et al., 2002) 
C. difficile ǻerm PCR-ribotype 012 
Erythromycin sensitive strain of C. difficile 630 
(Hussain, et al., 2005) 
C. difficile R20291 BI/NAP1/027 (Stoke Mandeville, UK).  Isolated 
in 2004/5 
Anaerobe Reference 
Laboratory, Cardiff 
CRG789 C. difficile ǻerm spo0A::intron ermB (Heap, et al., 2007) 
CRG878 C. difficile 630ǻerm CD3563::intron ermB This work 
CRG879 C. difficile 630ǻerm CD0552::intron ermB This work 
CRG1115 C. difficile 630ǻerm sleC::intron ermB This work 
CRG1143 C. difficile R20291 CD0552::intron ermB This work 
CRG1166 C. difficile R20291 sleC::intron ermB This work 
CRG1375 C. difficile R20291 spo0A::intron ermB (Heap, et al., 2010) 
CRG1555 CRG1115 containing pMTL-DB1 (sleC 
complementation plasmid) 
This work 
CRG1556 CRG1115 containing pMTL84151 This work 
CRG1628 CRG1166 containing pMTL84151 This work 
CRG1634 CRG1166 containing pMTL-DB1 (sleC 
complementation plasmid) 
This work 
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CRG1651 C. difficile ǻerm containing pMTL84151 This work 
CRG1652 C. difficile R20291 containing pMTL84151 This work 
CRG1718 C. difficile 630ǻerm cspC::intron ermB This work 
CRG1719 C. difficile ǻerm cwlD::intron ermB This work 
CRG1720 C. difficile 630ǻerm CD0065::intron ermB This work 
CRG1894 C. difficile ǻerm cspBA::intron ermB This work 
CRG1948 C. difficile R20291 cwlD::intron ermB This work 
C. difficile CDC 32  Historical BI/NAP1/027 (USA) (Killgore, et al., 2008) 
C. difficile CDC 38 BI/NAP1/027 (USA) (Killgore, et al., 2008) 
C. difficile M13042 BI/NAP1/027 (Canada) (Killgore, et al., 2008) 
C. difficile DH326 BI/NAP1/027 (Sheffield, Yorkshire and 
Humberside, UK).  Isolated in 2005 
Anaerobe Reference 
Laboratory, Cardiff 
C. difficile DH1329 BI/NAP1/027 (Coventry, West Midlands, UK).  
Isolated in 2007/8 
Anaerobe Reference 
Laboratory, Cardiff 
C. difficile R12087 Historical BI/NAP1/027 (European Union) Michel Popoff, Institut 
Pasteur, Paris 
C. difficile GAI 
95601 
PCR-ribotype 017 (Japan) (van den Berg, et al., 
2007) 
C. difficile 001-3 PCR-ribotype 001 ECDC ± Cardiff 
collection 
C. difficile 
Serosubtype A2 
PCR-ribotype 002 ECDC ± Cardiff 
collection 
C. difficile Wilcox 
078 
PCR-ribotype 078 Mark Wilcox 
C. difficile R10459 PCR-ribotype 106 ECDC ± Cardiff 
collection 
C. difficile VPI 10463 PCR-ribotype 003, toxinotype 0 reference strain (Sullivan, et al., 1982) 
Table 2.1. Bacterial strains used in this study. 
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2.3 List of plasmids 
Strain Relevant properties Source/reference 
pMTL007C-E2 ClosTron plasmid containing catP and intron 
containing ermB RAM 
(Heap, et al., 2010) 
pMTL007C-E2::Cdi-
CD3563-226s 
pMTL007C-E2 retargeted to Cdi-CD3563-226s This work 
pMTL007C-E2::Cdi-
CD0552-75a 
pMTL007C-E2 retargeted to Cdi-CD0552-75a This work 
pMTL007C-E2::Cdi-
sleC-493s 
pMTL007C-E2 retargeted to Cdi-sleC-493s This work 
pMTL007C-E2::Cdi-
sleC-128a 
pMTL007C-E2 retargeted to Cdi-sleC-128a This work 
pMTL007C-E2::Cdi-
cspC-737a 
pMTL007C-E2 retargeted to Cdi-cspC-737a This work 
pMTL007C-E2::Cdi-
cwlD-198s 
pMTL007C-E2 retargeted to Cdi-cwlD-198s This work 
pMTL007C-E2::Cdi-
CD0065-440a 
pMTL007C-E2 retargeted to Cdi-CD0065-440a This work 
pMTL007C-E2::Cdi-
cspBA-825s 
pMTL007C-E2 retargeted to Cdi-cspBA-825s This work 
pMTL007C-E2::Cdi-
cspBA-1844a 
pMTL007C-E2 retargeted to Cdi-cspBA-1844a This work 
pMTL84151 Clostridium modular plasmid containing catP (Heap, et al., 2009) 
pMTL-DB1 pMTL84151 containing 1,272 bp SleC coding 
region and 244 bp upstream promoter region 
This work 
pMTL-DB2 pMTL84151 containing 1674 bp CspC coding 
region and a presumed 305 bp upstream 
promoter region. 
This work 
Table 2.2. List of plasmids used in this study. 
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2.4 Bioinformatics methods 
2.4.1 Sequence data analysis 
Sequence data were routinely handled using GENtle, VectorNTI and DNA 
Baser. 
 
2.4.2 BLAST 
Searches of translated nucleotide databases using the Basic Local Alignment 
Search Tool (BLAST) were routinely carried out using the tBLASTn algorithm 
available at http://www.ncbi.nlm.nih.gov. 
 
2.4.3 Plasmid map design and production 
Vector maps were designed using Vector NTI or GENtle, produced using 
Savvy, and edited using Inkscape. 
 
2.4.4 Sequence alignments during cloning studies 
GENtle or Vector NTI was used for the alignment of two sequences.  For 
alignments of more than two sequences, DNA Baser and/or Vector NTI were 
used. 
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2.4.5 Oligonucleotide design 
Oligonucleotides for PCR primers were designed manually using GENtle or 
DNA Baser, and analysed for predicted hairpin formation, self dimerisation 
and melting temperatures with Oligo Calc software available at 
http://www.basic.northwestern.edu. 
 
2.4.6 Data analysis 
All data and statistical analysis were carried out in GraphPad Prism, using 
6WXGHQW¶V W-test for individual comparisons, and one-way analysis of variance 
ZLWK7XNH\¶Vpost hoc compensation for multiple comparisons. 
 
2.5 Microbiological materials and methods 
2.5.1 Aerobic bacterial strains and growth conditions 
All Escherichia coli were cultured using Luria-Bertani (LB) broth or agar as 
appropriate at 37 °C, with 200 rpm shaking for liquid cultures.  Media was 
supplemented as appropriate with chloramphenicol (25 µg/ml in agar or 12.5 
µg/ml in broth), 5-bromo-4-chloro-3-indolyl-ȕ-galactopyranoside (Xgal, 40 
µg/ml) and kanamycin (50 µg/ml in agar or 25 µg/ml in broth).  E. coli TOP10 
was used throughout as a cloning host and E. coli CA434 was used as a donor 
strain for transfer of plasmid DNA into C. difficile by conjugation. 
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2.5.2 Anaerobic bacterial strains and growth conditions 
Unless indicated otherwise, all C. difficile strains were cultured at 37°C in an 
anaerobic workstation (Don Whitley, United Kingdom) in BHIS (brain heart 
infusion supplemented with L-cysteine [0.1%; Sigma, United Kingdom] and 
yeast extract [5 mg/ml; Oxoid]) broth or agar; a medium that has been shown 
to aid C. difficile spore formation (Sorg and Sonenshein, 2008).  The medium 
was supplemented as appropriate with F\FORVHULQH  ȝJPO FHIR[LWLQ 
ȝJPOWKLDPSKHQLFROȝJPOLQDJDURUȝJPOLQEURWKHU\WKURP\FLQ
ȝJPORUȝJPORUOLQFRP\FLQȝJPO$OOOLTXLGPHGLDZHUHSUH-
reduced with overnight incubation in the anaerobic chamber, and all solid 
growth media were pre-reduced for at least 4 h prior to inoculation. 
 
2.5.3 Preparation of electro-competent E. coli cells 
A 500 ml conical flask, containing 200 ml of LB broth (pre-warmed to 37 °C), 
supplemented with antibiotics as required, was inoculated 1/100 with fresh 
overnight culture.  E. coli cells were cultured at 37 °C with 200 rpm shaking 
until an optical density at 600 nm (OD600) of between 0.5 and 1 was reached, 
indicative of the exponential growth phase.  Cells were harvested by pooling 
into separate 50 ml falcon tubes, cooling on ice for 30 min, and then 
centrifugation for 15 min at 4000 ×g.  Pellets were then gently re-suspended in 
40 ml of ice-cold, sterile dH2O before centrifugation as described above.  
Following centrifugation, the pellets were re-VXVSHQGHG LQ  ȝO RI VWHULOH
10% glycerol, pooled, and stored at -&LQȝODOLTXRWV 
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2.5.4 Transformation of electro-competent E. coli by electroporation 
$ȝO DOLTXRWRI HOHFWUR-competent E. coli cells was thawed on ice.  DNA 
was then added and gently mixed with a pipette tip.  The mixture was then 
gently pipetted into a cold 0.2 cm gap electroporation cuvette and a pulse 
DSSOLHGDFURVVWKHFXYHWWHXVLQJDQHOHFWURSRUDWRUZLWKN9YROWDJHȝ)
FDSDFLWDQFH DQG  ȍ UHVLVtance.  A  ȝO supplement of Invitrogen SOC 
medium was then immediately added to the mixture and the entire contents of 
the electroporation cuvette were then transferred to an eppendorf tube and 
incubated at 37 °C, at 200 rpm, for 1 h.  This incubation step is necessary to 
allow expression of antibiotic resistance genes.  The mixture was then plated 
onto LB agar at suitable dilutions, supplemented with appropriate antibiotics. 
 
2.5.5 Transfer of plasmid DNA into C. difficile by conjugation 
Conjugative transfer of plasmid DNA into C. difficile was carried out as 
described by Purdy and co-workers (Purdy, et al., 2002).  Briefly, both donor 
and recipient cells were grown to stationary phase in overnight cultures and 
washed with phosphate-buffered saline (PBS) as necessary to remove traces of 
antibiotics.  A pellet of donor cells was prepared by centrifugation for 2 min at 
4000 ×g, before being moved to the anaerobic chamber and re-suspended in a 
suspension of recipient cells, yielding a suspension containing an approximate 
5:1 ratio of donor to recipient cells.  The donor-recipient suspension was then 
inoculated onto BHIS agar in discrete spots and incubated anaerobically at 37 
°C.  For conjugation into C. difficile ǻerm (Hussain, et al., 2005), 
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suspensions were incubated for 4-8 h, and for conjugation into C. difficile 
R20291, suspensions were incubated for a minimum of 10 h as the efficiency 
of conjugation into R20291 appears lower than the efficiency of conjugation 
LQWR ǻerm.  Cells were then re-VXVSHQGHG LQ  ȝO RI 3%6 E\ JHQWO\
VFUDSLQJ DQG WKHQ SODWHG RQWR PHGLD FRQWDLQLQJ F\FORVHULQH  ȝJPO
FHIR[LWLQ  ȝJPO WKLDPSKHQLFRO  ȝJPO DQG OLQFRP\FLQ  ȝJPO DV
appropriate to counter select against growth of E. coli donor strains and to 
positively select for C. difficile transformants.  Plates were incubated 
anaerobically at 37 °C for 24-72 h before colonies were picked and purified by 
subculture for further analysis. 
 
2.5.6 Preparation of C. difficile spores using a Trypticase Peptone broth 
C. difficile was cultivated in a sporulation medium which contained 90 g of 
Trypticase Peptone (BBL Microbiology Systems), 5 g of Proteose Peptone no. 
3 (Difco), 1 g of (NH4)2SO4 and 1.5 g of TrisHCl in 1 litre of dH2O, adjusted 
to pH 7.4 with hydrochloric acid, and pre-reduced for at least 24 h prior to 
inoculation.  Briefly, a loop-full of C. difficile cells was used to inoculate the 
sporulation medium, and the mixture was incubated anaerobically, at 37 °C, 
IRU  GD\V  7R PHDVXUH VSRUH GHYHORSPHQW  ȝO VDPSOHV ZHUH UHPRYHG
from the anaerobic chamber and either heat treated at 80 °C for 10 min, or 
incubated in EtOH (100%), Chloroform (10% in dH2O), NaOH (0.25M) or 
PBS for 10 min.  Following this incubation, samples were washed twice in 
PBS and then returned to the anaerobic chamber, serially diluted in PBS and 
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plated onto BHI agar.  The plates were incubated for 24 h before colony 
forming units (CFU) were enumerated. 
 
2.5.7 Preparation of C. difficile spores on solid media 
Sporulation of C. difficile on solid media was achieved by incubating cultures 
on BHI agar for 10-14 days.  Briefly, C. difficile was cultivated in BHI broth 
and an overnight culture spread onto BHI agar.  Plates were incubated 
anaerobically, at 37 °C, for 10-14 days, or until significant spore titres were 
observed under phase-contrast microscopy.  Following incubation, a 
spore/vegetative cell mixture was re-suspended in PBS and removed from the 
anaerobic chamber.  This mixture was separated into two identical samples 
which were incubated in either ethanol (EtOH, 100%) or PBS, for 10 min.  
Samples were then washed twice in PBS and then returned to the anaerobic 
chamber, serially diluted in PBS and plated onto BHI agar supplemented with 
0.1% taurocholate (Sigma, United Kingdom).  Plates were incubated for 24 h 
before CFU were enumerated. 
 
2.5.8 Preparation of C. difficile spores in a nutrient-rich liquid medium 
Sporulation of C. difficile in a nutrient-rich liquid medium was achieved by 
incubating cultures anaerobically in BHIS broth for five days at 37 °C.  To 
ensure that no spores were present when the sporulation medium was 
inoculated, a starter culture was prepared in BHIS broth using a 1/100 
inoculum of a C. difficile culture and incubated until an OD600 of between 0.2 
36 
 
and 0.5 was reached.  The sporulation medium was then inoculated 1/100 with 
this exponential starter culture. 
 
2.5.9 Purification of C. difficile spores 
Sporulation cultures were set up as described in 2.5.8.  To prepare pure C. 
difficile spores following five days of incubation, cultures were repeatedly 
washed with ice-cold distilled H2O (dH2O) until they contained no cell debris 
or vegetative cells as observed by phase-contrast microscopy.  Spores were 
stored at -20 °C in dH2O. 
  
2.5.10 Measurement of C. difficile growth in BHIS broth 
To measure the growth rates of C. difficile, sporulation cultures were set up as 
described in 2.5.8.  At different time points, 1 ml samples were removed from 
the sporulation medium and the OD600 was measured (Biomate 3, Thermo 
Scientific). 
 
2.5.11 Measurement of C. difficile colony formation after heat treatment 
Sporulating cultures of C. difficile were prepared as described in 2.5.8.  At 
GLIIHUHQWWLPHVȝOVDPSOHVZHUHUHPRYHGIURPWKHDQDHURELFFKDPEHUDQG
heated at 60 °C for 25 min to kill the vegetative cells but not the spores.  To 
control for any effects of oxygen exposure during heat treatment, a non-heated 
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sample was also removed from the anaerobic chamber for 25 min.  Samples 
were then returned to the anaerobic chamber, serially diluted in PBS, and 
plated onto BHIS agar supplemented with 0.1% taurocholate (Sigma, United 
Kingdom).  C. difficile spo0A mutants RIERWKǻerm and R20291 were used 
as sporulation-negative controls (Heap, et al., 2007; Heap, et al., 2010).  Plates 
were incubated for 24 h before CFU were enumerated.  Samples were analysed 
in the same way every 24 h for five days. 
 
2.5.12 Counting C. difficile spores by phase-contrast microscopy 
Sporulation cultures were set up as described in 2.5.8.  Following incubation in 
BHIS broth for five days, spores were enumerated by phase-contrast 
microscopy using a Bright-Line haemocytometer (Sigma, United Kingdom).  
To load the haemocytometer, a drop of water was placed on each corner of the 
FRYHUVOLS7KHFRYHUVOLSZDVWKHQSODFHGLQWKHDSSURSULDWHSRVLWLRQDQGȝO
of C. difficile spore culture was loaded onto the haemocytometer.  C. difficile 
spores were then visualised by phase-contrast microscopy.  Spores were 
FRXQWHG LQ   ȝP KDHPRF\WRPHWHU VTXDUHV DYHUDJHG DQG H[SUHVVHG DV
spores/ml using the appropriate dilution factors. 
 
2.5.13 Decoating C. difficile spores 
Sporulation cultures were set up, and spores were purified as described above.  
Purified spores were decoated as described by Popham and co-workers.  
Briefly, a spore pellet was re-suspended in 1 ml of 50 mM Tris-HCl (pH 8.0)-8 
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M urea-1% (wt/vol) sodium dodecyl-sulphate-50 mM dithiothreitol and 
incubated at 37 °C for 90 min (Popham, et al., 1995).  Following this 
incubation, decoated spores were washed three times in PBS.  Samples were 
then heat treated as described above and plated onto BHIS medium 
supplemented with 1 ȝJPOO\VR]\PH 
  
2.6 Molecular biological materials and methods  
2.6.1 Extraction and purification of C. difficile chromosomal DNA 
Chromosomal DNA was extracted and purified from C. difficile cultures using 
previously published methods (Fenicia, et al., 2007).  Briefly, a C. difficile 
pellet was re-VXVSHQGHGLQȝORIFKHOH[6LJPD8QLWHG.LQJGRP
This suspension was vortexed and then incubated at 100 °C for 10 min, before 
centrifugation at 10,000 ×g for 10 min.  The supernatant (containing purified 
chromosomal DNA) was removed and stored at -20 °C.  
 
2.6.2 Extraction and purification of plasmid DNA 
Plasmid DNA was extracted from all organisms using the Qiagen QIAprep 
6SLQ0LQLSUHSNLWLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV 
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2.6.3 Spectrophotometric quantification of DNA 
The concentration of DNA from preparations was measured using a nanodrop 
ND-1000 spectrophotometer.  The OD260 of the preparation was measured and 
DNA concentration calculated, given that with a 1 cm path, a 50 µg/ml 
solution of double-stranded DNA has an OD260 of 1. 
 
2.6.4 Amplification of DNA by PCR 
For cloning, DNA was amplified using either the Epicentre Failsafe PCR 
system and Failsafe Premix E, or NEB Phusion polymerase in accordance with 
WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV  )RU VFUeening PCR, Promega Taq DNA 
SRO\PHUDVHZDVXVHGLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV 
 
2.6.5 Amplification and splicing of DNA using SOEing PCR 
Complete or partial genetic elements were spliced together without the use of 
restriction endonucleases by splicing by overlap extension (SOEing) PCR with 
appropriate primers (Horton, et al., 1989; Horton, et al., 1990). 
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Oligonucleotide 6HTXHQFHƍ-ƍ 
Intron retargeting  
Cdi-CD3563-226s-
IBS 
AAAAAAGCTTATAATTATCCTTAATGAGCGACAGGGTGCGCCC
AGATAGGGTG 
Cdi-CD3563-226s-
EBS1d 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCGACAGGTTT
AACTTACCTTTCTTTGT 
Cdi-CD3563-226s-
EBS2 
TGAACGCAAGTTTCTAATTTCGGTTCTCATCCGATAGAGGAAA
GTGTCT 
Cdi-CD0552-75a-
IBS 
AAAAAAGCTTATAATTATCCTTATTCTCCACAATAGTGCGCCCA
GATAGGGTG 
Cdi-CD0552-75a-
EBS1d 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCACAATATCT
AACTTACCTTTCTTTGT 
Cdi-CD0552-75a-
EBS2 
TGAACGCAAGTTTCTAATTTCGGTTGAGAATCGATAGAGGAAA
GTGTCT 
Cdi-sleC-493s-IBS AAAAAAGCTTATAATTATCCTTAGTAGTCCCTGAAGTGCGCCC
AGATAGGGTG 
Cdi-sleC-493s-
EBS1d 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCCTGAATTT
AACTTACCTTTCTTTGT 
Cdi-sleC-493s-
EBS2 
TGAACGCAAGTTTCTAATTTCGATTACTACTCGATAGAGGAAA
GTGTCT 
Cdi-sleC-128a-IBS AAAAAAGCTTATAATTATCCTTACATTACTTCTTAGTGCGCCCA
GATAGGGTG 
Cdi-sleC-128a-
EBS1d 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCTTCTTAGGT
AACTTACCTTTCTTTGT 
Cdi-sleC-128a-
EBS2 
TGAACGCAAGTTTCTAATTTCGGTTTAATGTCGATAGAGGAAA
GTGTCT 
EBS Universal CGAAATTAGAAACTTGCGTTCAGTAAAC 
ClosTron 
sequencing 
 
Spofdx_F1 GATGTAGATAGGATAATAGAATCCATAGAAAATATAGG 
pMTL007_R1 AGGGTATCCCCAGTTAGTGTTAAGTCTTGG 
Mutant screening 
 
CD3563_F1 CTTTTAGAACTGTTAATCCACCTAATCCCG 
CD3563_R1 CTTTACATTTTTGTGTTTAACAACAACTTATTTATCGC 
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CD0552_F1 ATGAATTTAGTTCCCTTATATTTCAAGATATGAATATAGC 
CD0552-R1 CTTGTGTGTCATTTATTATACTTTAATTATTTATGTCTTTCC  
sleC_F1 GGGAACTAAATTCATTTAAAGAAAGGGTG 
sleCB5ǻerm) GGCTGTTATGAACTAATATATACCATAAGTATTAC 
sleC_R1 (R20291) GTATTTTTACTTATAAGTATTGTAGTCTTAACAGCC 
cspC_F1 CAAGGTGATATAGAATCTGCCCTACAAG 
cspC_R1 CCCATATCCCTGCGATACATTTGGAT 
cspBA_F1 CATGGGACACATGTTGCAGGTATTTGT 
cspBA_R1 CTATATCCCATATCCTCTGTTTCTAAGTCTTG 
cspBA_F2 GATTCGGGAATAGATTATACTCTACCTG 
cspBA_R2 GTGAGAGAATACGGTGCTATAGGG 
cspBA_F3 GCAAGTGATGCCAGAATAATAGTGGTTA 
cspBA_R3 CCTACTGTTATAACTCTACTTGCTGTTC 
cspBA_F4 CTACTCAAGAGCTTACTGTAACAGTTCCT 
cspBA_R4 GCGATAGCTCGATTTATATCTTCTCGTG 
cwlD_F1 
ǻerm) 
GTTAGATAAACATAGCGAATTAAATAGGGGCAG 
cwlD_F1 (R20291) GTTAGATAAACATAGTGAATTAAATAGGGGCAG 
cwlD_R1 CCTATGTAGATTGCCCATGCTATTTTTTCTTG 
CD0065_F1 GCAACAAAAGGTATTGGATTAGCATCAGC 
CD0065_R1 GCTATATCATCTGGTTCCCCTATACG 
RAM_R1 ACGCGTGCGACTCATAGAATTATTTCCTCCCG 
R20291 specific primers  
CDR20291_F1 GCTATTATTATGCCAGGATACTTTTATACACC 
CDR20291_R1 GACTCACTAATTTCTATTCCATATATTGATGC 
Table 2.3. List of oligonucleotides used in this study.  Oligonucleotides were 
used as described in the text. 
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2.6.6 Restriction endonuclease digestion of DNA 
DNA was cleaved at specific points using appropriate NEB restriction 
HQGRQXFOHDVHVLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV 
 
2.6.7 De-phosphorylation of DNA 
7RUHPRYHƍSKRVSKDWHJURXSV IURP OLQHDULVHGSODVPLG'1$IUDJPHQWVDQG
prevent self-ligation, NEB Antarctic Phosphatase was used in accordance with 
PDQXIDFWXUHU¶VLQVWUXFWLRQV 
 
2.6.8 Agarose gel electrophoresis 
PCR products, restriction fragments and plasmid DNA were separated by 
electrophoresis at 90 V for 20 ± 60 min through 1% agarose gels in TAE 
FRQWDLQLQJ  ȝJPO HWKLGLXP EURPLGH  '1$ ZDV VXEVHTXHQWO\ YLVXDOLVHG
under ultra-violet light. 
 
2.6.9 Extraction of DNA from agarose gels and reaction mixtures 
Agarose gel pieces containing DNA were excised under ultra-violet light, and 
DNA was extracted using the Qiagen QIAquick Gel Extraction Kit in 
DFFRUGDQFH ZLWK WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV  '1$ ZDV H[WUDFWHG IURP
reaction mixtures using the Qiagen QIAquick PCR Purification Kit in 
DFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXctions. 
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2.6.10 Ligation of DNA 
Digested plasmid DNA fragments were ligated to small DNA insert fragments 
with compatible ends using NEB T4 DNA ligase, in accordance with the 
PDQXIDFWXUHU¶VLQVWUXFWLRQV 
 
2.6.11 Nitrocellulose membrane dialysis of DNA during ligations 
Following ligation reactions, the products were dialysed through a Millipore 
 ȝP QLWURFHOOXORVH PHPEUDQH RYHU G+2O for 30 min.  The reaction 
mixture was then transformed into E. coli as required. 
 
2.6.12 Nucleotide sequencing 
DNA sequencing was performed by Geneservice Ltd, Cambridge and 
Geneservice Ltd, Nottingham. 
 
'LVWLQJXLVKLQJEHWZHHQ&GLIILFLOHǻHUPDQG&GLIILFLOH5 
During construction of mutant strains, it was occasionally necessary to confirm 
the presence of C. difficile ǻerm and C. difficile R20291 DNA.  
Accordingly, genomic DNA was extracted from putative mutant strains and 
amplified by PCR using the primer pair CDR20291_F1/CDR20291_R1. This 
primer pair amplifies CDR20291_0242, which encodes a flagella glycosyl 
44 
 
transferase not found in C. difficile ǻerm (Logan, 2006; Sebaihia, et al., 
2006; Stabler, et al., 2009) When analysed by agarose gel electrophoresis, the 
presence of R20291 DNA is indicated by a single 294 bp band. 
 
2.7 Strain construction 
Target genes were insertionally inactivated using the ClosTron system as 
previously described (Heap, et al., 2007), using the modular ClosTron plasmid 
pMTL007C-E2, described in Figure 2.1 (Heap, et al., 2010). 
 
 
Figure 2.1. The second generation, modular ClosTron plasmid pMTL007C-E2 
(Cartman, et al., 2010; Heap, et al., 2010).  This plasmid uses the strong fdx 
promoter to drive expression of the ClosTron (Heap, et al., 2007).  Intron re-
targeting using the HindIII and BsrGI restriction sites replaces a lacZƍ VWXIIHU
IUDJPHQW ZLWK WKH ƍ exon and the region of the intron conferring target 
specificity, and allows for the re-targeted pMTL007C-E2 to be analysed by 
blue/white screening, PCR or restriction analysis. 
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Figure 2.1A. ClosTron insertion using pMTL007C-E2, adapted from Cartman 
et al., 2010.  (A) pMTL007C-E2 is transferred into C. difficile by conjugation.  
(B) As the group I intron is transcribed in the incorrect orientation to splice 
out, expression from the C. acetobutylicum thiolase promoter does not confer 
erythromycin resistance.  (C) Expression of the group II intron yields a 
ribonuclear protein complex (RNP) upon binding of LtrA to the intron 
transcript.  This results in the group I intron being transcribed in the correct 
orientation, allowing it to splice out.  (D) The RNP locates the target DNA, the 
group II intron RNA is inserted, and LtrA reverse transcribes the cDNA strand.  
As the group I intron has spliced out, erythromycin resistance is conferred in 
successful integrants.  The pMTL007C-E2 plasmid is then lost due to its 
instability.  
 
2.7.1 Construction of re-targeted pMTL007C-E2 
Target sites were identified and intron re-targeting PCR primers designed 
using a computer algorithm (Perutka, et al., 2004), available free-of-charge at 
http://www.clostron.com.  The 353 bp PCR products containing modified IBS, 
EBS1d and EBS2 sequences, responsible for target specificity of the intron, 
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were amplified and assembled using SOEing PCR.  This 353 bp fragment was 
cloned as a HindIII/BsrGI fragment into pMTL007C-E2, and the re-targeted 
intron verified by sequencing, using oligonucleotide primer pairs 
Spofdx_F1/pMTL007_R1.  Re-targeted introns were named in accordance 
with the previously published ClosTron nomenclature (Karberg, et al., 2001; 
Perutka, et al., 2004; Heap, et al., 2007).  For example, the intron on plasmid 
pMTL007C-E2::cdi-sleC-128a has been retargeted to insert in the antisense 
orientation after base 128 of the sleC open reading frame (ORF) of C. difficile.  
Re-targeted pMTL007C-E2 vectors were initially analysed by blue/white 
screening, restriction analysis with SacI or BglII and/or PCR using primer pair 
spofdx_F1/pMTL007_R1.  Vectors were then confirmed by sequencing.             
 
2.7.2 Synthesis of re-targeted pMTL007C-E2 
The advance of commercial DNA synthesis technology during this study 
allowed for the construction of re-targeted pMTL007C-E2 plasmids to be 
outsourced (DNA2.0, USA; Heap, et al., 2010).  Target sites and PCR primers 
were designed as described above, and the supplier synthesised and cloned the 
subsequent 353 bp fragment into pMTL007C-E2.  The re-targeted vector was 
delivered, sequence-verified, ready for transfer into C. difficile. 
 
2.7.3 Isolation and confirmation of C. difficile ClosTron mutants 
Re-targeted pMTL007C-E2 plasmids were transferred into C. difficile by 
conjugation as described above.  Transconjugants were selected on media 
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suppOHPHQWHG ZLWK F\FORVHULQH  ȝJPO FHIR[LWLQ  ȝJPO DQG
WKLDPSKHQLFROȝJPODQGWKHQVHULDOO\VXE-cultured to obtain pure clones.  
A loop-full of transconjugant cells was re-VXVSHQGHG LQ ȝO3%6 VHULDOO\
diluted as appropriate, and plated onto media supplemented with cycloserine 
 ȝJPO FHIR[LWLQ  ȝJPO DQG HLWKHU HU\WKURP\FLQ  ȝJPO C. 
difficile ǻermRUOLQFRP\FLQȝJPOC. difficile R20291), to select for 
integration of the ClosTron.  Genomic DNA was extracted from erythromycin-
UHVLVWDQW ǻerm) or lincomycin-resistant (R20291) clones at random and 
used in a PCR to amplify the intron-exon junction.  One clone of each desired 
mutant was selected, and the intron site was verified by sequencing using the 
primers pairs EBS Universal, RAM_R1 and screening primers R1 and F1. 
 
2.7.4 Complementation of a C. difficile sleC mutant with parental SleC 
For complementation studies of sleC mutant strains of C. difficile ǻerm 
and C. difficile R20291, a 1,516 bp fragment encompassing the sleC structural 
JHQH DQG ƍ QRQ-coding region was cloned into the modular plasmid 
pMTL84151 (Heap, et al., 2009) to generate plasmid pMTLDB1 (Figure 2.2).  
7KHESƍQRQ-coding region likely encompassing the sleC promoter and 
the 1,272 bp region containing the sleC structural gene were independently 
amplified by PCR using oligonucleotide primer pairs pSleC_F1/pSleC_R1 and 
SleC_F2/SleC_R2, respectively.  The primers were designed to allow 
subsequent cleavage of the two fragments generated with NotI/NdeI and 
NdeI/XhoI, respectively, where the ATG of the NdeI site was synonymous 
with the translational start codon of sleC.  The two cleaved fragments were 
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subsequently ligated with plasmid pMTL84151 cut with NotI and XhoI, which 
yielded plasmid pMTL-DB1, in which the two fragments were inserted 
contiguously.  The strategy of separating the two regions into two independent 
fragments was adopted to allow the plasmid to be easily modified for 
VXEVHTXHQWXVHRIDKHWHURORJRXVSURPRWHULIWKHSUHVHQFHRIWKHƍQRQ-coding 
region did not result in expression of sleC.  As the protein encoded by sleC is 
the same in C. difficile ǻerm and R20291, only one plasmid (pMTL-DB1) 
was constructed for use with both sleC mutants.  Both the pMTL-DB1 
complementation plasmid and a pMTL84151 empty vector control were then 
transferred into C. difficile by conjugation, using additional lincomycin (20 
ȝJPOVHOHFWLRQLQsleC mutant strains. 
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Figure 2.2. Vector map of plasmid pMTL-DB1.  This vector conforms to the 
pMTL80000 modular system for Clostridium shuttle plasmids, based upon the 
pMTL84151 vector (Heap, et al., 2009).  The plasmid backbone consisted of 
the pCD6 Gram-positive replicon (repA and ORFB), the origin of replication 
gene oriV, catP conferring thiamphenicol resistance, the Gram-negative 
replicon ColE1, and the conjugal transfer function traJ.  A 1,516 bp fragment 
encompassing the sleC VWUXFWXUDOJHQHDQGƍQRQ-coding region presumed to 
contain the sleC promoter was cloned into the plasmid as described in the text.  
The transcriptional tHUPLQDWRUV ȍ DUH LGHQWLFDO LQ VHTXHQFH WR WKRVH IRXQG
immediately downstream of the fdx gene of Clostridium pasteurianum and the 
CD0164 ORF of C. difficile 630. 
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2.7.5 Complementation of a C. difficile cspC mutant with parental CspC  
For complementation studies of a cspC mutant strain of C. difficile ǻerm, a 
1,976 bp fragment encompassing the cspC VWUXFWXUDOJHQHDQGDƍQRQ-coding 
upstream region was cloned into plasmid pMTL84151 to generate plasmid 
pMTL-DB2 (Figure 2.3).  The 302 bp non-coding region, located immediately 
upstream of cspBA, and the 1,674 bp region containing the cspC structural 
gene were spliced and amplified as a single fragment using SOEing PCR and 
primer pairs PcspC_F2/PcspC_R3 and cspC_F4/cspC_R2, respectively.  The 
subsequent fragment was cleaved with NotI/XhoI and then ligated into plasmid 
pMTL84151 cut with NotI/XhoI, which yielded plasmid pMTL-DB2.  Both 
the pMTL-DB2 plasmid and a pMTL84151 empty vector control were 
transferred into C. difficile by conjugation, using additional lincomycin (20 
ȝJPOVHOHFWLRQLQ&ORV7URQPXWDQWVWUDLQV 
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Figure 2.3. Vector map of plasmid pMTL-DB2.  Similarly to pMTL-DB1, the 
plasmid backbone is based on the modular pMTL84151 plasmid (Heap, et al., 
2009).  A 1,976 bp fragment encompassing the cspC structurDO JHQH DQG ƍ
non-coding region presumed to contain the cspBA/cspC promoter was 
amplified by SOE PCR and cloned into the plasmid as described in the text. 
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Oligonucleotide 
                                              SequencHƍ-3ƍ) 
pSleC_F1 TAAAGAATGCGGCCGCAGATTATTTTCCTTTCAAAATTTTTGATT
TATTTATGATTTATATCATCTAC 
pSleC_R1 TAAAGAATCATATGATCACCCTTTCTTTAAATGAATTTAGTTCCC 
SleC_F2 TAAAGAATCATATGCAAGATGGTTTCTTAACAGTAAGCATAATT
GATGC 
SleC_R2 TAAAGAATCTCGAGATCTCCATGGTTAAATTAAAGGATTTAAAG
AAGCTATTCTAGTTGTAGC 
pCspC_F2 TAAAGAATGCGGCCGCCCAGAACTTAGAGATGGATGGGATTCAA
TTA 
pCspC_R2 TAAAGAATCATATGGACTTCTAAAATTATTATTAATGTATATGTT
TTGTGTGA 
pCspC_R3 ATACAATAAGATTTTTCCATCTCGACTTCTAAAATTATTATTAAT
GTATATGTTTTG 
CspC_F2 TAAAGAATCATATGGAAAAATCTTATTGTATAATTTATCAAGGT
GATAT 
CspC_F4 TAATAATTTTAGAAGTCGAGATGGAAAAATCTTATTGTATAATTT
ATCAAGGTG 
CspC_R2 TAAAGAATCTCGAGATCTCCATGGCTATAGAGTATTTGCTATCTG
TTGAATCGTAT 
Table 2.5. Oligonucleotides used for complementation studies.  
Oligonucleotides were used as described in the text. 
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Chapter Three 
 
Development of assays to accurately measure the sporulation and 
germination characteristics of C. difficile mutants 
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3.1 Introduction 
Progress in the genetic manipulation of many clostridia, and particularly C. 
difficile, has been severely delayed by a historic lack of methods for the 
directed mutagenesis of targeted genes.  However, the recent development of 
the ClosTron system has now opened the way for studying C. difficile using a 
reverse genetics approach (Heap, et al., 2007; Heap, et al., 2010).  
Consequently, it is now important to have appropriate methods at hand for 
studying processes such as germination in the mutant strains we are now able 
to generate. 
 
3.1.1 Methods for studying germination in other spore formers 
Current knowledge of sporulation and germination has been principally 
derived from studying spores of the model organism, B. subtilis.  Therefore, 
reproducible methods for preparing B. subtilis spores, measuring sporulation 
rates, and assessing germination properties have been in place for a number of 
years.  When B. subtilis spore germination is initiated, subsequent events 
include the release of monovalent cations (H+, Na+ and K+) and the large spore 
depot of dipicolinic acid (DPA) (Setlow, 2003).  These events can be measured 
experimentally by observing the drop in optical density of spore samples, and 
by quantifying the release of DPA from spores during germination.  
Unfortunately, there have been very few published examples of using optical 
density measurements to quantitatively measure C. difficile germination (Sorg 
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and Sonenshein, 2008; Sorg and Sonenshein, 2009) and to-date, measurements 
of DPA release from C. difficile spores are not present in the literature.  
 
3.1.2 Previous knowledge of sporulation and germination in C. difficile 
Perhaps a consequence of the poor availability of tools to manipulate C. 
difficile genetically, studies of the sporulation and germination mechanisms of 
C. difficile have been infrequent.  To effectively study sporulation and 
germination, one must understand (i) the conditions under which the organism 
forms spores efficiently; and (ii) the chemicals or compounds which can 
stimulate spore germination.  In organisms such as B. subtilis, the mechanisms 
of sporulation are well understood, and growth medium which starves the 
organism of nutrients has been shown to efficiently induce sporulation 
(Schaeffer, et al., 1965).  However, the sporulation mechanisms of C. difficile 
are yet to be fully elucidated, and the precise conditions for optimal C. difficile 
sporulation are not known.  Germination has also been well studied in B. 
subtilis, and the chemicals and compounds known to stimulate the germination 
of B. subtilis spores include nutrients such as amino acids and sugars, and non-
nutrients such as exogenous CaDPA, lysozyme, salts and peptidoglycan 
(Paidhungat and Setlow, 2000; Setlow, 2003; Setlow, 2008; Shah, et al., 2008).  
On the other hand, prior to the beginning of this study, only the bile salt 
taurocholate had been strongly linked to stimulating the germination of C. 
difficile spores, as it can improve spore recovery on solid media (Wilson, et al., 
1982; Wilson, 1983).  These same studies also suggested media in which C. 
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difficile sporulates efficiently, and this has formed the vast majority of the 
ILHOGV¶NQRZOHGJHRIC. difficile sporulation and germination in vitro. 
 
3.1.3 Aim of this study 
As a range of genetic tools are now available for studying C. difficile, it is 
imperative that appropriate procedures are put in place for analysing the 
phenotypes of mutants.  This study aimed to develop and optimise effective 
assays for the analysis of sporulation and germination in the directed mutants 
of C. difficile to be studied in the following chapters.  A principal aim was to 
ensure that the assay could accurately distinguish between sporulation and 
germination defects.  As spores must complete germination in order to form 
colonies on solid medium, it was decided to develop a reproducible colony 
formation-based assay. 
 
3.2 Results 
3.2.1 Conditions suitable for efficient C. difficile sporulation 
Detailed studies of C. difficile sporulation and germination characteristics had 
not been reported prior to the beginning of this study.  As a result, it was 
necessary to gain a better understanding of the conditions in which C. difficile 
forms spores efficiently and reproducibly.  It has been suggested that C. 
difficile can form spores efficiently in a Trypticase Peptone broth containing 
Proteose Peptone (12.5 mg/ml), (NH4)SO4 (2.5 mg/ml) and TrisHCl (3.75 
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mg/ml), at a pH of 7.4 (Wilson, et al., 1982).  It was, therefore, decided to 
prepare C. difficile ǻerm spores using this medium and enumerate spore 
titres based upon colony formation on BHI agar.   
 
As the sporulation medium would likely contain a mixture of spores and 
vegetative cells, it is necessary to treat the culture in such a way to kill all 
vegetative cells but not the spores.  Accordingly, after seven days incubation in 
the sporulation medium, a range of treatments were analysed to determine (i) 
their efficacy against C. difficile ǻerm vegetative cells; and (ii) the 
sporulation efficiency of C. difficile ǻerm in the Trypticase Peptone broth 
(Figure 3.1).  In comparison to the colony formation of a negative control, in 
which cultures were incubated in PBS for 10 min before being plated onto BHI 
agar, colony formation appeared similar following treatment with chloroform 
(10%) or NaOH (0.25M), suggesting that both chloroform and NaOH may be 
ineffective at removing vegetative cells from the spore mixture.  When cultures 
were heated at 80 °C for 10 min, or incubated in EtOH (100%) for 10 min, no 
colonies were observed after 24 h incubation on BHI agar.  This suggested that 
while these treatments are suitable for removing vegetative cells from the spore 
mixture, these treatments may have killed/inactivated the spores or, more 
likely, there were no spores present following incubation in the sporulation 
medium.  Indeed, when cultures from the sporulation medium were analysed 
by phase-contrast microscopy, no spores were observed.  This suggests that the 
sporulation medium used in this assay is not suitable for reproducibly 
preparing C. difficile spores.  Nonetheless, both heat treatment (80 °C for 10 
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min), and EtOH treatment (100% for 10 min) were effective at killing 
vegetative cells of C. difficile ǻerm. 
 
 
Figure 3.1.  Colony formation of C. difficile ǻerm after seven days 
incubation in a Trypticase Peptone sporulation broth, and treatment with either 
heat (80 °C for 10 min), 100% EtOH, 10% Chloroform, 0.25M NaOH or PBS.  
The bars indicate a single experiment and the detection limit for the assay was 
50 CFU/ml. 
 
In order to improve the yield of C. difficile spores, and efficiently recover 
spores on BHI agar, the assay described above was altered in three main ways.  
First, it was attempted to induce sporulation on solid medium by incubating 
cultures of C. difficile on BHI plates for 10-14 days, or until a considerable 
number of spores were observed by phase-contrast microscopy.  The spore 
mixture was then incubated in 100% EtOH for 10 min to kill vegetative cells 
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but not spores.  Finally, the spore mixture was plated onto BHI agar 
supplemented with the bile salt taurocholate (0.1%), which has been shown to 
improve the recovery of C. difficile spores on solid medium (Wilson, et al., 
1982).  A considerable number of spores were observed by phase-contrast 
microscopy after 10-14 days incubation, and the colony formation after EtOH 
treatment was then compared to the colony formation following incubation in 
PBS, with spore recovery expressed as the percentage of CFU survival 
following EtOH treatment (Figure 3.2).  In comparison to a negative control, in 
which the master regulator of sporulation spo0A was inactivated (Heap, et al., 
2007), approximately 90% survival was observed in C. difficile ǻerm.  
This suggests that C. difficile is able to form spores efficiently on solid media.  
In addition, adding the bile salt taurocholate as a supplement allows for 
suitable recovery of C. difficile spores.  
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Figure 3.2.  Recovery of C. difficile ǻerm after 10-14 days incubation on 
BHI plates.  Spore recovery is the number of CFU following incubation in 
100% EtOH for 10 min, as a percentage of the number of CFU observed 
following incubation in PBS.  A C. difficile ǻerm spo0A mutant was used 
as a sporulation-negative control.  The bars indicate the averages of three 
independent experiments and the error bars indicate the standard errors of the 
means. 
 
3.2.2 Optimisation of C. difficile sporulation and spore recovery 
The assay described above allows for measurements of C. difficile spore 
survival at a precise time-point.  However, this study required an assay that 
could (i) determine the rate of C. difficile sporulation; (ii) accurately quantify 
sporulation, independent of colony formation; and (iii) assess the colony 
forming ability of C. difficile mutant spores when germination was induced 
with taurocholate.   
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In order to measure the rate of sporulation, samples must be analysed at 
multiple time-points, which requires the use of a liquid sporulation medium.  
Accordingly, sporulation of C. difficile was induced in a brain-heart infusion 
broth enriched by supplementation with L-cysteine and yeast extract (BHIS), 
as it had recently been described that C. difficile sporulates efficiently in 
nutrient-rich medium (Sorg and Sonenshein, 2008).  Therefore, C. difficile was 
incubated anaerobically in BHIS broth and the CFU titre in a sample was 
enumerated every 24 h, following heat treatment at 60 °C for 25 min and 
plating onto BHIS agar supplemented with 0.1% taurocholate.  Heat-resistant 
CFU were measured until the CFU titre no longer increased (Figure 3.3).  In 
this case, heat treatment was preferred to EtOH incubation as the wash steps 
required to remove traces of EtOH following incubation were time consuming.  
The resulting colony formation clearly showed that C. difficile ǻerm 
sporulates efficiently in BHIS broth.  Furthermore, incubation for five days 
appeared to be appropriate for a plateau of C. difficile sporulation. 
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Figure 3.3.  The development of heat-UHVLVWDQW &)8 RI Ɣ C. difficile 
ǻermDQGŶ&5*spo0A) over a five-day period in BHIS broth.  The 
symbols indicate the averages of three independent experiments, and the error 
bars indicate the standard errors of the means.  The detection limit for the assay 
was 50 CFU/ml. 
 
As heat-resistant CFU represent successfully sporulated vegetative cells, which 
were able to survive heat treatment, germinate and grow vegetatively, an assay 
to measure both sporulation and germination must be able to distinguish 
between these processes.  Therefore, C. difficile 630ǻerm spore titres were 
enumerated after five days by using phase-contrast microscopy and then 
compared to the CFU observed, before and after heat treatment, at the same 
time-point (Figure 3.4).  It was possible to recover more than 90% of the C. 
difficile ǻerm spores which were observed by microscopy.  Taken together, 
these data demonstrate that this assay allows for efficient C. difficile 
sporulation in a liquid medium, allowing analysis at multiple time-points.  
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Furthermore, spore titres can be quantified independently of colony formation 
by phase-contrast microscopy, and the observed recovery of spores on BHIS 
medium supplemented with taurocholate indicates that C. difficile ǻerm 
germinates efficiently under these conditions. 
 
 
Figure 3.4.  Numbers of untreated CFU, spores counted by phase-contrast 
microscopy, and heat-resistant CFU of C. difficile ǻerm after five days of 
incubation in BHIS broth.  The bars indicate the averages of three independent 
experiments, and the error bars indicate the standard errors of the means.  The 
detection limit for colony counts was 50 CFU/ml, and the detection limit for 
spore counts was 5 ×103 spores. 
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&RPSDULVRQRIVSRUXODWLRQDQGJHUPLQDWLRQRI&GLIILFLOHǻHUPDQG
R20291 
,WKDVEHHQVXJJHVWHGWKDWµHSLGHPLF¶%,1$3VWUDLQVRIC. difficile may 
EHPRUHSUROLILFLQWHUPVRIVSRUXODWLRQWKDQµQRQ-HSLGHPLF¶C. difficile types 
(Wilcox and Fawley, 2000; Fawley, et al., 2007; Akerlund, et al., 2008; 
Merrigan, et al., 2010), although the evidence for this is currently limited.  
Therefore, it was decided to showcase the applications of the assay developed 
in this chapter, by studying the sporulation and germination characteristics of a 
BI/NAP1/027 strain, R20291, and a non-HSLGHPLFVWUDLQǻerm. 
 
First, the development of heat-resistant CFU was observed over a five-day 
period (Figure 3.5).  The resultant colony formation clearly showed that C. 
difficile ǻerm developed heat-resistant spores more rapidly than R20291.  
ǻerm formed countable heat-resistant CFU after 24 h of incubation, while 
it was only after 48 h WKDWWKLVZDVWKHFDVHIRU5,QDGGLWLRQǻerm 
cultures contained approximately 400-fold more heat-resistant CFU than 
R20291 cultures after five days. 
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Figure 3.5.  Development of heat-UHVLVWDQW&)8RIƔC. difficile ǻerm; Ÿ, 
C. difficile 5 DQG ź &5* spo0A) over a five-day period.  The 
symbols indicate the averages of three independent experiments, and the error 
bars indicate the standard errors of the means.  The detection limit for the assay 
was 50 CFU/ml. 
 
It is possible that the observed difference in heat-resistant CFU was not due to 
sporulation or germination and instead was a result of growth differences 
between the two strains.  The data for non-heat-treated CFU recovered on 
BHIS agar supplemented with taurocholate after five days were also compared, 
and as the colony formation was found to be 30-fold lower for R20291 than for 
ǻerm (Figure 3.7), the changes in OD600 IRU ERWK ǻerm and R20291 
were analysed over a five-day period.  No difference was seen between the two 
strains (Figure 3.6), which ruled out an elementary growth difference between 
ǻerm and R20291.  Therefore, it is possible that the observed difference in 
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the number of non-heat-treated CFU for R20291 could be due to the death of 
non-sporulating cells. 
 
 
Figure 3.6.  *URZWKRIƔC. difficile ǻermDQGŶC. difficile R20291 in 
BHIS broth during a 24 h period.  Strains were cultivated as described in 
Chapter Two, and the change in OD600 was measured.  The symbols represent 
the average of three independent experiments, and error bars indicate the 
standard errors of the means.  
 
To pinpoint any difference in sporulation between the two strains, the cultures 
used to measure heat-resistant CFU after five days were analysed by phase-
contrast microscopy, and the numbers of spores/ml were determined.  C. 
difficile ǻerm was found to produce approximately 100-fold more 
spores/ml than R20291 (Figure 3.7), suggesting that the previously observed 
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difference in heat-resistant CFU between the two strains was due in part to 
sporulation.  
 
 
Figure 3.7.  Numbers of untreated CFU, spores counted by phase-contrast 
microscopy, and heat-resistant CFU of C. difficile ǻerm and C. difficile 
R20291 after five days of incubation in BHIS broth.  The bars indicate the 
averages of three independent experiments and error bars indicate the standard 
errors of the means.  The detection limit for colony counts was 50 CFU/ml, 
and the detection limit for spore counts was 5 ×103 spores. 
 
$Vǻerm produced 400-fold more heat-resistant CFU than R20291, it was 
also hypothesised that fewer R2 VSRUHV WKDQ ǻerm spores had 
completed germination and outgrowth under the conditions used in this assay.  
To test the hypothesised differences in germination and outgrowth between 
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ǻerm and R20291, the observed spore titres were compared to the numbers 
of heat-resistant CFU on BHIS agar supplemented with taurocholate (Figure 
DIWHUILYHGD\V,WZDVIRXQGWKDWDJUHDWHUSURSRUWLRQRIǻerm spores 
(>95%) than of R20291 spores (<30%) formed colonies after heat treatment.  
Thus, the data suggest not only that the non-epidemic strain C. difficile 
ǻerm sporulates earlier and to a greater degree than the BI/NAP1/027 
isolate R20291 under the growth conditions employed, but also that a higher 
SURSRUWLRQRIǻerm spores than of R20291 spore complete germination and 
form colonies in association with the bile salt taurocholate. 
 
Figure 3.8.  The proportion of C. difficile ǻerm and C. difficile R20291 
spores, counted by phase-contrast microscopy, that formed colonies after heat 
treatment.  The bars represent three independent experiments, and the error 
bars indicate the standard errors of the means. 
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3.3 Discussion 
One of the most challenging aspects of studying C. difficile sporulation and 
germination has been developing suitable methods for analysing mutant 
phenotypes.  A historic lack of genetic tools has, up until now, perhaps 
prevented research into this area, but a range of tools are now available (Heap, 
et al., 2007; Heap, et al., 2009; Cartman and Minton, 2010; Heap, et al., 2010).  
This chapter described the development of a reproducible assay for studying 
both the sporulation and germination characteristics of C. difficile.  Such an 
assay will provide the means by which genes required for C. difficile 
sporulation and germination can be identified in the future. 
 
Unfortunately, the precise mechanisms by which C. difficile forms spores 
remain unclear.  As a result, it is difficult to understand the specific conditions 
that are optimal for C. difficile sporulation.  The data presented above suggest 
that C. difficile forms spores efficiently in a nutrient-rich liquid medium, which 
is interesting as nutrient starvation has long been described as a trigger of 
sporulation in bacilli (Schaeffer, et al., 1965; Sonenshein, 2000).  It was 
possible to reproducibly induce sporulation of C. difficile by incubating 
cultures in the nutrient-rich broth for five days.  The rate of sporulation was 
then determined by observing the development of heat-resistant CFU at 
different time-points, with the bile salt taurocholate acting as a germinant to 
recover C. difficile spores.  Importantly, spore titres were enumerated 
independently of colony formation after five days, using phase-contrast 
microscopy, and this spore titre was then compared to the observed CFU titre 
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at the same time-point.  This made it possible to distinguish between C. 
difficile sporulation and germination. 
 
The emergence of C. difficile BI/NAP1/027 strains (Dawson, et al., 2009) has 
strengthened the need to understand C. difficile sporulation and germination 
characteristics.  These strains are associated with more severe disease and 
greater virulence, and although it is still unclear how sporulation and 
germination in epidemic and non-epidemic strains compare, it has been 
suggested that the rate of sporulation is higher in particular BI/NAP1/027 
isolates (Wilcox and Fawley, 2000; Fawley, et al., 2007; Akerlund, et al., 
2008; Merrigan, et al., 2010).  The assay developed above was, therefore, used 
to determine the sporulation and germination characteristics of a BI/NAP1/027 
isolate, R20291, and a non-HSLGHPLF VWUDLQ ǻerm.  C. difficile R20291 
formed spores slower (Figure 3.5) and formed fewer spores than C. difficile 
ǻerm over a five-day period (Figure 3.7).  Furthermore, a lower number of 
the observed spores of C. difficile R20291 than of the observed spores of 
ǻerm completed germination and formed colonies after heat treatment.  
Given the current literature on the sporulation characteristics of different C. 
difficile types, these findings indicate that caution should be taken when 
general conclusions are drawn about the properties of types of C. difficile 
strains without an adequate sample size.  Studies encompassing a larger 
number of C. difficile isolates are necessary to define what role sporulation and 
germination play in disease. 
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3.4 Key outcomes 
x An assay was optimised to accurately assess the in vitro sporulation 
and germination/outgrowth characteristics of C. difficile strains based 
on colony formation after heat treatment, with the bile salt taurocholate 
acting as a germinant.  Measurements were taken at multiple time-
points to analyse the rate of sporulation, and total sporulation was 
enumerated, independent of colony formation, by phase-contrast 
microscopy. 
x The C. difficile BI/NAP1/027 type strain R20291 was found to 
sporulate more slowly and produce fewer spores than the non-epidemic 
ǻerm.  Furthermore, fewer R20291 spores appeared to germinate 
and form colonies under the conditions employed.  These findings are 
in contrast to the previously published literature, which has suggested 
that BI/NAP1/027 strains are more prolific in terms of sporulation in 
vitro. 
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Chapter Four 
 
The diverse sporulation and germination characteristics of C. difficile 
clinical isolates 
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4.1 Introduction 
In the last decade, there has been an alarming rise in reported cases of CDAD 
across Europe and North America (Brazier, et al., 2008; Rupnik, et al., 2009).  
Outbreaks of severe disease, high rates of relapse, and increased mortality have 
all become associated with the so-FDOOHG µK\SHUYLUXOHQFH¶ RI an emerging 
group of C. difficile strains.  Cases of CDAD associated with the BI/NAP1/027 
type have now been reported in 16 European countries (Kuijper, et al., 2008).  
Furthermore, three countries have described imported disease associated with 
BI/NAP1/027 strains, where the patient acquired the C. difficile strain abroad 
(Kuijper, et al., 2008).   
 
Outbreaks of CDAD due to BI/NAP1/027 strains of C. difficile continue to be 
reported and these types are now the most clinically relevant type in the United 
Kingdom (Brazier, et al., 2008).  Consequently, as these strains are also 
associated with more severe disease, studies of the mechanisms behind the 
pathogenesis of BI/NAP1/027 strains are now at the forefront of C. difficile 
research worldwide.  The first characteristic of BI/NAP1/027 strains to be 
associated with hypervirulence was the production of toxins, the major 
virulence factors of C. difficile.  As described in Chapter One, a number of 
BI/NAP1/027 strains have been shown to produce higher levels of toxin in 
vitro (Warny, et al., 2005), although the molecular basis of this observation 
remains unclear. 
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4.1.1 Association of sporulation/germination with hypervirulence 
The increased disease incidence and severity associated with C. difficile types 
such as BI/NAP1/027 have largely been attributed to the increase in toxin 
production described above.  However, whilst this observed higher toxin 
production is doubtless important, perhaps the recent attention given to 
BI/NAP1/027 strains has focused too much on toxins.  It seems likely that a 
number of other factors may play a role in the emergence of hypervirulent C. 
difficile strains, factors such as increased antibiotic resistance (Kuijper, et al., 
2006), increased adherence (Schwan, et al., 2009), and possibly the rate of 
spore formation and the subsequent spore germination.  It has recently been 
suggested that BI/NAP1/027 strains have a greater in vitro sporulation capacity 
than non-outbreak strains (Wilcox and Fawley, 2000; Fawley, et al., 2007; 
Akerlund, et al., 2008; Merrigan, et al., 2010).  As spores represent the 
infectious stage of C. difficile, and BI/NAP1/027 strains have become the most 
frequently clinically isolated type in the United Kingdom, a detailed 
understanding of the sporulation properties of such epidemic types is important 
and may have practical implications on future cleaning and treatment 
procedures.  However, given the findings in Chapter Three that the 
BI/NAP1/027 isolate R20291 forms spores slower and to a lower degree in 
vitro than a non-HSLGHPLF3&5ULERW\SHLVRODWHǻerm, the differences 
in sporulation efficiency between C. difficile strains may not be as 
straightforward as has been previously suggested.  To-date, there has been no 
convincing evidence published for or against the type-association of C. difficile 
sporulation rates.  Consequently, until multiple isolates from many families of 
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C. difficile have been analysed, it may be premature to assume such differences 
exist between epidemic and non-outbreak strains. 
 
As spores must germinate to cause disease following ingestion by susceptible 
individuals, it is also desirable to study any differences in germination between 
C. difficile types.  Knowledge of diversity in the germination characteristics of 
C. difficile clinical isolates could help to develop a more detailed 
understanding of those types associated with more severe disease.  The 
evidence presented in Chapter TKUHHWKDWPRUHǻerm spores than R20291 
spores appear to germinate and form colonies in association with the bile salt 
taurocholate, suggests that differences in germination may exist between 
epidemic and non-epidemic isolates.  Consequently, a study of both the 
sporulation and germination characteristics of a large range of C. difficile 
isolates, from a variety of types, could help in understanding better the 
characteristics that affect the virulence of C. difficile strains.  
 
4.1.2 Aim of this study 
In order to gather more data and better understand any differences in 
sporulation and germination between different C. difficile types, the study 
presented in this chapter used a series of assays to measure these 
characteristics in a variety of C. difficile types, including several BI/NAP1/027 
isolates from both North America and Europe (Table 4.1 lists the strains used 
in this study and their relevant properties). 
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4.2 Results 
4.2.1 C. difficile strains used in this study 
Previous studies of sporulation efficiencies between different C. difficile types 
have been limited to a few individual strains.  It is, therefore, difficult to 
currently link processes such as sporulation (or germination) with increased 
disease severity.  To investigate this subject in more detail, the sporulation and 
germination characteristics of C. difficile types were analysed using 14 strains.  
The group incorporated seven isolates belonging to the BI/NAP1/027 group, 
and seven isolates of a variety of other types, including isolates of PCR-
ribotypes 017 and 078, which are also of interest due to their recent emergence 
and association with infection of animals used for food (Songer and Anderson, 
2006).  An isolate associated with particularly high levels of toxin production, 
VPI 10463, was also analysed as it has been suggested that those types 
producing high levels of toxin sporulate less prolifically than other types 
(Sullivan, et al., 1982; Akerlund, et al., 2008).   
 
The BI/NAP1/027 isolates chosen for this study were all previously isolated 
from outbreaks across Europe and North America (Killgore, et al., 2008).  
Interestingly, two of these isolates, CDC 32 and R12087, were examples of 
µKLVWRULFDO¶ %,1$3 VWUDLQV LVRODWHG DV HDUO\ DV WKH V (Killgore, et 
al., 2008).  The non-BI/NAP1/027 group included a wide range of PCR-
ULERW\SHV *LYHQ WKH ILQGLQJV LQ&KDSWHU7KUHH WKDWǻerm sporulates and 
forms colonies after heat treatment to greater levels than the BI/NAP1/027 
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strain R20291, the C. difficile ǻerm parental strain was also selected for 
comparison with the other BI/NAP1/027 strains in this study.  Table 4.1 lists 
the C. difficile strains selected for analysis, which also included a C. difficile 
ǻerm spo0A mutant to act as a sporulation-negative control. 
 
Strain Relevant properties Source/reference 
BI/NAP1/027   
R20291 Stoke Mandeville (2004/2005) isolate Anaerobe Reference 
Laboratory, Cardiff 
CDC 32 Historical USA isolate (Killgore, et al., 2008) 
CDC 38 USA isolate (Killgore, et al., 2008) 
M13042 Canada isolate (Killgore, et al., 2008) 
DH326 Yorkshire and Humberside, Sheffield 
isolate (2005) 
 
Anaerobe Reference 
Laboratory, Cardiff 
DH1329 West Midlands, Coventry isolate (2007/8) Anaerobe Reference 
Laboratory, Cardiff 
R12087 Historical EU isolate (1980s) Michel Popoff, Institut 
Pasteur, Paris 
Non-BI/NAP1/027   
ǻerm PCR ribotype 012 
Erythromycin sensitive strain of C. difficile 
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(Hussain, et al., 2005) 
ǻerm spo0A::intron ermB C. difficile sporulation-negative control 
 
 
(Heap, et al., 2007) 
GAI 95601 PCR-ribotype 017, Japan (van den Berg, et al., 
2007) 
001-3 PCR-ribotype 001 ECDC ± Cardiff 
collection 
Serosubtype A2 PCR-ribotype 002 ECDC ± Cardiff 
collection 
Wilcox 078 PCR -ribotype 078 Mark Wilcox 
R10459 PCR-ribotype 106 ECDC ± Cardiff 
collection 
VPI 10463 PCR-ribotype 003 
Toxinotype 0 reference strain 
(Sullivan, et al., 1982) 
Table 4.1. C. difficile strains selected for analysis of sporulation and 
germination characteristics. 
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4.2.2 Growth of C. difficile strains in BHIS medium 
As sporulation and germination measurements may be affected by growth 
differences between strains, all C. difficile strains were first cultivated in BHIS 
broth for 24 h, and growth was monitored by measuring the change in OD600 
(Figure 4.1 and Figure 4.2).  All strains showed highly similar growth 
characteristics, which allows for the exclusion of growth differences when 
interpreting the subsequent experiments in this chapter.  It was interesting to 
observe that there were no obvious growth differences between the selected C. 
difficile types, as it has been suggested in the past that a particular 
characteristic of the BI/NAP1/027 type is for the cell density at 24 h to be 
approximately 20% higher than that of other C. difficile types (Warny, et al., 
2005; Akerlund, et al., 2008). 
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Figure 4.1.  The growth of C. difficile BI/NAP1/027 strains in BHIS broth, as 
indicated by the change in OD600, during DKSHULRG  $Ɣ&'&Ŷ
5ż5Ƒ0%Ɣ&'&Ŷ'+ż'+7KH
symbols represent the averages of three independent experiments, and error 
bars indicate standard errors of the means. 
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Figure 4.2.  The growth of C. difficile non-BI/NAP1/027 strains in BHIS 
broth, as indicated by the change in OD600, GXULQJ D  K SHULRG  $ Ɣ
5Ŷǻermż93,%Ɣ*$,Ŷ6HURVXEW\SH$ż
001- Ƒ :LOFR[   7KH V\PEROV UHSUHVHQW WKH DYHUDJHV RI WKree 
independent experiments, and error bars indicate standard errors of the means. 
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4.2.3 Colony formation of C. difficile strains after heat treatment 
In order to understand the rate at which the selected C. difficile strains formed 
spores in vitro, the development of heat-resistant CFU was measured over 5 
days.  At 24 h time intervals, samples were heated at 60 °C for 25 min to kill 
vegetative cells but not spores, and plated onto BHIS agar supplemented with 
the bile salt taurocholate to recover viable C. difficile spores.  The observed 
colony formation appeared to show a large degree of variation within, but not 
necessarily between C. difficile types (Figure 4.3 and Figure 4.4), which 
suggests that the variation in sporulation rates between strains is not associated 
with type.   
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Figure 4.3. The development of heat-resistant CFU of BI/NAP1/027 C. 
difficile VWUDLQVRYHU ILYHGD\V  $ż&'&Ŷ0Ÿ5Ɣ
5 Ƒ C. difficile ǻerm spo0A % Ɣ &'&  Ŷ '+ Ÿ
DH1329; żC. difficile ǻerm spo0A.  The symbols represent the averages 
of three independent experiments, and error bars indicate standard errors of the 
means.  The detection limit for colony counts was 50 CFU/ml. 
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Figure 4.4. The development of heat-resistant CFU of non-BI/NAP1/027 C. 
difficile strains over five days.  $Ÿ5ƔǻermŶ93,ż
C. difficile ǻerm spo0A%Ŷ-Ÿ6HURVXEW\SH$Ɣ*$,
ż :LOFR[  Ƒ C. difficile ǻerm spo0A.  The symbols represent the 
averages of three independent experiments, and error bars indicate standard 
errors of the means.  The detection limit for colony counts was 50 CFU/ml. 
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To allow for a better comparison of the sporulation rate of C. difficile strains, 
the levels of heat-resistant CFU for each strain at both 24 and 120 h were then 
plotted and compared separately (Figure 4.5).  No obvious difference in the 
level of heat-resistant CFU was seen between the BI/NAP1/027 and non-
BI/NAP1/027 groups after 24 h suggesting that, under the conditions of the 
assay, there is no association between C. difficile type and sporulation over a 
24 h period.  However, the BI/NAP1/027 group appeared to form lower levels 
of heat-resistant CFU after 120 h when compared to the non-BI/NAP1/027 
group, although this difference was not quite statistically significant (p = 
0.054).  
  
Interestingly, a low level of heat-resistant CFU after 24 h in comparison to 
other isolates, such was the case with C. difficile VPI 10463, did not 
necessarily correlate to a low level of heat-resistant CFU after 120 h.  To the 
contrary, it was noted that while VPI 10463 formed few heat-resistant CFU 
after 24 h, significantly more heat-resistant CFU were observed after 120 h 
than all tested BI/NAP1/027 isolates (p < 0.05).  Likewise, when compared to 
the other individual strains, a high level of colony formation observed after 24 
h, such was the case with the BI/NAP1/027 isolate C. difficile M13042, did not 
always result in high levels of colony formation after 120 h when compared to 
other strains.  This suggests that in a case where a strain initiates sporulation 
particularly early, such a strain may not necessarily form a higher total of 
spores than a strain which initiates sporulation at a later stage. 
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Figure 4.5. The colony formation following heat treatment of C. difficile 
strains after 24 h (open bars) and 120 h (filled bars).  Heat-resistant CFU were 
enumerated from the same cultures as analysed in Figure 4.3 and Figure 4.4.  
The bars represent the averages of three independent experiments, and error 
bars indicate standard errors of the means.  The detection limit for colony 
counts was 50 CFU/ml. 
 
4.2.4 Sporulation of C. difficile strains after 5 days 
As the BI/NAP1/027 group appeared to form fewer heat-resistant CFU after 
five days than the non-BI/NAP1/027 group, it is conceivable that differences 
exist in the sporulation characteristics of these groups.  However, as heat-
resistant CFU represent successfully sporulated vegetative cells that were also 
able to germinate and grow vegetatively, a discrepancy between CFU of 
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different strains may also due to the in vitro germination characteristics of the 
strains.  In order to accurately compare the sporulation of C. difficile strains, 
spores titres were therefore enumerated independently of colony formation, by 
phase-contrast microscopy (Figure 4.6).  Spore titres varied significantly 
among the 14 isolates studied (p < 0.05), and although the BI/NAP1/027 group 
appeared to form fewer spores than the non-BI/NAP1/027 group, this 
difference was not statistically significant.  These data suggest that while spore 
titres varied greatly between individual strains, there was no obvious type-
associated variation in the spore titres obtained from the C. difficile strains in 
this study.  However, in a number of cases there was a discrepancy between 
the microscopically-observed spore titre and heat-resistant CFU. 
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Figure 4.6.  C. difficile spore titres enumerated by phase-contrast microscopy 
following five days of incubation in BHIS broth.  The bars represent the 
averages of three independent experiments, and error bars indicate standard 
errors of the means.  The detection limit for spore counts was 5 ×103 spores. 
 
4.2.5 Colony forming characteristics of C. difficile spores 
As spores must complete germination in order to form colonies, an 
inconsistency between spore titre and colony formation may be caused by a 
difference in the frequency of germination and spore outgrowth.  Accordingly, 
the proportion of spores counted by phase-contrast microscopy that formed 
heat-resistant CFU at 120 h, when germination was induced by plating onto 
BHIS agar supplemented with taurocholate, were analysed (Figure 4.7).  This 
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colony formation varied significantly among the 14 C. difficile isolates tested 
(p < 0.001), and it was also noted that spores of a number of non-BI/NAP1/027 
strains formed more colonies than the spores of certain BI/NAP1/027 strains.  
In particular, a significantly higheU SURSRUWLRQ RI 93,  DQG ǻerm 
spores formed colonies than the BI/NAP1/027 strains R20291, R12087, CDC 
32 and CDC 38 (p < 0.05).  Furthermore, spores of the non-BI/NAP1/027 
isolates Serosubtype A2 and R10459 formed significantly more colonies than 
R12087 and CDC 38 (p < 0.05).  However, it was also noted that spores of a 
PCR-ribotype 078 isolate (Wilcox 078) formed significantly fewer colonies in 
comparison to VPI 10463 (p < 0.05).  Not all BI/NAP1/027 strains formed 
proportionally fewer colonies than microscopically-observed spores, as a 
significantly higher proportion of DH326 spores formed colonies when 
compared to R12087 (p < 0.05), while not showing any significant differences 
WR 93,  5 6HURVXEW\SH $ RU ǻerm (non-BI/NAP1/027).  
Additionally, when the BI/NAP1/027 and non-BI/NAP1/027 groups were 
directly compared, there was no significant variation observed in the 
proportion of spores which formed colonies (p = 0.14).  Taken together, these 
data indicate that following heat treatment, spores of a number of C. difficile 
BI/NAP1/027 isolates appear to form colonies at a lower frequency than 
certain non-BI/NAP1/027 isolates.  However, a large degree of variation was 
observed between individual C. difficile strains, and the smaller proportion of 
spores forming colonies was not specific to the BI/NAP1/027 type.  
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Figure 4.7.  The proportion of C. difficile spores, counted by phase-contrast 
microscopy, that formed colonies after heat treatment.  The bars represent the 
averages of three independent experiments, and error bars indicate standard 
errors of the means. 
 
4.3 Discussion 
Given the recent suggestions that C. difficile strains belonging to the 
BI/NAP1/027 type are more prolific in terms of sporulation than spores of 
other C. difficile types, the data presented in this chapter are perhaps 
surprising.  This study used 14 isolates to compare sporulation and germination 
characteristics in vitro, the largest sample-size used to-date in such a study, and 
it was observed that the substantial variation in sporulation and germination 
properties between isolates does not seem to be type-associated. 
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A particularly interesting difference between this study and previous work was 
noted in C. difficile VPI 10463.  It has been suggested by Akerlund et al. that 
VPI 10463 sporulates poorly over a 48 h period (Akerlund, et al., 2008), but 
the data presented here show the opposite.  While few heat-resistant CFU were 
seen after 24 h (Figure 4.5), VPI 10463 formed spores just as prolifically as 
any other strain tested from 48 h onwards (Figure 4.3, Figure 4.4 and Figure 
4.6).  Two notable differences between this study and the one by the Åkerlund 
laboratory are the growth conditions employed and the methods of assaying 
sporulation.  Akerlund and co-workers cultivated C. difficile strains in a broth 
containing peptone-yeast and without cysteine and glucose (Akerlund, et al., 
2008), while the C. difficile strains in this study were cultivated in BHIS broth 
as described in Chapter Two.  Furthermore, Akerlund et al. (2008) expressed 
sporulation rate as a ratio of spores to vegetative cells within the population 
after 48 h, a method that has previously been used to compare the sporulation 
of C. difficile isolates (Wilcox and Fawley, 2000; Fawley, et al., 2007).  
However, this relative measure can be affected by growth differences between 
strains and also by the survival of non-sporulating cells.  Additionally, without 
an actual spore titre it is difficult to accurately quantify sporulation.  Based on 
the data presented in this chapter, it may be more appropriate to (i) measure the 
change in OD600 to evaluate growth differences; (ii) observe the development 
of heat-resistant CFU to assess the rate of sporulation; and (iii) enumerate 
spore titres independently of colony formation, by microscopy, to allow for a 
direct comparison of C. difficile sporulation with germination and outgrowth.  
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The most obvious follow-up to this study would be a comprehensive analysis 
of the sporulation and germination characteristics of a wider range of C. 
difficile strains, incorporating many more isolates from many more types of C. 
difficile.  Only with such a study will it be possible to make a more definitive 
statement about the sporulation and germination properties of C. difficile 
strains and types, and the subsequent role in disease incidence and severity.   
 
Overall, the findings in this chapter show that the variation in C. difficile 
sporulation and germination frequency is far greater within PCR-ribotypes 
than between PCR-ribotypes.  The obvious question remains of how the in 
vitro sporulation characteristics described in this study relate to sporulation 
proficiency in vivo.  Consequently, until our understanding of in vivo C. 
difficile sporulation improves, it will be difficult to associate the sporulation 
characteristics of C. difficile BI/NAP1/027 with the severity of disease caused 
by this type.  Furthermore, the observed inconsistency between spore counts 
and heat-resistant CFU of a number of C. difficile strains in this study also 
raises questions about the germination rates of different C. difficile strains.  If 
differences do exist in the germination rates of different C. difficile types, 
future studies analysing these characteristics may provide a greater 
understanding of what factors contribute to the incidence and severity of C. 
difficile disease. 
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4.4 Key outcomes 
x The sporulation characteristics of fourteen C. difficile strains were 
analysed, incorporating a variety of PCR-ribotypes, including several 
BI/NAP1/027 isolates from both North America and Europe. 
x The rate of sporulation and total sporulation after five days varied 
substantially between individual isolates, but this variation did not 
appear to be PCR-ribotype-associated. 
x Spores of a number of BI/NAP1/027 formed colonies at a lower 
frequency than spores of some non-BI/NAP1/027 strains, suggesting 
differences exist in the germination properties of C. difficile strains.  
However, the observed lower colony formation was not specific to the 
BI/NAP1/027 type, and substantial variation was observed between 
individual isolates. 
x Taken together, these data cast doubt on the suggestions that 
BI/NAP1/027 strains of C. difficile sporulate more prolifically than 
other PCR-ribotypes.  Careful experimental design may therefore be 
required when measuring the in vitro sporulation characteristics of C. 
difficile, and larger sample sizes should be studied before 
generalisations are made. 
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Chapter Five 
 
SleC is essential for germination of C. difficile spores in nutrient-rich 
medium supplemented with the bile salt taurocholate 
 
 
 
 
 
 
 
 
 
 
 
94 
 
5.1 Introduction 
The precise mechanisms of germination in C. difficile have not been studied in 
great depth, due in part to an absence of genetic tools.  However, the ClosTron 
now provides an efficient means to study C. difficile spore germination 
mechanisms using a reverse genetics approach (Heap, et al., 2007; Heap, et al., 
2010), by identifying homologues of genes important for germination in other 
spore formers, inactivating them, and inferring their function from mutant 
phenotypes. 
 
5.1.1 Spore cortex-lytic enzymes 
In spores of B. subtilis, the spore core, which contains the spore DNA, RNA 
and most enzymes, is surrounded by the germ cell wall, a thin layer of PG 
identical to that of vegetative cell PG.  The germ cell wall is surrounded by the 
cortex, a thicker layer of spore-specific PG which, as described in Chapter 
One, is chemically distinct from vegetative cell PG.  One such modification in 
spore PG is that approximately 50% of muramic acid residues are converted to 
muramic-į-lactam (Warth and Strominger, 1969; Warth and Strominger, 
1972).  It is believed that this muramic-į-lactam serves as a recognition 
component for germination-specific spore cortex-lytic enzymes (SCLEs) 
(Popham, et al., 1996c), which are responsible for hydrolysis of the PG cortex.  
It is during this hydrolysis that the previously low water content of the spore 
core is restored to the water content of a normal vegetative cell and the core is 
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able to expand, which in turn allows enzyme activity, metabolism, and spore 
outgrowth (Setlow, 2003). 
 
B. subtilis encodes two semi-redundant SCLEs, CwlJ and SleB, which are 
involved in cortex hydrolysis, breaking down PG containing muramic-į-lactam 
(Popham, et al., 1996a).  SleB has been shown to localise in both the inner and 
outer layers of B. subtilis spores through interaction of the enzyme 
peptidoglycan-ELQGLQJ PRWLI DQG WKH į-lactam structure of the cortex 
(Masayama A, 2006) and in association with YpeB, which is required for sleB 
expression during sporulation (Boland, et al., 2000; Chirakkal, et al., 2002).  It 
has been demonstrated that CwlJ is localised to the spore coat during 
sporulation in association with GerQ (Bagyan and Setlow, 2002; Ragkousi, et 
al., 2003), and is required for CaDPA-induced germination (Paidhungat, et al., 
2001).  Activation of CwlJ can be due to either CaDPA released from the spore 
core at the onset of germination or exogenous CaDPA (Paidhungat, et al., 
2001).  This mechanism of germination is interesting, as it completely by-
passes the B. subtilis germinant receptors (Paidhungat and Setlow, 2000), and 
this provides strong evidence for alternative germination pathways which may 
allow for germination of the spore under a range of conditions.  While CwlJ is 
essential for CaDPA-mediated germination in B. subtilis, neither CwlJ nor 
SleB is essential for complete cortex hydrolysis during nutrient germination, 
although inactivation of both cwlJ and sleB results in a spore unable to 
complete this process (Ishikawa, et al., 1998).  The role of a third SCLE, SleL, 
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has recently been studied in Bacillus anthracis.  A sleL mutant in B. anthracis 
is still able to complete germination, although this process is retarded.  
 
The SCLEs of Clostridium are less well studied than those of Bacillus.  The 
SCLEs SleC (Miyata, et al., 1995) and SleM (Chen, et al., 1997) have been 
identified in C. perfringens, and a study demonstrated that SleC is absolutely 
required during germination for complete cortex hydrolysis (Paredes-Sabja, et 
al., 2009b).  Although SleM has been shown to degrade spore cortex 
peptidoglycan, and inactivation of both sleC and sleM decreased the ability of 
spores to germinate more than inactivation of sleC alone, SleM was not 
essential (Paredes-Sabja, et al., 2009b).  In addition, it has recently been shown 
that the germination-specific serine protease CspB is essential for cortex 
hydrolysis and functions to convert the inactive pro-SleC found in dormant 
spores to an active enzyme (Shimamoto, et al., 2001; Paredes-Sabja, et al., 
2009c).  The action of these proteases represents a significant difference 
between the germination of C. perfringens spores and the Bacillus paradigm as 
Bacillus encodes no known germination-specific proteases. 
 
5.1.2 Germination targets in C. difficile 
Thus far, there have been no detailed studies of any genes responsible for spore 
germination in C. difficile, although genes showing homology to cwlJ and sleB 
of B. subtilis (CD3563) and sleC of C. perfringens (CD0551, annotated as 
sleC) have now been identified in the C. difficile 630 genome (Sebaihia, et al., 
97 
 
2006).  The product of sleC shows 53% amino acid identity to the previously 
characterised SleC of C. perfringens, and the product of CD3563 shows 30% 
and 45% amino acid identity to B. subtilis CwlJ and SleB respectively.  In 
addition, CD0552 has been annotated as sleB in the C. difficile 630 genome, 
and examination of an incomplete genome sequence available at 
http://www.sanger.ac.uk indicated that these equivalent homologues are also 
present in a BI/NAP1/027 strain, R20291.  
 
5.1.3 Aim of this study 
With a range of genetic tools now at our disposal, the way has been opened to 
understand more thoroughly the mechanisms of C. difficile spore germination.  
The study presented in this chapter, therefore, aimed to utilise the ClosTron 
system to inactivate sleC, CD3563 and CD0552 in both C. difficile ǻerm 
and R20291, and analyse the role played by these genes in the germination of 
C. difficile spores. 
 
5.2 Results 
5.2.1 Construction of mutant strains 
To assess the importance of sleC, CD3563 and CD0552 in C. difficile 
germination, the ClosTron system (Heap, et al., 2007; Heap, et al., 2010) was 
used, as described in Chapter Two, to create independent insertional mutants 
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of C. difficile ǻerm in which either the CD3563, CD0552 or sleC gene was 
inactivated, yielding strains CRG878, CRG879 and CRG1115, respectively.  
 
To confirm correct ClosTron insertion, putative mutant strains were analysed 
by PCR (Figure 5.1), and one erythromycin-resistant clone each of CRG878, 
CRG879 and CRG1115 were picked for sequencing at the intron insertion site 
(Table 5.1 shows intron insertion sites and the frequencies of the desired 
mutants obtained).  In the case of sleC, it was not possible to isolate the desired 
mutant using the base 493 target site.  Screening of a pool of genomic DNA 
from >100 erythromycin-resistant clones indicated that no desired mutants 
were present.  The intron or target site was therefore judged to be inefficient 
(as can occasionally occur when using group II intron technology), so another 
target site (base 128 with the antisense orientation) was chosen for sleC. 
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Figure 5.1. An example of PCR screening for putative C. difficile ǻerm 
sleC ClosTron insertion mutants.  PCR was used initially to screen for intron 
insertion using (A) the gene-specific primer pairs SleC_F1 and SleC_R1 
ǻerm), and (B) intron-specific EBS Universal primer and the gene-
VSHFLILFSULPHU6OH&B5ǻerm).  Lane L, 2-log DNA ladder; Lanes 1-5, 
putative sleC mutant clones; Lane 6, C. difficile ǻerm; Lane 7, 
pMTL007C-E2::cdi-SleC-128a.  The presence of a large band in (A) indicated 
putative intron insertion, and the 1,458 bp band in (B) was consistent with the 
size of band expected following 128a insertion of the ClosTron. 
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 Strain and target site Frequency of desired mutant among 
clones screened 
  
       %        No. positive/no. screened 
 
 
 C. difficile ǻerm 
CD3563 226s 
 
          100                         8/8  
 C. difficile 63ǻerm 
CD0552 75a 
 
            90                        9/10  
 C. difficile ǻerm sleC 
493s 
           0                         0/20  
  
C. difficile ǻerm sleC 
128a 
            
        100                         5/5 
 
  
C. difficile R20291 sleC 128a 
 
            
        100                         4/4 
 
 
Table 5.1. ClosTron insertion frequencies with erythromycin or lincomycin 
selection.  Introns were inserted after the indicated number of bases from the 
start of the open reading frame in either the sense (s) or antisense (a) 
orientation.  Erythromycin-UHVLVWDQW ǻerm) and lincomycin-resistant 
(R20291) clones were picked at random and screened by PCR to amplify the 
intron-exon junction.  One clone of each desired mutant was selected, and the 
intron insertion site verified by sequencing. 
 
5.2.2 Colony formation by C. difficile mutant strains after heat treatment 
Following inactivation of CD3563, CD0552 and sleC in C. difficile ǻerm, 
these mutant strains were tested to determine their ability to form heat-resistant 
CFU over a 5-day period on BHIS agar supplemented with the bile salt 
taurocholate (Figure 5.2).  Although inactivation of CD3563 or CD0552 
appeared to have no effect on C. difficile ǻerm colony formation, a sleC 
mutant was unable to form heat-resistant CFU at any point over the 5-day 
period.  This suggests that sleC is absolutely required for sporulation and/or 
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taurocholate-induced germination in C. difficile ǻerm, while neither 
CD3563, nor CD0552, play an obvious role in either process. 
 
In light of the findings in Chapter Three of sporulation and germination 
differences between C. difficile ǻerm and R20291, the effect of sleC 
inactivation was analysed in both strains.  In this analysis, an equivalent 
ClosTron-derived sleC mutant of C. difficile R20291 (CRG1166) was 
constructed (Table 5.1 shows the intron insertion site and frequency of mutants 
obtained), and the effect on colony formation was determined using the 
FRQGLWLRQVHPSOR\HGSUHYLRXVO\IRUǻerm.  This mutant exhibited the same 
phenotype DVLWVǻerm counterpart (Figure 5.3), suggesting that the role of 
sleC is the same in both strains. 
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Figure 5.2. Development of heat-resistant CFU of C. difficile ǻerm 
mutants over 5 days on BHIS agar supplemented with 0.1% taurocholate.  C. 
difficile strains were cultivated as described in Chapter Two.  Ɣ C. difficile 
ǻerm ź &5* &' ż &5* &' Ÿ &5*
(sleC); Ƈ, CRG789 (spo0A).  The symbols indicate the averages of three 
independent experiments, and the error bars indicate standard errors of the 
means.  The detection limit for the assay was 50 CFU/ml.    Data points for 
CRG1115 and CRG789 are overlaid because neither formed any colonies. 
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Figure 5.3. Development of heat-resistant CFU of C. difficile R20291 mutants 
over 5 days on BHIS agar supplemented with 0.1% taurocholate.  C. difficile 
strains were cultivated as described in Chapter Two.  ż, C. difficile R20291; Ɣ, 
CRG1166 (sleC)Ÿ&5*spo0A).  The symbols indicate the averages 
of three independent experiments, and the error bars indicate standard errors of 
the means.  The detection limit for the assay was 50 CFU/ml.    Data points for 
CRG1166 and CRG1375 are overlaid because neither formed any colonies. 
 
To ensure that the observed phenotypes of the sleC PXWDQWVRIǻerm and 
R20291 did not result from growth deficiencies, the change in OD600 was used 
to monitor growth over 5 days in BHIS broth (Figure 5.4 and Figure 5.5).  The 
growth of both mutants was found to be indistinguishable from the growth of 
their respective parental strains, which suggests that there were no obvious 
growth defects following inactivation of sleC in either ǻerm or R20291. 
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Figure 5.4. Growth of C. difficile ǻerm strains in BHIS broth over five 
days.  Strains were cultivated as described in Chapter Two, and the OD600 
PHDVXUHG  Ɣ C. difficile ǻerm Ÿ &5* sleC Ŷ &5*
&' ż &5* &' Ƈ &5* spo0A).  The symbols 
represent the averages of three independent experiments, and the error bars 
represent standard errors of the means.   
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Figure 5.5. Growth of C. difficile R20291 strains in BHIS broth over five 
days.  Strains were cultivated as described in Chapter Two, and the OD600 
PHDVXUHGƔC. difficile 5Ÿ&5*sleCƇ&5*spo0A).  
The symbols represent the averages of three independent experiments, and the 
error bars represent standard errors of the means.   
 
5.2.3 Complementation of sleC mutant with parental SleC 
In order to show that the observed phenotypes of CRG1115 and CRG1166 
were a specific consequence of sleC inactivation, complementation studies 
were performed.  Plasmid pMTL-DB1 was constructed, which contains the 
parental sleC structural gene and the 244 bp region immediately upstream of 
the open reading frame presumed to contain its promoter.  Strains CRG1555 
and CRG1634 were created by introducing this plasmid into sleC mutants of 
C. difficile 6ǻerm and C. difficile R20291, respectively.  Empty vector 
FRQWURO VWUDLQV &5* ǻerm) and CRG1628 (R20291) were also 
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created through introduction of pMTL84151 into the respective sleC mutant 
strains.  Successful plasmid transfer was confirmed by recovery of the plasmid, 
followed by PCR and/or restriction analysis.  In order to control for the 
thiamphenicol selection needed to maintain the plasmids in culture, strains 
CRG1651 and CRG1652 were created by introducing pMTL84151 into 
parental strains 630ǻerm and R20291, respectively.  The development of heat-
resistant CFU was then measured in the same way as previously described, and 
the data were compared to data obtained previously.  The levels of heat-
resistant CFU associated with the taurocholate supplement were fully restored 
in the sleC mutant strains of both C. difficile ǻerm (Figure 5.6) and 
R20291 (Figure 5.7) carrying pMTL-DB1 to the levels of the parental strains 
FDUU\LQJWKHFRQWUROYHFWRUS07/,QWKHFDVHRIǻerm, there was a 
difference between the level of heat-resistant CFU obtained for the strain with 
the control plasmid and the level obtained for the plasmid-free parental strain.  
This difference is presumably as a result of growth under thiamphenicol 
selection conditions, as the antibiotic selection may affect the sporulation 
IUHTXHQF\RIǻerm.  The sleC mutant controls containing the empty vector 
performed like the original mutant, with no observed colony formation over 
the five day period.  Thus it was possible to complement the heat-resistant 
CFU defect, indicating that the observed phenotype was due solely to 
inactivation of sleC. 
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Figure 5.6. Development of heat-resistant CFU of C. difficile ǻerm 
mutants over 5 days on BHIS agar supplemented with 0.1% taurocholate.  C. 
difficile VWUDLQV ZHUH FXOWLYDWHG DV GHVFULEHG LQ &KDSWHU 7ZR  Ɣ C. difficile 
ǻermŸ&5*sleC); ż&5*&5*FRPSOHPHQWHGZLWK
parental sleCƑ&5*&5*KDUERXULQJS07/HPSW\YHFWRU
FRQWURO Ŷ &5* C. difficile ǻerm harbouring pMTL84151).  The 
symbols indicate the averages of three independent experiments, and the error 
bars indicate standard errors of the means.  The detection limit for the assay 
was 50 CFU/ml.   
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Figure 5.7. Development of heat-resistant CFU of C. difficile R20291 mutants 
over 5 days on BHIS agar supplemented with 0.1% taurocholate.  C. difficile 
strains were cultivated as described in Chapter Two.  ż, C. difficile R20291; Ɣ, 
CRG1166 (sleC)Ŷ&5*&5*FRPSOHPHQWHGZLWKSDUHQWDO sleC); 
ź&5* &5*KDUERXULQJS07/Ƈ&5* C. difficile 
R20291 harbouring pMTL84151).  The symbols indicate the averages of three 
independent experiments, and the error bars indicate standard errors of the 
means.  The detection limit for the assay was 50 CFU/ml.    Data points for 
CRG1166 and CRG1628 are overlaid because neither formed any colonies. 
 
5.2.4 Effect of sleC mutation on C. difficile sporulation 
The inability of a sleC PXWDQWRIERWKǻerm and R20291 to develop heat-
resistant CFU could be a consequence of a number of possible defects.  By 
definition, a heat-resistant CFU represents a successfully sporulated vegetative 
cell that was able to survive heat treatment, complete germination, and finally 
grow vegetatively.  A reduction in the observed colony formation following 
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heat shock would suggest that the mutant strains are unable to complete one or 
more of these processes.  To examine the sporulation efficiencies of the mutant 
strains, spores of all C. difficile ǻerm and R20291 strains were counted 
after five days by phase-contrast microscopy and the results were compared to 
the observed development of heat-resistant CFU (Figure 5.8 and Figure 5.9).  
Except for a sporulation negative control, in which the master regulator of 
sporulation spo0A was insertionally inactivated (Heap, et al., 2007), the 
sporulation frequencies of all mutant strains were found to be equivalent to 
those of the corresponding parental strains.  These data confirm that the sleC 
mutants of both C. difficile ǻerm and R20291 sporulate at parental levels 
but are unable to form colonies after heat treatment, even in the presence of the 
bile salt taurocholate. 
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Figure 5.8. Numbers of heat-resistant CFU and spore titres after five days 
incubation in BHIS broth.  Spore counts (bars with diagonal lines) and heat-
resistant CFU (filled bars) were determined for C. difficile ǻerm, 
CRG1115 (sleC), CRG878 (CD3563), and CRG789 (spo0A).  Spore titres and 
heat-resistant CFU were enumerated as described in Chapter Two.  The bars 
represent the averages of three independent experiments, and the error bars 
indicate the standard errors of the means.  The detection limit for colony 
counts was 50 CFU/ml, and the detection limit for spore counts was 5 ×103 
spores. 
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Figure 5.9. Numbers of heat-resistant CFU and spore titres after five days 
incubation in BHIS broth.  Spore counts (bars with diagonal lines) and heat-
resistant CFU (filled bars) were determined for C. difficile R20291, CRG1166 
(sleC) and CRG1375 (spo0A).  Spore titres and heat-resistant CFU were 
enumerated as described in Chapter Two.  The bars represent the averages of 
three independent experiments, and the error bars indicate the standard errors 
of the means.  The detection limit for colony counts was 50 CFU/ml, and the 
detection limit for spore counts was 5 ×103 spores. 
 
5.2.5 Effect of sleC mutation on C. difficile spore viability 
Having shown that the rate of sporulation of sleC mutant strains of C. difficile 
ǻerm and R20291 was not affected compared to the rate of sporulation of 
the respective parental strain, it was important to demonstrate that the 
previously noted reduction in heat-resistant CFU was not a result of altered 
spore heat resistance properties.  Decoating of spores has previously been used 
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to distinguish between spore viability and germination phenotypes (Popham, et 
al., 1995; Paredes-Sabja, et al., 2009b) as decoating and plating with 
supplemental lysozyme allow a germination-deficient spore to form heat-
resistant CFU.  Purified spores of both C. difficile ǻerm and R20291 plated 
without taurocholate formed few heat-resistant CFU compared to spores plated 
with taurocholate (Figure 5.10 and Figure 5.11).  Decoating spores of the 
parental strains resulted in much higher numbers of heat-resistant CFU even in 
the absence of taurocholate, when compared to plating dormant spores without 
taurocholate.  Purified spores of sleC mutants of both C. difficile ǻerm and 
R20291 were unable to form heat-resistant CFU on BHIS agar, with or without 
taurocholate supplement, but decoated sleC spores formed colonies to parental 
levels when plated with lysozyme supplement (Figure 5.10 and Figure 5.11), 
confirming that they were viable. 
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Figure 5.10. Viability of C. difficile ǻerm and CRG1115 (sleC) spores.  
Heat-resistant CFU were determined as described in Chapter Two.  Dormant 
spore cultures were heated before being plated onto BHIS agar (filled bars) or 
BHIS agar supplemented with 0.1% taurocholate (bars with diagonal lines).  
Spore cultures were also decoated before they were plated onto BHIS agar 
VXSSOHPHQWHG ZLWK  ȝJPO O\VR]\PH EDUV ZLWK KRUL]RQWDO OLQHV  7KH EDUV
indicate the averages of three independent experiments, and the error bars 
indicate standard errors of the means.  The detection limit for the assay was 50 
CFU/ml. 
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Figure 5.11. Viability of C. difficile R20291 and CRG1166 (sleC) spores.  
Heat-resistant CFU were determined as described in Chapter Two.  Dormant 
spore cultures were heated before being plated onto BHIS agar (filled bars) or 
BHIS agar supplemented with 0.1% taurocholate (bars with diagonal lines).  
Spore cultures were also decoated before they were plated onto BHIS agar 
VXSSOHPHQWHG ZLWK  ȝJPO O\VR]\PH EDUV ZLWK KRUL]RQWDO OLQHV  7KH EDUV
indicate the averages of three independent experiments, and the error bars 
indicate standard errors of the means.  The detection limit for the assay was 50 
CFU/ml. 
 
Finally, spores of C. difficile ǻerm, R20291 and their respective sleC 
mutant strains were observed by phase-contrast microscopy after heat 
treatment and incubation in BHIS broth supplemented with taurocholate.  
Spores of sleC PXWDQWV RI ERWK ǻerm and R20291 appeared to lose their 
µSKDVH-EULJKW¶FKDUDFWHULVWLFVWRWKHVDPHGHJUHHDVSDUHQWDOVSRUHVDIWHUKRI
incubation.  This is consistent with the characterisation of sleC in C. 
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perfringens (Paredes-Sabja, et al., 2009b) and suggests that C. difficile sleC 
mutant spores undergo the initial stages of germination in association with 
taurocholate, but do not complete the process and go on to grow as vegetative 
cells. 
 
5.3 Discussion 
This study has identified an apparent homologue of sleC from C. perfringens 
that is essential for complete germination and spore outgrowth (in the presence 
of the bile salt taurocholate) of C. difficile spores in both the non-epidemic 
VWUDLQ ǻerm and the BI/NAP1/027 isolate R20291.  Loss of SleC 
eliminated the development of heat-resistant CFU over five days despite 
normal spore formation by the parental strain, and the viability of sleC mutant 
spores was proven as their colony-forming ability after heat shock was restored 
by decoating the dormant sleC spores and supplementing the growth media 
with lysozyme.   
 
It is interesting that SleC is essential for C. difficile spore germination and 
vegetative cell outgrowth.  While Bacillus has traditionally been thought of as 
the model genus for spore germination studies and previous work has 
identified three SCLEs, the cwlJ, sleB, and sleL products (Ishikawa, et al., 
1998; Boland, et al., 2000; Lambert and Popham, 2008), these enzymes are not 
individually essential for complete cortex lysis (Ishikawa, et al., 1998; 
Paidhungat, et al., 2001).  On the other hand, recent work with C. perfringens 
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suggests that the mechanisms of germination are somewhat different in 
Clostridium (Paredes-Sabja, et al., 2008; Paredes-Sabja, et al., 2009b).  The 
identification of SleC as an essential C. perfringens SCLE underlined the 
difference between this clostridial species and the Bacillus paradigm (Paredes-
Sabja, et al., 2009b), and the findings discussed in this chapter support the 
hypothesis that there is a generic difference between the germination of 
Bacillus spores and the germination of Clostridium spores. 
 
It has been shown in B. subtilis that CwlJ is important for CaDPA-induced 
germination (Paidhungat, et al., 2001), providing evidence that a CaDPA-
mediated germination signalling pathway exists in B. subtilis.  In contrast, this 
study has found that an apparent homologue of B. subtilis cwlJ, CD3563, plays 
no obvious role in taurocholate-induced C. difficile spore germination.  Indeed, 
a recent study has suggested that SCLEs in C. perfringens are not triggered by 
CaDPA (Paredes-Sabja, et al., 2009b), although further analysis of CD3563 is 
required to understand its importance, if any, to C. difficile spore germination.  
As CD3563 shares homology with both B. subtilis cwlJ and sleB, it is 
worthwhile to consider the possibility that a variety of functions are possible, 
although under our assay conditions CD3563 does not seem to play any role.  
This becomes more important with the knowledge that although CD0552 has 
been annotated as sleB in the C. difficile 630 genome (Sebaihia, et al., 2006), 
further analysis has shown that the 238 residue protein shares no similarity 
with any known SCLE.  The annotation of CD0552 as sleB may, therefore, be 
a mistake. 
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The absolute requirement for SleC for C. difficile to complete bile-induced 
spore germination could represent a therapeutic target in the healthcare 
environment.  Spore germination in the patient could be prevented through 
inhibition of SleC, and this could reduce the ability of C. difficile to cause 
disease.  Conversely, activating SleC could force spores to germinate on 
surfaces.  As the resulting vegetative cells are exquisitely sensitive to 
traditional decontamination procedures, this may allow for a second or 
combined disinfection step. 
 
5.4 Key outcomes 
x SleC was found to be essential for the complete germination and 
outgrowth of C. difficile spores in both the non-HSLGHPLFǻerm and 
the BI/NAP1/027 isolate R20291. 
x CD3563 was found to play no obvious role in the germination and 
outgrowth of C. difficile spores, suggesting that there may be a generic 
difference between the germination of Bacillus and Clostridium spores. 
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Chapter Six 
 
Analysis of further C. difficile targets which show homology to genes 
important for germination in other spore formers  
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6.1 Introduction 
The study in the previous chapter described the absolute requirement of SleC 
for complete germination and outgrowth of C. difficile spores, while an 
apparent homologue of B. subtilis CwlJ and SleB plays no obvious role in this 
process.  As SleC is also essential for germination in C. perfringens, this 
suggests that the germination mechanisms of Clostridium spores may be 
somewhat different to the germination mechanisms of Bacillus spores.  It is, 
therefore, important to further investigate the germination mechanisms of C. 
difficile, in an effort to better understand how they relate to the germination 
mechanisms of organisms such as C. perfringens and B. subtilis. 
 
6.1.1 Germination-specific proteases 
In dormant spores of C. perfringens, SleC exists in an inactive form, which is 
cleaved into an active enzyme during germination (Urakami, et al., 1999; 
Okamura, et al., 2000; Shimamoto, et al., 2001).  During sporulation, a SleC 
precursor is synthesised consisting of four domains: an N-terminal pre-
sequence (113 amino acid residues); an N-terminal pro-sequence (35 amino 
acid residues); a mature enzyme (264 amino acid residues); and a C-terminal 
pro-sequence of 25 residues (Miyata, et al., 1995; Urakami, et al., 1999; 
Okamura, et al., 2000; Shimamoto, et al., 2001).  During the later stages of 
sporulation, both the N-terminal pre-sequence and the C-terminal pro-sequence 
are cleaved generating an inactive pro-enzyme with a mass of 35 kDa (termed 
³SUR-6OH&´ FRQVLVWLQJ RI WKH 1-terminal pro-sequence and mature enzyme 
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domains (Okamura, et al., 2000).  The inactive pro-SleC is located on the 
outside of the cortex layer in the dormant spore, presumably in the spore outer 
membrane or inner coat layer (Miyata, et al., 1997).  In the pro-SleC form the 
enzyme cannot degrade spore PG, but requires cleavage of the N-terminal pro-
sequence to yield an active SleC (Miyata, et al., 1995; Okamura, et al., 2000). 
 
Work in C. perfringens has identified three germination-specific proteases, 
CspA, CspB and CspC.  These proteins are thought to be important for 
cleaving the N-terminal pro-sequence and generating active SleC, as a 
germination-specific protease consisting of CspA, CspB and CspC can 
accomplish this process (Shimamoto, et al., 2001).  Recently, mutagenesis 
studies have shown that CspB is essential for converting pro-SleC to an active 
enzyme (Paredes-Sabja, et al., 2009c).  Consequently, C. perfringens cspB 
mutant spores do not generate active SleC, are unable to initiate cortex 
hydrolysis, and cannot complete germination and outgrowth.  Whilst this 
information would suggest that the sole function of CspB is to activate pro-
SleC upon initiation of C. perfringens spore germination, in which case the 
phenotype of a cspB mutant would be identical to the phenotype of a sleC 
mutant, there is evidence to suggest that CspB has some other function.  It was 
noted that cspB mutant spores were not able to release CaDPA during 
germination, while a sleC mutant does release CaDPA, albeit slowly (Paredes-
Sabja, et al., 2009c).  This observation of a more severe germination defect in 
cspB mutant strains compared to sleC mutant strains is consistent with CspB 
having another germination-related function other than to activate pro-SleC. 
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Given that the role of SleC appears to be similar in C. perfringens and C. 
difficile, it is desirable to evaluate if germination-specific proteases are also 
involved in C. difficile spore germination.  Genome analysis has shown that 
apparent homologues of these Csp proteases are present in both C. difficile 
ǻerm and C. difficile R20291.  The product of CD2246 (annotated as cspC) 
shows 32% amino acid identity to both CspA and CspC of C. perfringens, and 
the product of CD2247 (annotated as cspBA) shows 36% and 35% identity to 
C. perfringens CspA and CspB, respectively. 
 
6.1.2 Spore-specific peptidoglycan 
As described in Chapter One, cortex PG has a unique, spore-specific structure.  
There are two main differences between the structure of spore PG and 
vegetative cell PG.  First, spore cortex PG is less highly cross-linked compared 
to vegetative cell PG, which may play a role in properties such as heat 
resistance (Atrih and Foster, 1999).  The second main difference is that 
approximately half of NAM residues in spore cortex PG have been converted 
to muramic-į-lactam, a modification not found in vegetative cell PG (Atrih and 
Foster, 1999).  It has been shown that the delta lactam of cortex PG likely 
allows for substrate recognition by SCLEs (Popham, et al., 1996a), and in turn 
prevents SCLE-associated damage to vegetative cell PG following the 
completion of germination.  In B. subtilis, the CwlD protein is required for 
muramic-į-lactam formation during sporulation (Sekiguchi, et al., 1995; 
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Popham, et al., 1996a).  Spores of a cwlD mutant are able to complete the 
earliest stages of germination, including the release of CaDPA and partial 
spore core rehydration, but cortex lysis and, therefore, spore outgrowth does 
not occur (Moir, 2003).  An apparent homologue of B. subtilis cwlD has been 
identified in C. difficile, CD0106 (annotated as cwlD), the product of which 
shows 37% amino acid identity to B. subtilis CwlD. 
 
6.1.3. Bile salts and C. difficile germination 
It is not yet known how C. difficile spores sense a suitable environment for 
germination, although there is evidence to suggest that this involves the 
interaction of C. difficile spores with bile salts.  As described in Chapter One, 
the primary bile acids cholate and chenodeoxycholate are synthesised in the 
liver and further metabolised via conjugation to glycine or taurine.  
Taurocholate is well known to stimulate the germination of C. difficile spores 
(Wilson, et al., 1982; Wilson, 1983; Sorg and Sonenshein, 2008; Giel, et al., 
2010), while chenodeoxycholate acts as an inhibitor of C. difficile spore 
germination (Sorg and Sonenshein, 2009).  Various members of intestinal 
microflora can modify these primary bile acids, converting them to secondary 
bile acids (Coleman and Hudson, 1995; Ridlon, et al., 2006).  The conversion 
of cholate derivatives (which can stimulate C. difficile germination) to the 
secondary bile acid deoxycholate (which can inhibit C. difficile vegetative cell 
growth) may be important for prevention of CDAD in healthy individuals 
(Sorg and Sonenshein, 2008).  Analysis of the C. difficile 630 genome has 
indicated the presence of CD0065, a putative bile acid inducible NADP-
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dependent 7-alpha-hydroxysteroid dehydrogenase, hypothesised to convert 
chenodeoxycholate into the secondary bile acid 7-keto-lithocholate (Sebaihia, 
et al., 2006).  As chenodeoxycholate has been shown to inhibit C. difficile 
germination, but lithocholate is not known to affect the germination of C. 
difficile spores or vegetative cell growth (Sorg and Sonenshein, 2008; Sorg and 
Sonenshein, 2009), such a system may allow vegetative cells of C. difficile to 
µFUHDWH¶DVXLWDEOHHQYLURQPHQWIRUWKe germination of surrounding spores. 
 
6.1.4 Aim of this study 
The previous chapter described the first use of reverse genetics to study the 
germination of C. difficile spores.  This study aimed to inactivate and 
characterise CD0065, cspBA, cspC and cwlD in both C. difficile ǻerm and 
C. difficile R20291, in an effort to further understand how the germination 
mechanisms of C. difficile compare with the germination mechanisms of 
Bacillus and C. perfringens spores. 
 
6.2 Results 
6.2.1 Construction of mutant strains 
To assess the role of CD0065, cspBA, cspC and cwlD in C. difficile spore 
germination, the ClosTron system (Heap, et al., 2007; Heap, et al., 2010) was 
used, as described in Chapter Two, to create insertional mutants of C. difficile 
ǻerm, in which either CD0065, cspBA, cspC or cwlD were inactivated, 
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yielding strains CRG1720, CRG1894, CRG1718 and CRG1719, respectively 
(Table 6.1 shows intron insertion sites and the frequencies of the desired 
mutants obtained).  Correct ClosTron insertion of putative mutant strains was 
confirmed as described in Chapter Five.  In the case of cspBA, it was not 
SRVVLEOH WR LVRODWH WKHGHVLUHGPXWDQW LQǻerm using the base 825s target 
site.  Further screening of >100 erythromycin-resistant clones indicated that no 
desired mutants were present.  The intron site was therefore judged to be 
inefficient (as occasionally occurs when using group II intron technology), so 
another target site (base 1844 with the antisense orientation) was chosen to 
inactivate cspBA. 
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 Strain and target site Frequency of desired mutant among 
clones screened 
  
       %        No. positive/no. screened 
 
 
 C. difficile ǻerm 
CD0065 440a 
 
          100                          2/2  
 C. difficile 630ǻerm cspBA 
825s 
              0                      0/100+  
 C. difficile ǻerm cspBA 
1844a 
       12.5                         1/8  
  
C. difficile ǻerm cspC 
737a 
 
            
        100                         2/2 
 
 C. difficile ǻerm cwlD 
198s 
        100                         2/2  
  
C. difficile R20291 cwlD 
198s 
 
            
        100                         5/5 
 
Table 6.1. ClosTron insertion frequencies with erythromycin or lincomycin 
selection.  Introns were inserted after the indicated number of bases from the 
start of the open reading frame in either the sense (s) or antisense (a) 
orientation.  Erythromycin-UHVLVWDQW ǻerm) and lincomycin-resistant 
(R20291) clones were picked at random and screened by PCR to amplify the 
intron-exon junction.  One clone of each desired mutant was selected, and the 
intron insertion site verified by sequencing. 
 
6.2.2 Colony formation of C. difficile mutant strains after heat treatment 
To assess the importance of CD0065, cspBA, cspC and cwlD in C. difficile 
spore germination, the C. difficile ǻerm mutant strains described above 
were tested to determine their ability to form heat-resistant CFU on BHIS agar 
supplemented with taurocholate (Figure 6.1).  Inactivation of CD0065 had no 
effect on colony formation, but those strains with mutations in either cspBA, 
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cspC or cwlD were unable to form colonies at any point over the five-day 
period.  These data suggest that cspBA, cspC and cwlD are essential for 
sporulation and/or taurocholate-induced germination in C. difficile ǻerm, 
while CD0065 plays no obvious role in either process. 
 
 
Figure 6.1. Development of heat-resistant CFU of C. difficile ǻerm mutant 
strains over a five-day period on BHIS agar supplemented with 0.1% 
WDXURFKRODWH ƔC. difficile ǻermż&5* &'ǻ&5*
(cspBAŶ&5*cspCŸ&5*cwlDDQGƑ&5*spo0A) 
strains were cultivated as described in Chapter Two.  The symbols indicate the 
averages of three independent experiments, and the error bars indicate standard 
errors of the means.  The detection limit for the assay was 50 CFU/ml.  Data 
points for CRG1718, CRG1719 and CRG789 are overlaid due to no colony 
formation.     
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As described in Chapter Three and Chapter Four, differences appear to exist in 
the sporulation and germination characteristics of different C. difficile types.  
Consequently, it was decided to study the effect of cspBA, cspC and cwlD 
inactivation in both C. difficile ǻerm and C. difficile R20291.  An 
equivalent ClosTron-derived cwlD mutant of C. difficile R20291 (CRG1948) 
has been isolated and confirmed (Table 6.1 shows the intron insertion site and 
the frequency of mutants obtained), and the effect on colony formation was 
analysed as described for C. difficile ǻerm (Figure 6.2).  This mutant 
H[KLELWHGWKHVDPHSKHQRW\SHDVLWVǻerm counterpart, which suggests that 
the role of cwlD LVWKHVDPHLQERWKǻerm and R20291. 
 
Figure 6.2. Development of heat-resistant CFU of C. difficile R20291 mutant 
strains over a five-day period on BHIS agar supplemented with 0.1% 
WDXURFKRODWH ƔC. difficile 5Ŷ&5* cwlD DQGƑ&5*
(spo0A) strains were cultivated as described in Chapter Two.  The symbols 
indicate the averages of three independent experiments, and the error bars 
indicate standard errors of the means.  The detection limit for the assay was 50 
CFU/ml.  Data points for CRG1948 and CRG1375 are overlaid because neither 
formed any colonies.     
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In order to determine if the observed phenotypes of cspBA, cspC and cwlD 
mutants were the result of growth deficiencies, the change in OD600 was used 
to monitor growth over 24 h.  The growth of all mutants was indistinguishable 
from the growth of their parental strains (Figure 6.3 and Figure 6.4), which 
suggests that there were no obvious growth defects following inactivation of 
cspBA, cspC or cwlD in either C. difficile ǻerm or C. difficile R20291. 
 
 
Figure 6.3.  Growth of C. difficile ǻerm strains in BHIS broth over 24 h.  
Ɣ C. difficile ǻerm Ŷ &5* cspBA ż &5* cspC DQG Ŷ
CRG1719 (cwlD) strains were cultivated as described in Chapter Two, and the 
OD600 measured.  The symbols represent the averages of three independent 
experiments and error bars indicate the standard errors of the means. 
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Figure 6.4.  Growth of C. difficile 5VWUDLQVLQ%+,6EURWKRYHUKƔ
C. difficile 5 DQG Ŷ &5* cwlD) strains were cultivated as 
described in Chapter Two, and the OD600 measured.  The symbols represent 
the averages of three independent experiments and error bars indicate the 
standard errors of the means. 
 
6.2.3 Effect of cspBA, cspC and cwlD inactivation on C. difficile sporulation 
As described in the previous chapter, an inability to develop heat-resistant 
CFU could be the result of a sporulation defect, altered spore heat-resistance 
properties and/or the inability to complete germination and outgrowth.  To 
study efficiencies of the mutant strains, spores of all C. difficile strains were 
enumerated using phase-contrast microscopy after five days (Figure 6.5 and 
Figure 6.6).  Aside from a sporulation-negative control, a spo0A mutant, the 
spore titres of all mutant strains were the same as their respective parental 
strain.  This suggests that inactivating cspBA, cspC or cwlD does not affect C. 
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difficile spore formation, but that these mutant spores are unable to form 
colonies after heat treatment in association with the bile salt taurocholate. 
 
 
Figure 6.5.  Numbers of heat-resistant CFU and spore titres after five days 
incubation in BHIS broth.  Spore counts (bars with diagonal lines) and heat-
resistant CFU (filled bars) were determined for C. difficile ǻerm, 
CRG1720 (CD0065), CRG1894 (cspBA), CRG1718 (cspC), CRG1719 (cwlD) 
and CRG789 (spo0A).  Spore titres and heat-resistant CFU were enumerated as 
described in Chapter Two.  The bars represent the averages of three 
independent experiments and error bars indicate the standard errors of the 
means.  The detection limit for colony counts was 50 CFU/ml, and the 
detection limit for spore counts was 5 ×103 spores. 
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Figure 6.6.  Numbers of heat-resistant CFU and spore titres after five days 
incubation in BHIS broth.  Spore counts (bars with diagonal lines) and heat-
resistant CFU (filled bars) were determined for C. difficile R20291, CRG1948 
(cwlD) and CRG1375 (spo0A).  Spore titres and heat-resistant CFU were 
enumerated as described in Chapter Two.  The bars represent the averages of 
three independent experiments and error bars indicate the standard errors of the 
means.  The detection limit for colony counts was 50 CFU/ml, and the 
detection limit for spore counts was 5 ×103 spores. 
 
6.2.4 Effect of cspBA, cspC and cwlD inactivation on C. difficile spore viability 
In order to show that the observed phenotype of a cspBA, cspC or cwlD mutant 
was not a consequence of altered spore heat resistance, spores of all C. difficile 
strains were decoated and plated with lysozyme supplement, as described in 
Chapter Two and Chapter Five.  This treatment is important, as it allows a 
viable, germination-deficient spore to form colonies after heat treatment 
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(Popham, et al., 1995; Paredes-Sabja, et al., 2009b).  Purified spores of cspBA, 
cspC and cwlD mutants of C. difficile ǻerm formed very few heat-resistant 
CFU on BHIS agar supplemented with taurocholate, but decoated cspBA, cspC 
and cwlD spores formed parental levels of colonies after heat treatment, 
confirming that these mutant spores were viable (Figure 6.7). 
 
Figure 6.7.  Viability of C. difficile ǻerm, CRG1115 (sleC), CRG1894 
(cspBA), CRG1718 (cspC) and CRG1719 (cwlD) spores.  Heat-resistant CFU 
were determined as described in Chapter Two.  Dormant spore cultures were 
heated before being plated onto BHIS agar (filled bars) or BHIS agar 
supplemented with 0.1% taurocholate (bars with diagonal lines).  Spore 
FXOWXUHV ZHUH DOVR GHFRDWHG DQG SODWHG ZLWK  ȝJPO O\VR]\PH VXSSOHPHQW
(bars with horizontal lines).  The bars indicate the averages of three 
independent experiments and error bars indicate the standard errors of the 
means.  The detection limit for colony counts was 50 CFU/ml. 
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Together, the data presented in this chapter show that cspBA, cspC and cwlD 
mutant strains are able to form parental levels of spores at a normal rate.  The 
spores produced by these mutant strains are viable and heat resistant, but are 
unable to complete germination and return to vegetative cell growth.  This 
suggests that CspBA, CspC and CwlD may all be essential for the germination 
and outgrowth of C. difficile spores. 
 
6.3 Discussion 
In this study, a number of apparent homologues of genes important for 
germination in other spore formers have been analysed for their role in C. 
difficile sporulation and germination.  Loss of cspBA, cspC and cwlD did not 
affect the sporulation ability of C. difficile ǻerm, but the spores were 
unable to germinate and return to vegetative cell growth following heat 
treatment, in association with the bile salt taurocholate.  Decoating mutant 
spores and plating with lysozyme supplement restored colony formation, 
confirming their viability.  This suggests that cspBA, cspC and cwlD may all 
be essential for the germination and outgrowth of C. difficile ǻerm spores, 
providing an interesting follow-up to the previous chapter, which suggested 
that there may be a generic difference between the germination of Bacillus and 
Clostridium spores.  While the germination-specific protease CspB has been 
shown to be essential for SleC processing in C. perfringens (Paredes-Sabja, et 
al., 2009c), these proteases, or in fact proteases of any kind, are not known to 
play any role in the regulation of SCLE activity during the germination of 
Bacillus spores. 
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The hypothesised necessity of a B. subtilis cwlD homologue for complete 
germination and outgrowth of C. difficile ǻerm spores appears to provide 
evidence that the role of cwlD may be the same in both B. subtilis and C. 
difficile.  CwlD in B. subtilis is required during sporulation for the formation of 
delta lactam of muramic acid, a component of spore-specific peptidoglycan.  In 
cwlD mutant strains, germinant receptors are active and the earliest stages of 
germination are completed, however, cortex lysis does not occur.  Such a role 
of CwlD in C. difficile could account for the heat-resistant CFU defect 
observed in this study. 
 
It was observed that inactivation of CD0065 appeared to have no affect on the 
sporulation or germination characteristics of C. difficile ǻerm.  This 
finding is not entirely unexpected, as a protein important for the conversion of 
chenodeoxycholate into lithocholate may not play any direct role as such in the 
sporulation or germination mechanisms of C. difficile.  However, it is expected 
that future studies will analyse in more detail the interaction of C. difficile with 
bile salts such as chenodeoxycholate, as this is clearly an important aspect of 
C. difficile colonisation. 
 
The characterisation of cspBA, cspC and cwlD described in this chapter has 
suggested a possible role of each gene in C. difficile germination and 
outgrowth, although it is obvious that these targets must be further analysed to 
pinpoint the role that they may be playing in C. difficile spore germination.  In 
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particular, it is necessary to complement the heat-resistant CFU defect in these 
three mutant strains, in order to show that the observed phenotypes were a 
specific consequence of the inactivation of the respective target gene.  
However, initial attempts to complement the defect in a cspC mutant were not 
successful.  As described in Chapter Two, plasmid pMTL-DB2 was 
constructed, carrying the parental cspC structural gene and a 302 bp non-
coding region immediately upstream of cspBA, presumed to contain the 
promoter for cspC (Figure 2.3).  This plasmid was introduced into the cspC 
mutant strain of C. difficile ǻerm, but no colony formation was observed 
over five days, suggesting that pMTL-DB2 was not suitable for 
complementing the heat-resistant CFU defect.  There are a number of reasons 
why the heat-resistant CFU defect was not restored following expression of 
pMTL-DB2.  Identification of a putative cspC promoter region was principally 
based on speculation that the promoter would be located immediately upstream 
of cspBA (Figure 6.8).  However, approximately 150 bp upstream of cspBA are 
CD2248 and CD2249 and it is therefore possible that a suitable promoter lies 
further upstream of CD2249 (Figure 6.8).  Identification of this promoter could 
be achieved using techniques such as primer extension but, alternatively, use 
of a known strong promoter may allow for efficient expression of cspC when 
attempting complementation studies in this mutant strain. 
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Figure 6.8. (A) Arrangement of cspBA and cspC, with an annotated 302 bp 
region upstream of cspBA, presumed to contain the promoter for both cspBA 
and cspC.  (B) The arrangement of cspBA, cspC, CD2248 and CD2249 in the 
C. difficile ǻerm genome.   
 
Other explanations for the failure of pMTL-DB2 expression to restore colony 
formation in a cspC mutant include the loss of pMTL-DB2 during cultivation 
in the sporulation medium, altered sporulation frequency of mutant strains 
carrying pMTL-DB2 (an effect that could be analysed by observing spores 
under phase-contrast microscopy), or indeed the possibility that the observed 
mutant phenotype is not a consequence of cspC inactivation, instead a result of 
a potential second ClosTron insertion.  The latter hypothesis could be clarified 
by using Southern blot analysis to identify intron insertions in the cspC mutant 
strain.  The observed mutant phenotype could also be the result of a 
spontaneous mutation, which cannot be confirmed by any method.  In such a 
case, the obvious strategy would be to create further identical mutants and then 
attempt to complement their respective mutant phenotypes.   
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A cwlD mutant in C. difficile R20291 was also unable to form heat-resistant 
CFU over five days, despite forming a parental spore titre.  However, in order 
to confirm spore viability, it will be necessary in the future to analyse heat-
resistant CFU after decoating the mutant spores, as has been described for 
ǻerm mutants.  Future studies will also aim to study cspBA and cspC 
mutants in C. difficile R20291, in order to determine if the mutant phenotype is 
VLPLODU LQ ǻerm.  Interestingly, during the recent development of a 
transposon system for in vivo random mutagenesis of C. difficile, a C. difficile 
R20291 cspBA mutant was isolated (Cartman and Minton, 2010).  This mutant 
strain was unable to form heat-resistant CFU after five days incubation in 
BHIS broth, which suggests that the phenotype of a C. difficile R20291 cspBA 
mutant is the same as the phenotype of a cspBA PXWDQWLQǻerm.  However, 
it will be necessary to analyse spore titres and, if necessary, observe colony 
formation after decoating mutant spores, to clarify the mutant phenotype.  In 
addition, it is important that it is possible to complement this colony formation 
defect. 
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6.4 Key outcomes 
x C. difficile strains with mutations in cspBA, cspC and cwlD formed 
parental spore titres, but were unable to form heat-resistant CFU on 
BHIS agar supplemented with the bile salt taurocholate.  Furthermore, 
a C. difficile R20291 cwlD mutant was also unable to form colonies 
after heat-treatment at any point over five days, despite a parental spore 
titre. 
x Spore viability of C. difficile ǻerm cspBA, cspC and cwlD mutants 
was confirmed by decoating, which suggests that CspBA, CspC and 
CwlD may all be required for complete germination and outgrowth of 
C. difficile spores. 
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Chapter Seven 
 
General discussion 
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7.1 Key findings of this work 
7.1.1 Genes required for germination of C. difficile spores 
To-date, the precise mechanisms by which C. difficile spores germinate have 
not been studied in great depth.  However, a number of genetic tools have now 
been developed for use with C. difficile and have provided a means for the 
reverse genetics studies presented in this thesis (Heap, et al., 2007; Heap, et 
al., 2009; Heap, et al., 2010).  Apparent homologues of genes important for 
germination in other spore formers have been identified in the C. difficile 
genome and this work has described the initial characterisation of six of these 
homologues, in both C. difficile ǻerm and the BI/NAP1/027 isolate 
R20291 (a type associated with outbreaks of increased disease severity).   
 
A homologue of C. perfringens sleC, known to be essential for spore-cortex 
lysis during C. perfringens germination (Paredes-Sabja, et al., 2009b), was 
found to be essential for complete germination of both C. difficile ǻerm 
and R20291 spores in nutrient-rich medium, when germination was induced 
with a supplement of the bile salt taurocholate.  By contrast, CD3563, an 
apparent homologue of both B. subtilis cwlJ and sleB, which encode the two 
major SCLEs of B. subtilis spores, CwlJ and SleB, was found to play no 
obvious role in the germination of C. difficile spores.  This work, described in 
Chapter Five, is the first report of using reverse genetics to study the 
germination of C. difficile spores and the first gene characterisation by 
mutagenesis in a BI/NAP1/027 isolate of C. difficile.  
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This study has also identified potential roles in the germination and outgrowth 
of C. difficile spores for CspBA and CspC, which show homology to the C. 
perfringens germination-specific proteases CspA, CspB and CspC, which are 
associated with the cleavage and activation of pro-SleC upon initiation of 
germination.  While inactivation of cspBA and cspC in C. difficile ǻerm 
did not affect sporulation or spore viability, the spores produced by either 
mutant strain were unable to germinate and return to vegetative cell growth 
with taurocholate supplement.  In addition, spores derived from mutants of C. 
difficile ǻerm and R20291 in which the gene equivalent to the B. subtilis 
cwlD gene was inactivated were unable to complete germination and 
outgrowth.  CwlD is required during the sporulation of B. subtilis for formation 
of the characteristic muramic-į-lactam of spore-cortex PG and is, therefore, an 
important pre-requisite for substrate recognition of SCLEs (Sekiguchi, et al., 
1995; Popham, et al., 1996a).  B. subtilis spores lacking CwlD are viable, but 
are unable to degrade the PG cortex and complete germination, presumably as 
SCLEs only degrade PG containing muramic-į-lactam.  The preliminary 
evidence presented in Chapter Six suggests that CspBA, CspC and CwlD may 
all be essential for germination and outgrowth of C. difficile spores.  To date, 
however, it has not proven possible to complement the germination defect in 
these mutant strains.  It is, therefore, not currently possible to definitively 
ascribe the observed phenotype to the ClosTron-mediated inactivation of the 
target gene. 
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7.1.2 Differences between the germination of Bacillus and Clostridium spores 
Given some of the recent studies that have enhanced our understanding of C. 
perfringens germination mechanisms (Paredes-Sabja, et al., 2009b; Paredes-
Sabja, et al., 2009c), perhaps the main outcome of the reverse genetics work 
presented here is the support for the hypothesis that there is a generic 
difference between the germination mechanisms of Bacillus spores and the 
germination mechanisms of Clostridium spores.  The absolute requirement for 
SleC for complete germination of C. difficile spores is consistent with the role 
of SleC during C. perfringens germination (Paredes-Sabja, et al., 2009b).  In 
contrast, none of the three identified SCLEs of B. subtilis, CwlJ, SleB and 
SleL, are individually essential for complete cortex lysis (Ishikawa, et al., 
1998; Paidhungat, et al., 2001).  Furthermore, while CwlJ is required for 
CaDPA-induced germination in B. subtilis (Paidhungat, et al., 2001), a C. 
difficile homologue, CD3563, appeared to play no obvious role in C. difficile 
germination, and it has been suggested that SCLEs of C. perfringens are not 
activated by CaDPA (Paredes-Sabja, et al., 2009b).   
 
The preliminary characterisation of cspBA and cspC in this work has also 
provided evidence that differences exist in the germination of Bacillus and 
Clostridium spores.  CspBA and CspC show amino acid similarity to the 
germination specific proteases of C. perfringens.  It was recently shown that 
CspB is essential for cortex hydrolysis during germination of C. perfringens 
spores, acting to cleave and activate pro-SleC upon initiation of germination 
(Paredes-Sabja, et al., 2009c).  The findings in Chapter Six, that CspBA and 
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CspC may be required for C. difficile germination, appear to support this 
hypothesis.  On the other hand, there is no known involvement of Csp 
proteases, or indeed any proteases, in the regulation of SCLE activity in 
Bacillus spores.   
 
The work described above has suggested that the activity and regulation of C. 
perfringens SCLEs is considerably different to the activity and regulation of 
Bacillus SCLEs.  Taken together, the reverse genetics studies presented in 
Chapter Five and Chapter Six suggest that the germination mechanisms of C. 
difficile spores appear to be similar to C. perfringens. 
 
7.2 Implications of findings for future experimental designs 
7.2.1 Mutant studies 
One of the most important aims of this work was to optimise an assay 
appropriate for analysing the sporulation and germination efficiencies of C. 
difficile mutant strains.  The historical lack of genetic tools has contributed to 
the sparse literature on media in which C. difficile sporulates efficiently, and 
the methods by which sporulation and germination can be independently 
quantified.  Chapter Three described the development of such an assay, which 
was subsequently used to analyse ClosTron mutants in following chapters.  
Use of this assay allows one to distinguish between (i) rate of sporulation; (ii) 
total sporulation; (iii) spore viability; and (iv) spore germination and outgrowth 
of C. difficile strains, all within a timeframe of approximately one week, with 
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the potential for high-throughput screening of a mutant library if required.  
Furthermore, as C. difficile appears to sporulate efficiently in BHIS broth over 
a five day period, the large C. difficile spore titre present in the culture after 
five days means that spores may then be purified from the same culture used to 
assay these sporulation and germination characteristics, without the need to 
prepare new stocks, for further analysis using other methods when they 
become available.  Figure 7.1 shows a flowchart of the steps required to 
pinpoint a particular defect when analysing C. difficile mutant strains.  Such an 
algorithm should be appropriate for initial screening of mutants in the future, 
to identify sporulation and/or germination defects. 
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Figure 7.1. A diagrammatic representation of the algorithm used in this work 
to characterise the sporulation and germination characteristics of C. difficile 
mutants.  This flowchart details the experimental procedures that, when 
applied together, can identify defects in (i) rate of sporulation; (ii) total 
sporulation at a defined end-point; (iii) viability of spores following heat 
treatment; and (iv) germination and outgrowth of spores. 
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7.2.2 Studying C. difficile sporulation and germination characteristics in vitro 
7KH µK\SHUYLUXOHQFH¶ DVVRFLDWHG ZLWK %,1$3 VWUDLQV RI C. difficile has 
been largely attributed to an increase in toxin production (Warny, et al., 2005), 
although recent studies have argued that an increased rate of sporulation may 
play a role in the incidence and severity of disease (Wilcox and Fawley, 2000; 
Fawley, et al., 2007; Akerlund, et al., 2008).  However, the hypothesis that 
BI/NAP1/027 strains of C. difficile sporulate more prolifically in vitro than 
other types has essentially been based on studies encompassing very few 
individual isolates.  Furthermore, the experimental procedures employed to 
quantify sporulation rates in these studies can be called into question, as it is 
not clear how sporulation was measured independently of aspects such as 
growth rates and the death of non-sporulating cells. 
 
It was shown in Chapter Four that sporulation rates and total sporulation after 
five days varied significantly among individual C. difficile strains, although 
this variation did not appear to be type-associated.  Based on this evidence, and 
contrary to previously published work, the in vitro sporulation rate of C. 
difficile BI/NAP1/027 strains does not appear to be significantly higher than 
non-BI/NAP1/027 strains.  It was also observed that the proportion of 
microscopically-enumerated spores which formed colonies with taurocholate 
supplement varied significantly among C. difficile strains.  However, these 
differences were again not type-associated.  This suggests that the frequency 
by which dormant spores are converted to vegetative cells in vitro varies 
among individual C. difficile isolates, when germination is stimulated on 
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nutrient-rich medium supplemented with the bile salt taurocholate.  This 
finding is not entirely surprising, as it has been suggested that the germination 
capacity of different C. difficile isolates may vary (Baines, et al., 2009), 
although this study only incorporated two individual strains. 
 
There are two main outcomes of the study presented in Chapter Four; that (i) 
current evidence does not support the hypothesis that BI/NAP1/027 strains of 
C. difficile sporulate more prolifically than other types; and (ii) careful 
experimental design is required when analysing C. difficile sporulation rates, to 
avoid over-interpreting data.  This work opens the question of sporulation and 
germination rates, and it is hoped that future studies will further investigate 
these characteristics in many more C. difficile strains.  However, it may be 
premature to link any in vitro differences in sporulation or germination with 
differences in the disease incidence and severity caused by different C. difficile 
types, as it is likely that in vitro models are not truly representative of in vivo 
events. 
 
7.3 The future of C. difficile germination research 
7.3.1 C. difficile germinant receptors 
Arguably, the most important aspect of C. difficile spore germination to 
understand is the mechanism(s) by which dormant spores sense a suitable 
environment for germination.  As outlined previously, this is typically due to 
germinants binding to receptors located in the spore inner membrane, and such 
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receptors have been identified in a number of other spore formers.  The most 
well known germinant receptor system is that of B. subtilis, which possesses 
three tricistronic operons, gerA, gerB and gerK (termed gerA operon 
homologues), and similar systems have been identified in spores of other 
Bacillus species (Clements and Moir, 1998; Paidhungat and Setlow, 2000; 
Hudson, et al., 2001; Setlow, 2003; Pelczar, et al., 2007; Mongkolthanaruk, et 
al., 2009).  Recent characterisation of C. perfringens has indicated the presence 
of monocistronic gerA and gerKB operons and a bicistronic gerKA-gerKC 
operon, which appear to play an important role in the initiation of germination, 
while a tricistronic gerA operon has also been identified in C. botulinum and C. 
sporogenes (Setlow, 2007).  In addition, many other spore formers have been 
shown to possess various receptors from the Ger family.  However, while 
recent studies of the kinetics of C. difficile germination have suggested that 
receptors of taurocholate and glycine are present within C. difficile spores 
(Ramirez, et al., 2010), C. difficile encodes no known homologues of any of 
the systems present in other spore formers and as a result, the genetic basis 
through which C. difficile spores initiate germination remains unknown.  As 
bile salts have not been shown to stimulate germination in any other spore 
formers, it is tempting to speculate that the interaction of C. difficile spores 
with bile salts may result in distinct mechanisms by which C. difficile spores 
initiate germination.  
 
One avenue to explore regarding C. difficile germinant receptors may lie with a 
novel mechanism in B. subtilis, where germination can proceed independent of 
Ger receptors, in response to peptidoglycan in the surrounding environment 
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(Setlow, 2008; Shah, et al., 2008).  This involves binding of small 
muropeptides to a spore inner membrane-bound kinase, a process for which 
PrkC is required.  C. difficile ǻerm encodes a homologue of B. subtilis 
prkC, CD2578 (Sebaihia, et al., 2006), and it would be interesting to evaluate 
what role it plays in the germination of C. difficile spores.  Given our 
knowledge of the role of taurocholate in C. difficile germination, it would be 
particularly interesting to study whether inactivation of CD2578 impairs the 
ability of C. difficile spores to germinate in response to taurocholate. 
 
7.3.2 Forward genetics studies 
Reverse genetic approaches allow for systematic identification and inactivation 
of target genes presumed to play a role in C. difficile spore germination, based 
on homology to genes important for germination in other spore formers.  
However, where no apparent homologues are present, a problem posed in the 
search for C. difficile germinant receptors, it is necessary to use another 
approach.  Forward genetics aims to identify the genetic basis of a particular 
phenotype without assumptions about the genes involved.  Based upon this 
principal, a novel mariner-based transposon system for C. difficile has recently 
been developed, which allows for the generation of libraries of random 
mutants (Cartman and Minton, 2010).  Phenotypic screening of a random 
mutant library in C. difficile R20291 yielded a putative 
sporulation/germination defective clone with an insertion in the cspBA gene, 
showcasing the potential of the system in the detection of genes important for 
C. difficile germination.  It is hoped that this system will now form a basis for 
identification of genes encoding putative C. difficile germinant receptors.   
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7.3.3 Genetic requirements for C. difficile spore germination in vivo 
This work has identified SleC as essential for in vitro germination of C. 
difficile spores in association with the bile salt taurocholate.  It is currently not 
known how the in vitro role of taurocholate in C. difficile germination relates 
to germination events in vivo, and this makes a C. difficile sleC mutant an 
appealing strain to study in an animal infection model.  If C. difficile sleC 
mutant spores were unable to germinate (and therefore unable to cause disease) 
in a Golden Syrian hamster, SleC could become a therapeutic target, as 
inhibition of SleC could potentially prevent C. difficile spore germination in 
susceptible individuals. 
 
7.4 Proposed future research 
7.4.1 Genetics of C. difficile spore germination 
Chapter Five described the identification of SleC as essential for germination 
of C. difficile spores with taurocholate.  Obvious follow-up studies to this one 
would describe the precise role of SleC during germination.  Is SleC required 
for cortex hydrolysis in the same way as SleC of C. perfringens?  Is C. difficile 
SleC synthesised as an inactive pro-enzyme, which must be cleaved and 
activated upon initiation of germination events?  Furthermore, is SleC 
regulated by other proteins within the spore, or can bile salts such as 
taurocholate directly activate SleC and drive germination?  
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The evidence presented in Chapter Six suggests that cspBA, cspC and cwlD 
may both be essential for germination and outgrowth of C. difficile spores.  
Further work, however, will be required to clarify the effect of inactivating 
these genes on C. difficile germination.  In particular, it is necessary to 
complement the germination defect in these mutant strains.  This is especially 
important with cspBA, as the positioning of cspBA and cspC in the genome 
could potentially lead to the cspBA mutant phenotype being the result of a 
polar effect on cspC when using the ClosTron (Figure 6.9).  Finally, given the 
close-relatedness of CspBA and CspC to the germination-specific proteases 
CspA, CspB and CspC of C. perfringens, it would then be interesting to study 
whether these proteins interact with SleC in a similar way to what has been 
described in C. perfringens (Paredes-Sabja, et al., 2009c).   
 
Pinpointing the role of CwlD in germination and outgrowth of C. difficile 
spores will require a detailed knowledge of the PG structure of C. difficile 
spores.  Analysis of spore PG structure by mass spectrometry and high-
performance liquid chromatography could show whether or not CwlD 
functions to modify C. difficile spore PG and, therefore, allow for substrate 
recognition of SCLEs. 
 
7.4.2 Establishment of useful assays to study C. difficile germination 
The studies presented in this thesis have relied on measurements of colony 
formation.  While such a procedure is appropriate for identifying a defect in 
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spore germination and outgrowth, it is worth considering that a number of 
questions will need to be answered in the future.  Where a particular mutation 
prevents colony formation, one such question is whether or not the mutant 
spore can undergo the initial stages of germination.  The most obvious 
procedure in this case is to analyse the loss of spore optical density following 
addition of germinants to a spore suspension.  Such an assay has been briefly 
described in C. difficile (Sorg and Sonenshein, 2008; Sorg and Sonenshein, 
2009), but may require further optimisation in order to improve its sensitivity 
and therefore identify small differences between strains.  A further measure of 
the initiation of C. difficile germination is quantifying the release of DPA from 
spores during germination.  This procedure has been widely used in studying 
Bacillus spores and in C. perfringens, but to-date there have been no published 
examples of such an assay in C. difficile. 
 
7.5 Concluding Remarks 
It is clear that our knowledge of C. difficile spore germination is rudimentary.  
However, it has now been shown that bile salts play a role in both in vitro and 
in vivo germination of C. difficile spores (Wilson, et al., 1982; Wilson, 1983; 
Sorg and Sonenshein, 2008; Sorg and Sonenshein, 2009; Giel, et al., 2010).  In 
addition, our understanding of the genetic basis of C. difficile spore 
germination has been enhanced through the reverse genetics studies described 
in this thesis, and this work has also uncovered evidence that variation in 
germination characteristics exist among C. difficile clinical isolates.  Reports 
to-date have only scratched the surface of C. difficile spore germination, but 
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with a range of genetic tools now at our disposal (Heap, et al., 2007; Heap, et 
al., 2009; Cartman and Minton, 2010; Heap, et al., 2010), the way is open to 
understand more thoroughly this important aspect of CDAD and thereby 
develop effective intervention strategies. 
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SleC Is Essential for Germination of Clostridium difficile Spores in
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Clostridium difficile is the major cause of infectious diarrhea and a major burden to health care services. The
ability of this organism to form endospores plays a pivotal role in infection and disease transmission. Spores
are highly resistant to many forms of disinfection and thus are able to persist on hospital surfaces and
disseminate infection. In order to cause disease, the spores must germinate and the organism must grow
vegetatively. Spore germination in Bacillus is well understood, and genes important for this process have
recently been identified in Clostridium perfringens; however, little is known about C. difficile. Apparent homo-
logues of the spore cortex lytic enzyme genes cwlJ and sleB (Bacillus subtilis) and sleC (C. perfringens) are present
in the C. difficile genome, and we describe inactivation of these homologues in C. difficile 630erm and a
B1/NAP1/027 clinical isolate. Spores of a sleC mutant were unable to form colonies when germination was
induced with taurocholate, although decoated sleC spores formed the same number of heat-resistant colonies
as the parental control, even in the absence of germinants. This suggests that sleC is absolutely required for
conversion of spores to vegetative cells, in contrast to CD3563 (a cwlJ/sleB homologue), inactivation of which
had no effect on germination and outgrowth of C. difficile spores under the same conditions. The B1/NAP1/027
strain R20291 was found to sporulate more slowly and produce fewer spores than 630erm. Furthermore, fewer
R20291 spores germinated, indicating that there are differences in both sporulation and germination between
these epidemic and nonepidemic C. difficile isolates.
The Gram-positive anaerobe Clostridium difficile causes
diarrheal diseases ranging from asymptomatic carriage to a
fulminant, relapsing, and potentially fatal colitis (8, 30). This
organism is resistant to various broad-spectrum antibiotics and
capitalizes on disruption of the normal intestinal flora to col-
onize and cause disease symptoms through the action of toxins
A and B (16, 40). While these toxins are the principal virulence
factors, the ability of the organism to produce endospores is
necessary for disease transmission.
Clostridial spores are extremely resistant to all kinds of
chemical and physical agents and provide the mechanism by
which C. difficile can evade the potentially fatal consequences
of exposure to heat, oxygen, alcohol, and certain disinfectants
(35). Thus, the spores shed in fecal matter are very difficult to
eradicate and can persist on contaminated surfaces in health
care facilities for extended periods of time (35). This leads to
infection or reinfection of cohabitating individuals through
inadvertent ingestion of infected material (10, 32). Once in the
anaerobic environment of the gut, spores presumably germi-
nate to form toxin-producing vegetative cells and, in suscepti-
ble individuals, diarrheal disease.
Spore germination is defined as the events that result in the
irreversible loss of spore characteristics. However, current
mechanistic knowledge of the germination process is based
principally on data derived from studying Bacillus subtilis. Lit-
tle is known about spore germination in clostridia and, in
particular, in C. difficile. Germination is initiated when the
bacterial spore senses specific effectors, termed germinants.
These effectors can include nutrients, cationic surfactants, pep-
tidoglycan, and a 1:1 chelate of pyridine-2,6-dicarboxylic acid
(dipicolinic acid) and Ca2 (CaDPA) (23, 34, 36). Spores of B.
subtilis can germinate in response to nutrients through the
participation of three sensory receptors located in the spore
inner membrane, GerA, GerB, and GerK (23). After activa-
tion, the events include the release of monovalent cations (H,
K, and Na) and CaDPA (accounting for approximately 10%
of the spore dry weight) (36). The third major step in germi-
nation involves hydrolysis of the spore peptidoglycan (PG)
cortex. It is during this hydrolysis that the previously low water
content of the spore is restored to the water content of a
normal vegetative cell and the core is able to expand, which in
turn allows enzyme activity, metabolism, and spore outgrowth
(36).
CwlJ and SleB are two specific spore cortex-lytic enzymes
(SCLEs) involved in Bacillus cortex hydrolysis, which break
down PG containing muramic--lactam (28). SleB has been
shown to localize in both the inner and outer layers of B.
subtilis spores through interaction of the enzyme peptidogly-
can-binding motif and the -lactam structure of the cortex (7,
19) and in association with YpeB, which is required for sleB
expression during sporulation (4, 7). SleB is a lytic transglyco-
sylase muramidase, but so far its mode of activation is un-
known (21). CwlJ is localized to the spore coat during sporu-
lation (3) and is required for CaDPA-induced germination in
B. subtilis. Activation can be due to either CaDPA released
from the spore core at the onset of germination or exogenous
CaDPA (22). Neither enzyme is individually essential for com-
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plete cortex hydrolysis during nutrient germination, although
inactivation of both cwlJ and sleB in B. subtilis results in a spore
unable to complete this process (15). The role of SleL has
recently been studied in Bacillus anthracis. Mutants unable to
produce this enzyme are still able to germinate, but the process
is retarded (18).
The SCLEs of Clostridium are less well studied than those of
Bacillus. The SCLEs SleC (20) and SleM (6) have been iden-
tified in Clostridium perfringens, and a recent study demon-
strated that SleC is required during germination for complete
cortex hydrolysis (26). Although SleM can degrade spore cor-
tex peptidoglycan and inactivation of both sleC and sleM de-
creased the ability of spores to germinate more than inactiva-
tion of sleC alone did, SleM was not essential (26). It has also
been shown that the germination-specific serine protease CspB
is essential for cortex hydrolysis and converts the inactive pro-
SleC found in dormant spores to an active enzyme (24). So far,
there has been no detailed study of any gene responsible for
spore germination in C. difficile, although genes showing ho-
mology to cwlJ and sleB of B. subtilis (CD3563) and sleC of C.
perfringens (CD0551) have now been identified in the C. diffi-
cile 630 genome (33).
With germinant receptors in C. difficile yet to be identified,
the mechanism by which the spores sense a suitable environ-
ment for germination is unclear. Recent studies have suggested
that this process may involve the interaction of C. difficile with
bile. Taurocholate has been shown to enhance recovery of C.
difficile spores in nutrient-rich medium (42), and it has been
proposed that glycine and taurocholate act as cogerminants
(38), while chenodeoxycholate inhibits C. difficile spore germi-
nation (39).
The emergence of C. difficile B1/NAP1/027 strains has in-
creased the burden on health care services worldwide. Such
strains have been shown to produce higher levels of toxin in the
laboratory than many other types of strains (41), although the
mechanism behind this production is not fully understood.
However, while the observed higher levels of toxin production
is doubtless important, perhaps the recent attention given to
B1/NAP1/027 strains has focused too much on toxins. As
spores represent the infectious stage of C. difficile, processes
such as spore germination may also contribute to the greater
virulence of these strains. In this study we evaluated the sporu-
lation and germination efficiencies of an “epidemic” B1/NAP1/
027 C. difficile strain (R20291, isolated from the Stoke
Mandeville outbreak in 2004 and 2005) and the “nonepidemic”
strain 630erm (14). We then constructed strains with muta-
tions in CD3563 (a cwlJ/sleB homologue) and a sleC homo-
logue to analyze the role of these genes in the germination of
C. difficile spores.
MATERIALS AND METHODS
Strains and growth conditions. Unless indicated otherwise, all C. difficile
strains were grown at 37°C in an anaerobic workstation (Don Whitley, United
Kingdom) in BHIS (brain heart infusion supplemented with L-cysteine [0.1%;
Sigma, United Kingdom] and yeast extract [5 mg/ml; Oxoid]) broth or agar,
which has been shown to aid C. difficile sporulation (38). All Escherichia coli
strains were grown using Luria-Bertani broth or agar at 37°C. Plasmid DNA was
transferred into C. difficile 630erm and R20291 by conjugation from an E. coli
donor, as previously described (13, 31). Table 1 shows the strains used in this
study.
Sporulation of C. difficile was achieved by incubating cultures anaerobically in
BHIS broth for 5 days at 37°C. To ensure that no spores were present when the
sporulation medium was inoculated, a starter culture was prepared in BHIS
broth using a 1% inoculum of a C. difficile culture and incubated until the optical
density at 600 nm (OD600) was between 0.2 and 0.5. The sporulation medium was
then inoculated with 0.01 volume of this exponential starter culture. To measure
the growth rates of C. difficile strains, 1-ml samples were removed from the
sporulation medium at different time points and the OD600 was measured (Bio-
mate 3; Thermo Scientific).
Measurement of C. difficile heat-resistant colony formation. Sporulating cul-
tures of C. difficile were prepared as described above. At different times, samples
(500 l) were removed from the anaerobic chamber and heated at 60°C for 25
min to kill the vegetative cells but not the spores. To control for any effects of
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant properties Source or reference
Strains
E. coli TOP10 Invitrogen
E. coli CA434 Conjugation donor 31
CRG789 C. difficile 630erm spo0A::intron ermB 12
C. difficile 630erm 14
C. difficile R20291 Stoke Mandeville (2004-2005) isolate Anaerobe Reference Laboratory,
Cardiff, Wales
CRG878 C. difficile 630erm CD3563::intron ermB This study
CRG1115 C. difficile 630erm sleC::intron ermB This study
CRG1166 C. difficile R20291 sleC::intron ermB This study
CRG1375 C. difficile R20291 spo0A::intron ermB S. A. Kuehne and N. P. Minton,
unpublished data
CRG1555 CRG1115 containing pMTL-DB1 (sleC complementation plasmid) This study
CRG1556 CRG1115 containing pMTL84151 This study
CRG1628 CRG1166 containing pMTL84151 This study
CRG1634 CRG1166 containing pMTL-DB1 (sleC complementation plasmid) This study
CRG1651 C. difficile 630erm containing pMTL84151 This study
CRG1652 C. difficile R20291 containing pMTL84151 This study
Plasmids
pMTL007C-E2 ClosTron plasmid containing catP and intron containing ermB RAM 11
pMTL84151 Clostridium modular plasmid containing catP 13
pMTL-DB1 pMTL84151 containing 1,272-bp SleC coding region and 244-bp upstream
promoter region
This study
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oxygen exposure during heat treatment, a nonheated sample was also removed
from the anaerobic chamber for 25 min. Samples were then returned to the
anaerobic chamber, serially diluted in phosphate-buffered saline (PBS), and
plated onto BHIS agar supplemented with 0.1% taurocholate (Sigma, United
Kingdom). C. difficile spo0A mutants of both 630erm and R20291 were used as
sporulation-negative controls (12). Plates were incubated for 24 h before CFU
were enumerated. Samples were analyzed in the same way every 24 h for 5 days.
The total sporulation after 5 days was measured by counting spores by phase-
contrast microscopy using a Bright-Line hemocytometer (Sigma, United King-
dom).
Assaying the viability of C. difficile spores by decoating. Sporulation cultures
were set up as described above. To prepare pure C. difficile spores following 5
days of incubation, cultures were repeatedly washed with ice-cold distilled H2O
(dH2O) until they contained no cell debris or vegetative cells as observed by
phase-contrast microscopy. Spores were stored at 20°C in dH2O.
Purified spores were decoated by resuspending a spore pellet in 1 ml of 50 mM
Tris-HCl (pH 8.0)-8 M urea-1% (wt/vol) sodium dodecyl-sulfate-50 mM dithio-
threitol and incubating the preparation at 37°C for 90 min as described by
Popham and coworkers (29). Following incubation, decoated spores were
washed three times in PBS. Samples were then heat treated as described above
and plated onto BHIS medium supplemented with lysozyme (1 g/ml).
Strain construction. Target genes were insertionally inactivated with the
ClosTron system as previously described (12), using modular ClosTron plasmid
pMTL007C-E2 (11). Table 2 lists the oligonucleotides used for construction of
insertional mutants. Erythromycin (2.5 g/ml) was used to select C. difficile
630erm integrants, while lincomycin (20 g/ml) was used for selection of C.
difficile R20291 integrants (Table 3). Mutants were confirmed by PCR and
sequencing.
For complementation studies, a 1,516-bp fragment encompassing the sleC
structural gene and 5 noncoding region was cloned into plasmid pMTL84151
(13) to generate plasmid pMTL-DB1. The 244-bp 5 noncoding region likely
encompassing the sleC promoter and the 1,272-bp region containing the sleC
structural gene were independently amplified by PCR using oligonucleotide
primer pairs pSleC_F1/pSleC_R1 and SleC_F2/SleC_R2, respectively. The prim-
ers were designed to allow subsequent cleavage of the two fragments generated
with NotI/NdeI and NdeI/XhoI, respectively, where the ATG of the NdeI site
was synonymous with the translational start codon of sleC. The two cleaved
fragments were subsequently ligated with plasmid pMTL84151 cut with NotI and
XhoI, which yielded plasmid pMTL-DB1, in which the two fragments were
inserted contiguously. The strategy of separating the two regions into two inde-
pendent fragments was adopted to allow subsequent use of a heterologous
promoter if the presence of the 5 noncoding region did not result in expression
of sleC. As the protein encoded by sleC is the same in C. difficile 630erm and
R20291, only one plasmid (pMTL-DB1) was constructed for use with both
mutants.
Both the pMTL-DB1 complementation plasmid and a pMTL84151 empty
vector control were transferred into C. difficile by conjugation, using additional
lincomycin (20 g/ml) selection in sleC mutant strains.
TABLE 2. Oligonucleotides used in this study
Oligonucleotide Sequence (5–3)
Intron retargeting
Cdi-CD3563-226s-IBS .....................AAAAAAGCTTATAATTATCCTTAATGAGCGACAGGGTGCGCCCAGATAGGGTG
Cdi-CD3563-226s-EBS1d................CAGATTGTACAAATGTGGTGATAACAGATAAGTCGACAGGTTTAACTTACCTTTCTTTGT
Cdi-CD3563-226s-EBS2..................TGAACGCAAGTTTCTAATTTCGGTTCTCATCCGATAGAGGAAAGTGTCT
Cdi-sleC-493s-IBS ............................AAAAAAGCTTATAATTATCCTTAGTAGTCCCTGAAGTGCGCCCAGATAGGGTG
Cdi-sleC-493s-EBS1d.......................CAGATTGTACAAATGTGGTGATAACAGATAAGTCCCTGAATTTAACTTACCTTTCTTTGT
Cdi-sleC-493s-EBS2.........................TGAACGCAAGTTTCTAATTTCGATTACTACTCGATAGAGGAAAGTGTCT
Cdi-sleC-128a-IBS............................AAAAAAGCTTATAATTATCCTTACATTACTTCTTAGTGCGCCCAGATAGGGTG
Cdi-sleC-128a-EBS1d ......................CAGATTGTACAAATGTGGTGATAACAGATAAGTCTTCTTAGGTAACTTACCTTTCTTTGT
Cdi-sleC-128a-EBS2 ........................TGAACGCAAGTTTCTAATTTCGGTTTAATGTCGATAGAGGAAAGTGTCT
EBS Universal..................................CGAAATTAGAAACTTGCGTTCAGTAAAC
ClosTron sequencing
Spofdx_F1.........................................GATGTAGATAGGATAATAGAATCCATAGAAAATATAGG
pMTL007_R1...................................AGGGTATCCCCAGTTAGTGTTAAGTCTTGG
Mutant screening
CD3563_F1.......................................CTTTTAGAACTGTTAATCCACCTAATCCCG
CD3563_R1 ......................................CTTTACATTTTTGTGTTTAACAACAACTTATTTATCGC
sleC_F1..............................................GGGAACTAAATTCATTTAAAGAAAGGGTG
sleC_R1 (630erm)..........................GGCTGTTATGAACTAATATATACCATAAGTATTAC
sleC_R1 (R20291)............................GTATTTTTACTTATAAGTATTGTAGTCTTAACAGCC
Complementation
pSleC_F1 ..........................................TAAAGAATGCGGCCGCAGATTATTTTCCTTTCAAAATTTTTGATTTATTTATGATTTATATCAT
CTAC
pSleC_R1..........................................TAAAGAATCATATGATCACCCTTTCTTTAAATGAATTTAGTTCCC
SleC_F2.............................................TAAAGAATCATATGCAAGATGGTTTCTTAACAGTAAGCATAATTGATGC
SleC_R2............................................TAAAGAATCTCGAGATCTCCATGGTTAAATTAAAGGATTTAAAGAAGCTATTCTAGTTGTAGC
TABLE 3. ClosTron insertion frequencies with erythromycin or
lincomycin selection
Strain Target sitea
Frequency of desired
mutant among clones
screenedb
%
No.
positive/no.
screened
C. difficile 630erm CD3563 226s 100 8/8
C. difficile 630erm sleC 493s 0 0/20c
C. difficile 630erm sleC 128a 100 5/5
C. difficile R20291 sleC 128a 100 4/4
a Introns were inserted after the indicated number of bases from the start of
the open reading frame in either the sense (s) or antisense (a) orientation.
b Genomic DNA was extracted from erythromycin-resistant (630erm) or lin-
comycin-resistant (R20291) clones at random and used in a PCR to amplify the
intron-exon junction. One clone of each desired mutant was selected, and the
intron insertion site was verified by sequencing.
c Further screening of a pool of genomic DNA from 100 erythromycin-
resistant clones indicated that no desired mutants were present using the base
493 target site. The intron or target site was therefore judged to be inefficient (as
occasionally occurs using group II intron technology), so another target (base 128
with the antisense orientation) was chosen for sleC.
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RESULTS
Comparison of sporulation and germination of C. difficile
630erm and C. difficile R20291. It has been suggested that
B1/NAP1/027 “epidemic” strains of C. difficile may have dif-
ferent sporulation characteristics than nonepidemic strains (1,
9), although the evidence for this is currently limited. As sporu-
lation is important in the study of spore germination, we de-
cided to study C. difficile germination both in a B1/NAP1/027
strain, R20291, and in a nonepidemic strain, 630erm. First, we
compared the differences in sporulation and germination be-
tween these two strains using a series of assays. In this analysis,
the development of heat-resistant CFU was observed over a
5-day period (Fig. 1). At different times, samples were heated
at 60°C for 25 min before they were plated onto BHIS agar
supplemented with 0.1% taurocholate. The resultant colony
formation clearly showed that C. difficile 630erm developed
heat-resistant spores more rapidly than R20291. 630erm
formed countable heat-resistant CFU after 24 h of incubation,
while it was only after 48 h that this was the case for R20291.
In addition, 630erm cultures contained approximately 400-
fold more heat-resistant CFU than R20291 cultures after 5
days.
It is possible that the observed difference in heat resistance
was not due to sporulation or germination and instead was a
result of growth differences between the two strains. The data
for non-heat-treated CFU recovered on BHIS agar supple-
mented with taurocholate after 5 days were also compared,
and as the colony formation was found to be 30-fold lower for
R20291 than for 630erm (Fig. 2), the changes in OD600 for
both 630erm and R20291 were analyzed over a 5-day period.
No difference was seen between the two strains (data not
shown), which ruled out an elementary growth difference be-
tween 630erm and R20291 and suggested that the observed
difference in the number of non-heat-treated CFU for R20291
was due to the death of nonsporulating cells.
To pinpoint any difference in sporulation between the two
strains, the cultures used to measure development of heat
resistance were analyzed by phase-contrast microscopy, and
the numbers of spores per milliliter were determined. C. diffi-
cile 630erm was found to produce approximately 100-fold
more spores per milliliter than R20291 (Fig. 2), suggesting that
the previously observed difference in heat resistance between
the two strains was due in part to sporulation. However, as
630erm produced 400-fold more heat-resistant CFU than
R20291, we also hypothesized that fewer R20291 spores than
630erm spores germinated under the conditions used for our
assay. To test the hypothesized differences in germination be-
tween 630erm and R20291, the observed spore titers were
compared to the numbers of heat-resistant CFU on BHIS agar
supplemented with taurocholate. It was found that a greater
proportion of 630erm spores (97%) than of R20291 spores
(30%) formed heat-resistant colonies (Fig. 2). Thus, our data
suggest not only that the nonepidemic strain C. difficile
630erm sporulates earlier and to a greater degree than the
B1/NAP1/027 isolate R20291 under the growth conditions em-
ployed but also that a higher proportion of 630erm spores
than of R20291 spores form colonies in association with the
bile salt taurocholate.
Heat-resistant colony formation by C. difficile mutant cul-
tures supplemented with taurocholate. Previous studies have
identified CwlJ and SleB as proteins that are important for
cortex hydrolysis in B. subtilis (15), while SleC is essential for
the same process in C. perfringens (26). Homologues are
present in C. difficile 630 (33); the product of CD0551 (anno-
tated as sleC) shows 53% amino acid identity to the previously
characterized SleC of C. perfringens (17, 26), and the product
of CD3563 shows 30% and 45% amino acid identity to B.
subtilis CwlJ and SleB, respectively. Examination of an incom-
plete genome sequence available at http://www.sanger.ac.uk
FIG. 1. Development of C. difficile heat-resistant CFU over a 5-day
period. Cultures of C. difficile 630erm (F), C. difficile R20291 (Œ), and
CRG789 (spo0A) () were incubated anaerobically at 37°C in BHIS
broth. At 24-h intervals, samples were heat treated at 60°C for 25 min
before they were plated onto BHIS agar supplemented with 0.1%
taurocholate and incubated at 37°C for 24 h. The numbers of heat-
resistant CFU per milliliter were determined. The symbols indicate the
averages of three independent experiments, and the error bars indicate
the standard errors of the means. The detection limit for the assay was
50 CFU/ml.
FIG. 2. Numbers of untreated CFU, spores, and heat-resistant
CFU of C. difficile 630erm and C. difficile R20291 after 5 days of
incubation. Following 5 days of anaerobic incubation at 37°C in BHIS
broth, the numbers of heat-resistant CFU were determined. Spore
titers were determined by counting spores by phase-contrast micros-
copy using a Bright-Line hemocytometer (Sigma, United Kingdom).
The bars indicate the averages of three independent experiments, and
the error bars indicate standard errors of the means. The detection
limit for colony counts was 50 CFU/ml, and the detection limit for
spore counts was 1.6  103 spores.
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indicated that equivalent homologues are also present in C.
difficile R20291. To assess the importance of these genes in C.
difficile germination, the ClosTron system (12) was used to
create independent insertional mutants of C. difficile 630erm
in which either the CD3563 or sleC gene was inactivated,
yielding strains CRG878 and CRG1115, respectively (Table 3
shows intron insertion sites and the frequencies of the desired
mutants obtained). These strains were then tested to deter-
mine their abilities to form heat-resistant colonies over a 5-day
period on BHIS agar supplemented with 0.1% taurocholate
(Fig. 3A). Although inactivation of CD3563 had no effect on
colony formation, a sleC mutant was unable to form heat-
resistant CFU at any point over the 5-day period. The data
suggest that sleC is absolutely required for sporulation and/or
taurocholate-induced germination in C. difficile 630erm, while
CD3563 plays no obvious role in either process.
In light of our findings of sporulation and germination dif-
ferences between C. difficile 630erm and R20291, we analyzed
the effect of sleC inactivation in both strains. In this analysis, an
equivalent ClosTron-derived sleC mutant of C. difficile R20291
(CRG1166) was constructed (Table 3 shows the intron inser-
tion site and frequency of mutants obtained), and the effect on
colony formation was determined using the conditions em-
ployed for strain 630erm. This mutant exhibited the same
phenotype as its 630erm counterpart (Fig. 3B), suggesting
that the role of sleC in C. difficile is the same in both strains.
To ensure that the observed phenotypes of the sleC mutants
of 630erm and R20291 did not result from growth deficien-
cies, the change in OD600 was used to monitor growth over 5
days. The growth of both mutants was indistinguishable from
the growth of their parental strains (data not shown), suggest-
ing that there were no obvious growth defects.
Complementation of sleC mutant with parental SleC. In
order to show that the observed phenotypes of CRG1115 and
CRG1166 were a specific consequence of sleC inactivation, we
performed complementation studies through construction of
plasmid pMTL-DB1 carrying the parental sleC structural gene
and the 244-bp region immediately upstream of the open read-
ing frame presumed to contain its promoter. Strains CRG1555
and CRG1634 were created by introducing this plasmid into
sleC mutants of C. difficile 630erm and C. difficile R20291,
respectively. Empty vector control strains CRG1556
(630erm) and CRG1628 (R20291) were also created through
introduction of pMTL84151 into the respective sleC mutant
strains. Successful plasmid transfer was confirmed by recovery
of the plasmid, followed by PCR and/or restriction analysis
(data not shown). To control for the thiamphenicol selection
needed to maintain the plasmids in culture, strains CRG1651
and CRG1652 were created by introducing pMTL84151 into
parental strains 630erm and R20291, respectively. The devel-
opment of heat-resistant CFU was then measured, and the
data were compared to data obtained previously. The levels of
heat-resistant colony formation associated with the tauro-
cholate supplement were fully restored in the sleC derivatives
of both C. difficile 630erm (Fig. 3A) and R20291 (Fig. 3B)
carrying pMTL-DB1 to the levels in the parental strains con-
taining the control vector pMTL84151. In the case of 630erm,
there was a difference between the level obtained for the strain
with the plasmid and the level obtained for the plasmid-free
parental strain, presumably as a result of growth under thiam-
phenicol selection conditions. The sleC mutant controls con-
taining the empty vector performed like the original mutant.
Thus, it was possible to complement the heat-resistant CFU
defect, indicating that the observed phenotype was due solely
to inactivation of sleC.
Effect of sleC mutation on C. difficile sporulation. An inabil-
ity to develop heat-resistant colonies could be a consequence
of a number of possible defects. By definition, a heat-resistant
colony represents a successfully sporulated vegetative cell that
was able to survive heat treatment, germinate, and grow veg-
etatively. A reduction in the number of observed CFU follow-
ing heat shock would suggest that a strain is unable to complete
one or more of these processes. To examine the sporulation
FIG. 3. Development of heat-resistant CFU of C. difficile mutants
over 5 days. Cultures of C. difficile were incubated anaerobically at
37°C in BHIS broth. Every 24 h, samples were heat treated at 60°C for
25 min before they were plated onto BHIS agar supplemented with
0.1% taurocholate and incubated at 37°C for 24 h. The numbers of
heat-resistant CFU per milliliter were determined. The symbols indi-
cate the averages of three independent experiments, and the error bars
indicate standard errors of the means. The detection limit for the assay
was 50 CFU/ml. (A) F, C. difficile 630erm; Œ, CRG1115 (sleC); E,
CRG1555 (CRG1115 complemented with parental sleC gene); ,
CRG1556 (CRG1115 harboring pMTL84151 empty vector control);f,
CRG1651 (C. difficile 630erm harboring pMTL84151); , CRG878
(CD3563); }, CRG789 (spo0A). (B) (E), C. difficile R20291; F,
CRG1166 (sleC); f, CRG1634 (CRG1166 complemented with paren-
tal sleC); , CRG1628 (CRG1166 harboring pMTL84151); },
CRG1652 (C. difficile R20291 harboring pMTL84151); Œ, CRG1375
(spo0A). All data points for CRG1115 and CRG789 in panel A and for
CRG1166, CRG1628, and CRG1375 in panel B are overlaid because
there was no heat-resistant colony formation.
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efficiencies of the mutant strains, spores of all C. difficile
630erm and R20291 strains were counted after 5 days by
using phase-contrast microscopy, and the results were com-
pared to the observed development of heat-resistant CFU (Fig.
4). Except for a sporulation-negative control, in which the
master regulator of sporulation spo0A was insertionally inac-
tivated (12), the sporulation frequencies of all mutant strains
were found to be equivalent to those of the corresponding
parental strains. This suggests that sleC mutants of both C.
difficile 630erm and C. difficile R20291 sporulate at parental
levels but are unable to form colonies even in the presence of
taurocholate.
Effect of sleC mutation on C. difficile spore viability. Having
shown that the rate of sporulation of an sleC mutant was not
affected compared to the rate of sporulation of the parental
strain for both C. difficile 630erm and R20291, we next dem-
onstrated that the previously noted reduction in heat-resistant
colony formation was not a result of altered spore heat resis-
tance properties. Decoating of spores has previously been used
to distinguish between spore viability and germination pheno-
types (26, 29) as decoating and plating with supplemental ly-
sozyme allow a germination-deficient spore to form heat-resis-
tant colonies. Purified spores of both C. difficile 630erm and
R20291 plated without taurocholate formed few heat-resistant
CFU compared to spores plated with taurocholate (Fig. 5).
Decoating spores of the parental strains resulted in much
higher numbers of heat-resistant CFU even in the absence of
taurocholate. Purified spores of sleC mutants of both C. difficile
630erm and C. difficile R20291 were unable to form heat-
resistant CFU on BHIS agar supplemented with taurocholate
(Fig. 4), but decoated sleC spores formed parental levels of
heat-resistant CFU (Fig. 5), confirming that they were viable.
Finally, we observed C. difficile spores by phase-contrast
microscopy after heat treatment and incubation in BHIS broth
supplemented with taurocholate. Spores of sleC mutants of
both 630erm and R20291 appeared to lose their “phase-
FIG. 4. Numbers of heat-resistant CFU and spore titers after 5
days. Spore counts (bars with diagonal lines) and numbers of heat-
resistant CFU (filled bars) were determined for (A) C. difficile
630erm, CRG1115 (sleC), CRG878 (CD3563), and CRG789 (spo0A)
and (B) C. difficile R20291, CRG1166 (sleC), and CRG1375 (spo0A)
after 5 days of anaerobic incubation at 37°C in BHIS broth. Following
this incubation, numbers of heat-resistant CFU were determined as
described in the legend to Fig. 2. Spore titers were obtained by count-
ing spores by phase-contrast microscopy using a Bright-Line hemocy-
tometer (Sigma, United Kingdom). The bars indicate the averages of
three independent experiments, and the error bars indicate standard
errors of the means. The detection limit for colony counts was 50
CFU/ml, and the detection limit for spore counts was 1.6  103 spores.
FIG. 5. Viability of C. difficile sleC mutant spores. Numbers of
heat-resistant CFU were determined for (A) C. difficile 630erm and
CRG1115 (sleC) spores and (B) C. difficile R20291 and CRG1166 (C.
difficile R20291 sleC) spores. Spore cultures were heated at 60°C for 25
min before they were plated onto BHIS agar (filled bars) or BHIS agar
supplemented with 0.1% taurocholate (bars with diagonal lines).
Spores were also decoated as described in Materials and Methods
before they were plated onto BHIS agar supplemented with 1 g/ml
lysozyme (bars with horizontal lines). The bars indicate the averages of
three independent experiments, and the error bars indicate standard
errors of the means. The detection limit for the assay was 50 CFU/ml.
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bright” characteristics to the same degree as parental spores
after 2 h of incubation. This is consistent with the character-
ization of sleC in C. perfringens (26) and suggests that C. difficile
sleC mutant spores undergo the initial stages of germination in
association with taurocholate but do not complete the process
and grow as vegetative cells.
DISCUSSION
In this study we identified a homologue of sleC from C.
perfringens that is essential for complete germination (in the
presence of taurocholate) of C. difficile spores in both the
nonepidemic strain 630erm and the B1/NAP1/027 isolate
R20291. Loss of SleC eliminated the development of heat-
resistant CFU over 5 days despite spore formation by the
parental strain, and the viability of sleC mutant spores was
proven as their colony-forming ability after heat shock was
restored by decoating. It is interesting that SleC is essential for
C. difficile spore germination and vegetative cell outgrowth.
While Bacillus has traditionally been thought of as the model
genus for spore germination studies and previous work has
identified three SCLEs, the cwlJ, sleB, and sleL products (4, 15,
18), these enzymes are not individually essential for complete
cortex lysis (15, 22). On the other hand, recent work with C.
perfringens suggests that the mechanisms of germination are
somewhat different in Clostridium (26, 27). The identification
of SleC as an essential C. perfringens SCLE underlined the
difference between this clostridial species and the Bacillus par-
adigm (26), and our findings support the hypothesis that there
is a generic difference between the germination of Bacillus
spores and the germination of Clostridium spores. Further-
more, while germination-specific serine proteases have been
characterized in C. perfringens (24, 37) and homologues have
been identified in C. difficile 630 (33), these proteases are not
known to play any role in Bacillus germination.
It has been shown that in B. subtilis CwlJ is important for
CaDPA-induced germination (22), providing evidence that
there is a CaDPA-mediated germination signaling pathway in
Bacillus. In contrast, we found that a B. subtilis cwlJ homo-
logue, CD3563, plays no obvious role in taurocholate-induced
C. difficile spore germination. Indeed, recent studies have sug-
gested that SCLEs in C. perfringens are not triggered by
CaDPA (26), although further analysis of CD3563 is required
to understand its importance, if any, to C. difficile spore ger-
mination. As CD3563 shares homology with both B. subtilis
cwlJ and sleB, it is worthwhile to consider the possibility that a
variety of functions are possible, although under our assay
conditions CD3563 does not seem to play any role. This be-
comes more important with the knowledge that CD0552 has
been annotated as sleB in the C. difficile 630 genome (33),
although the 238-residue protein shares no similarity with any
known SCLE.
While we can argue that our characterization of SleC and
early studies of a cwlJ/sleB homologue suggest similarities be-
tween the germination of C. difficile spores and the germina-
tion of C. perfringens spores, it must be noted that there are
obvious differences when germination characteristics as a
whole are compared. Early characterization of C. perfringens
germinant receptors indicated that monocistronic gerA and
gerKB operons and a bicistronic gerKA-gerKC operon play a
role in the early stages of germination (25, 27), and similar
mechanisms have been described for other spore formers. B.
subtilis has three tricistronic operons, gerA, gerB, and gerK (36),
while a tricistronic gerA operon has also been identified and
studied in both Clostridium botulinum and Clostridium sporo-
genes (2, 5). In contrast, none of these systems are present in C.
difficile. Spore cortex lysis may proceed in similar ways in C.
difficile and C. perfringens, but the circumstances under which
the spores germinate likely differ. As a result, identification of
C. difficile germinant receptors is crucial to understanding C.
difficile spore germination.
The emergence of C. difficile B1/NAP1/027 strains (8) has
strengthened the need to understand C. difficile spore germi-
nation, and our report is the first report of gene characteriza-
tion by mutagenesis in a B1/NAP1/027 isolate of C. difficile.
These strains are associated with more severe disease and
greater virulence, and although it is still unclear how sporula-
tion and germination in epidemic and nonepidemic strains
compare, it has been suggested that the rate of sporulation is
higher in particular B1/NAP1/027 isolates (1, 9). Therefore,
the data that we present showing that R20291 sporulates and
germinates less efficiently than 630erm is perhaps surprising.
We showed that C. difficile R20291 sporulates slower (Fig. 1)
and forms fewer spores than C. difficile 630erm over a 5-day
period (Fig. 2). Furthermore, a lower number of the observed
spores of R20291 than of the observed spores of 630erm
formed heat-resistant colonies, indicating that fewer R20291
spores germinate under our assay conditions. These findings
indicate that caution should be used when general conclusions
are drawn about the properties of types of C. difficile strains
without an adequate sample size. Studies encompassing a large
number of C. difficile isolates are necessary to define what role
sporulation and germination play in disease.
The absolute requirement for SleC for C. difficile to com-
plete bile-induced spore germination could represent a thera-
peutic target in the health care environment. Spore germina-
tion in the patient could be prevented through inhibition of
SleC, and this could reduce the ability of C. difficile to cause
disease. Conversely, activating SleC could force spores to ger-
minate on surfaces. As vegetative cells are far more susceptible
to traditional decontamination procedures, this may allow a
second, or combined, disinfection step. Thus, dissemination of
C. difficile infection may be reduced, and control of disease in
the health care environment could be a more realistic target.
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Abstract
Endospore production is vital for the spread of Clostridium difficile infection. However, in order to cause disease, these spores must
germinate and return to vegetative cell growth. Knowledge of germination is therefore important, with potential practical implications for routine
cleaning, outbreak management and potentially in the design of new therapeutics. Germination has been well studied in Bacillus, but until
recently there had been few studies reported in C. difficile. The role of bile salts as germinants for C. difficile spores has now been described in
some detail, which improves our understanding of how C. difficile spores interact with their environment following ingestion by susceptible
individuals. Furthermore, with the aid of novel genetic tools, it has now become possible to study the germination of C. difficile spores using both
a forward and reverse genetics approach. Significant progress is beginning to be made in the study of this important aspect of C. difficile disease.
 2010 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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1. Introduction
Clostridium difficile is the major cause of nosocomial
diarrhoea and a major burden to healthcare services world-
wide. Outbreaks of C. difficile-associated disease (CDAD) can
lead to patient isolation, ward closures, and in some cases,
hospital closure. In 2008, almost 6000 deaths in England and
Wales alone were attributed to CDAD (from the Office of
National Statistics, available at http://www.statistics.gov.uk).
The principal virulence factors of C. difficile have been
identified as toxins A and B, which target the Ras superfamily
of GTPases for modification via glycosylation, ultimately
leading to destruction of intestinal epithelial cells (Voth and
Ballard, 2005). Subsequent symptoms can range from mild
diarrhoea to a fulminant, relapsing and potentially fatal colitis.
In addition, the production of endospores plays a pivotal role
in the transmission of disease. Clostridial spores are resistant
to all manner of chemical and physical agents (Setlow, 2007),
and this provides the mechanism for C. difficile persistence on
surfaces, leading to infection through inadvertent ingestion of
contaminated material (Gerding et al., 2008; Riggs et al.,
2007). Spore germination is defined as the irreversible loss
of spore-specific properties and it is this process which allows
for vegetative cell growth and subsequent toxin production.
Consequently, the ability to manipulate C. difficile spore
germination mechanisms could have direct applications in
future disease prevention.
This review will focus on the latest studies which have
advanced our understanding of C. difficile spore germination,
and describe how novel genetic tools now at our disposal will
open the way for studies that have not previously been
possible in C. difficile.
2. Model of bacterial spore germination
Current mechanistic knowledge of germination is based
principally on data obtained by studying Bacillus subtilis.
Germination is initiated when a spore senses specific effectors,
termed germinants. Spores of B. subtilis can germinate through
the binding of germinants, either L-alanine or a mixture of
* Corresponding author. Tel.: þ44 0115 84 67458; fax: þ44 0115 82 32120.
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asparagine, glucose, fructose and potassium ions, to specific
receptors, GerA, GerB and GerK, located in the spore inner
membrane (Paidhungat and Setlow, 2000). The spore is then
committed to germination and subsequent events include the
release of monovalent cations (Hþ, Naþ and Kþ) and a large
depot (w25% of spore dry weight) of calcium dipicolinic acid
(CaDPA) (Setlow, 2003), a process for which SpoVA proteins
are required (Vepachedu and Setlow, 2004, 2007a, b). The third
major step in germination involves the hydrolysis of the spore
peptidoglycan (PG) cortex. It is during this hydrolysis that the
previously low water content of the spore is returned to that of
a vegetative cell and the core is able to expand, in turn allowing
for enzyme activity, metabolism and, ultimately, vegetative cell
outgrowth (Setlow, 2003). B. subtilis encodes two redundant
spore cortex lytic enzymes (SCLEs), CwlJ, required for
CaDPA-induced germination (Ishikawa et al., 1998; Paidhungat
et al., 2001), and SleB, the mode of activation of which is
unknown. The specific proteins YpeB (SleB) and GerQ (CwlJ)
are required for enzyme assembly and/or stability in spores
(Boland et al., 2000; Ragkousi et al., 2003) and these SCLEs
specifically degrade spore PG containing muramic-d-lactam
(Popham et al., 1996), which is not present in normal cell wall
PG. This PG modification occurs during sporulation in associ-
ation with the CwlD protein (Popham et al., 1996; Sekiguchi
et al., 1995) and prevents SCLE-associated damage to the
vegetative cell on completion of the germination process.
3. Role of bile salts in C. difficile spore germination
The specific conditions by which C. difficile spores sense
a suitable environment for germination remain unclear. Recent
work, however, has suggested that bile salts play a pivotal role.
Thus following on from the earlier observation that taur-
ocholate improves the recovery of C. difficile spores from
environmental surfaces (Wilson et al., 1982), a study by Sorg
and Sonenshein demonstrated that specific bile salts and
glycine act as cogerminants of C. difficile spores, while the
secondary bile salt deoxycholate prevented vegetative cell
growth (Sorg and Sonenshein, 2008). They hypothesise that, in
a healthy host, C. difficile spores can survive passage into the
jejunum where they germinate in response to the high
concentrations of cholate derivatives and glycine. However, in
such individuals, cholate derivatives that escape enterohepatic
circulation are metabolised into the secondary bile salt deox-
ycholate. Thus, outgrowth of C. difficile spores is prevented.
Conversely, following disruption of intestinal flora, secondary
bile salts such as deoxycholate are not readily produced.
C. difficile vegetative cell growth is therefore not prevented
and disease may occur in susceptible individuals.
A further study by Sorg and Sonenshein (2009) has
described the role of the primary bile salt chenodeoxycholate
in the inhibition of C. difficile spore germination. This adds an
interesting element to their model of C. difficile colonisation.
In equal concentrations, both cholate and chenodeoxycholate
derivatives may compete for binding to putative C. difficile
germinant receptors. However, as the rate of absorption by the
colon of chenodeoxycholate is 10 times that of cholate
(Mekhjian et al., 1979), spores reaching the large intestine
encounter a higher concentration of cholate derivatives. This
suggests that germination may be inhibited until C. difficile
spores reach the anaerobic environment of the large bowel,
where conditions are suitable for C. difficile vegetative cell
growth.
A recent study has further expanded our knowledge of how
C. difficile spores may interact with bile salts (Giel et al.,
2010). The authors described how, using an extract from
mouse small intestine, a factor produced in vivo stimulated
colony formation of C. difficile spores. Treatment of the
extract with cholestyramine, a bile salt binding resin, reduced
the ability of the extract to stimulate colony formation, sug-
gesting that the compound produced is likely a bile salt.
Furthermore, colony formation was stimulated to greater
levels in extracts from mice treated with clindamycin, ampi-
cillin or streptomycin, suggesting that disruption of normal
intestinal flora plays a role in the germination frequency of
C. difficile spores in vivo. Indeed, a possible role of antibiotics
such as fluoroquinolones and clindamycin in inducing
C. difficile germination has been described, further supporting
this hypothesis (Baines et al., 2009; Saxton et al., 2009).
These studies now suggest that the interaction of C. difficile
with bile salts and antibiotics, coupled with disruption of
normal intestinal flora, plays an important role in C. difficile
colonisation and subsequent disease. Consequently, it now
becomes important to understand the detailed mechanism of
such interactions and this requires knowledge of the genetic
basis of C. difficile spore germination.
4. Studying C. difficile spore germination using reverse
genetics
The precise mechanisms of germination in C. difficile have
not been studied in great depth, due in part to a historical
absence of genetic tools. However, the ClosTron, a facile
directed mutagenesis system, has recently been developed and
allows for the creation of stable, insertional mutants in
C. difficile (Heap et al., 2007; Heap et al., 2010). The result of
this is an efficient means to study C. difficile spore germination
using a reverse genetics approach, by identifying homologues
of genes important for germination in other spore formers,
inactivating them, and inferring their function from mutant
phenotypes.
A direct application of the ClosTron system in C. difficile
has now been reported with the characterization of an apparent
Clostridium perfringens sleC homologue in both an erythro-
mycin-sensitive variant of the C. difficile 630 genome strain
(630Derm) (Hussain et al., 2005) and a restriction endonu-
clease type BI, North American pulsed-field type NAP1 and
PCR ribotype 027 (BI/NAP1/027) isolate (R20291, isolated
from the 2004/2005 Stoke Mandeville outbreak). SleC was
found to be essential for colony formation when germination
of C. difficile spores was induced in nutrient-rich medium
supplemented with taurocholate, while CD3563 (an apparent
homologue of B. subtilis cwlJ and sleB) was found to play no
obvious role under the same conditions (Burns et al., 2010).
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This finding is in line with similar studies in C. perfringens, in
which sleC encodes an enzyme essential for cortex hydrolysis
during germination (Paredes-Sabja et al., 2009a, b; Miyata
et al., 1995; Shimamoto et al., 2001). It is interesting that
SleC is essential for germination and outgrowth of C. difficile
spores. While Bacillus is traditionally thought of as the model
organism for studying spore germination and previous work
has identified three SCLEs, CwlJ, SleB and SleL, these
enzymes are not individually essential for complete cortex
lysis. Furthermore, while B. subtilis CwlJ is required for
CaDPA-mediated cortex lysis, it has been suggested that
SCLEs in C. perfringens are not triggered by CaDPA
(Paredes-Sabja et al., 2009a, b). The evidence to suggest that
a CwlJ homologue in C. difficile plays no obvious role in
germination and outgrowth therefore suggests that the mech-
anisms of germination in Clostridium are somewhat different
from Bacillus.
With the aid of a directed mutagenesis system such as the
ClosTron, reverse genetics studies identifying additional genes
required for C. difficile spore germination will likely follow in
the future. Table 1 lists a number of apparent homologues in
C. difficile of genes important for spore germination in other
organisms, targets which may form a basis for future reverse
genetics studies of C. difficile germination. Additionally, the
336 spore-associated polypeptides identified by mass spec-
trometric analysis of C. difficile spores represent further key
targets for functional analysis, in particular the 88 clostridial
spore core proteins and the and 29 proteins identified as
C. difficile spore specific (Lawley et al., 2009).
5. The future of C. difficile germination research
Arguably, the most important aspect of spore germination
to understand is the mechanism(s) by which dormant spores
sense a suitable environment for germination. As outlined
above, this is typically due to germinants binding to receptors
located in the spore inner membrane, and such receptors have
been identified in a number of other spore formers. Charac-
terization of C. perfringens has indicated that monocistronic
gerA and gerKB operons and a bicistronic gerKA-gerKC
operon play an important role in the initiation of germination,
and similar mechanisms have been described in other spore
formers. B. subtilis has three tricistronic operons, gerA, gerB
and gerK, while a tricistronic gerA operon has also been
identified in Clostridium botulinum and Clostridium spor-
ogenes (Setlow, 2007). However, C. difficile encodes no
known homologues of any of these systems, and as a result,
the mechanism through which C. difficile spores initiate
germination remains unknown.
Reverse genetic approaches allow for systematic identifi-
cation and inactivation of target genes presumed to play a role
in C. difficile spore germination, based on homology to genes
important for germination in other spore formers. However,
where no apparent homologues are present, a problem posed
in the search for C. difficile germinant receptors, it is necessary
to use a forward genetics approach. Forward genetics aims to
identify the genetic basis of a particular phenotype without
assumptions about the genes involved. Based upon this prin-
cipal, a novel mariner-based transposon system for C. difficile
has recently been developed, which allows for the generation
of libraries of random mutants (Cartman and Minton, 2010).
Phenotypic screening of a random mutant library in a BI/
NAP1/027 strain of C. difficile yielded a putative sporulation/
germination defective clone with an insertion in a gene
showing homology to the germination-specific proteases cspB
and cspA of C. perfringens (Paredes-Sabja et al., 2009a, b),
showcasing the potential of the system in the detection of
genes important for C. difficile germination. It is hoped that
this system will now form a basis for identification of genes
encoding putative C. difficile germinant receptors.
6. BI/NAP1/027 strains of C. difficile
The recent emergence of BI/NAP1/027 strains of C. diffi-
cile has strengthened the need to develop effective treatments
and/or disinfection measures (O’Connor et al., 2009; Dawson
et al., 2009). This type is now the most commonly isolated
C. difficile type in England and Wales and is associated with
outbreaks of increased disease severity (Brazier et al., 2008).
Furthermore, some strains of this type have been shown to
produce higher levels of toxin in vitro (Warny et al., 2005).
Recently, it has been shown that the germination frequency of
Table 1
Known gene targets in C. difficile based on homology to genes important for spore germination in other spore formers.
C. difficile target
(630Derm)
Homologues Hypothesised function
CD0551 C. perfringens sleC (Paredes-Sabja et al., 2009a, b) Spore cortex lytic enzyme
CD3563 B. subtilis cwlJ/sleB (Ishikawa et al., 1998;
Masayama et al., 2006; Chirakkal et al., 2002)
Spore cortex lytic enzyme
CD2246 C. perfringens cspA/cspC (Paredes-Sabja et al., 2009a, b) Germination-specific protease
CD2247 C. perfringens cspA/cspB (Paredes-Sabja et al., 2009a, b) Germination-specific protease
CD0106 B. subtilis cwlD (Popham et al., 1996) Germination-specific N-acetylmuramoyl-L-alanine
amidase
CD0773 B. subtilis spoVAC (Vepachedu and Setlow, 2004, 2007a, b) CaDPA release
CD0774 B. subtilis spoVAD (Vepachedu and Setlow, 2004, 2007a, b) CaDPA release
CD0775 B. subtilis spoVAE (Vepachedu and Setlow, 2004, 2007a, b) CaDPA release
CD2578 B. subtilis prkC (Shah et al., 2008) Peptidoglycan-associated germination
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the ‘epidemic’ BI/NAP1/027 isolate R20291 is lower than that
of a ‘non-epidemic’ C. difficile, 630Derm (Burns et al., 2010).
This suggests that differences may exist in the germination of
epidemic and non-epidemic types of C. difficile. As spores
represent the infectious stage of C. difficile, diversity in the
germination characteristics of particular types may contribute
to the observed differences in disease severity.
7. Conclusions
It is clear that our knowledge of C. difficile spore germi-
nation is rudimentary. However, it has now been shown that
bile salts play a role in both in vitro and in vivo germination of
C. difficile spores (Sorg and Sonenshein, 2008, 2009; Giel
et al., 2010). In addition, our understanding of the genetic
basis of C. difficile spore germination has been enhanced
through early reverse genetics studies (Burns et al., 2010). As
spores represent the principal infectious stage of C. difficile
(Gerding et al., 2008; Riggs et al., 2007), and as these spores
must germinate to allow for vegetative cell growth and toxin
production, a detailed understanding of the germination
process may have direct applications for disease prevention in
the healthcare environment. Germinants could be used to
stimulate germination of C. difficile spores on surfaces. The
resulting vegetative cells are exquisitely sensitive to stresses
such as oxygen, traditional decontamination procedures and
the gastric barrier. Conversely, inhibition of germination
following ingestion of spores may reduce the ability of
C. difficile to colonise and cause disease. Reports to date have
only scratched the surface of C. difficile spore germination, but
with a range of genetic tools now at our disposal (Heap et al.,
2007, 2009, 2010; Cartman and Minton, 2010), the way is
open to understand more thoroughly this important aspect of
CDAD and thereby develop effective intervention strategies.
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a b s t r a c t
Clostridium difﬁcile causes diarrhoeal diseases ranging from asymptomatic carriage to a fulminant, relapsing,
andpotentially fatal colitis. Endosporeproductionplaysavital role in transmissionof infection, and inorder to
cause disease these spores must then germinate and return to vegetative cell growth. Type BI/NAP1/027
strains of C. difﬁcile have recently become highly represented among clinical isolates and are associatedwith
increased disease severity. It has also been suggested that these ‘epidemic’ types generally sporulate more
proliﬁcally than ‘non-epidemic’ strains, although the few existing reports are inconclusive and encompass
only a small number of isolates. In order to better understand any differences in sporulation rates between
epidemic and non-epidemic C. difﬁcile types, we analysed these characteristics using 14 C. difﬁcile clinical
isolatesof avarietyof types. Sporulation ratesvariedgreatlybetween individualBI/NAP1/027 isolates, but this
variation did not appear to be type-associated. Furthermore, a number of BI/NAP1/027 spores appeared to
form colonieswith a lower frequency than speciﬁc non-BI/NAP1/027 strains. The data suggest that (i) careful
experimental design is required in order to accurately quantify sporulation; and (ii) current evidence cannot
link differences in sporulation rates with the disease severity of the BI/NAP1/027 type.
 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Clostridium difﬁcile is the major cause of hospital-acquired diar-
rhoea and a burden to healthcare services worldwide. Endospores,
produced during sporulation, are pivotal to disease transmission. The
resistance of these spores to all manner of chemical and physical
agents [1] provides the mechanism for C. difﬁcile persistence on
surfaces, leading to infection through inadvertent ingestion of
contaminatedmaterial [2,3]. Sporegermination,deﬁnedastheevents
that lead to the irreversible loss of spore-speciﬁc characteristics, is
essential for the conversion of spores to vegetative cells, and is
absolutely required for subsequentdisease. Restriction-endonuclease
analysis type BI, North Americanpulsed-ﬁeld type 1 (NAP1) and PCR-
ribotype 027 (BI/NAP1/027) strains of C. difﬁcile have recently been
associated with outbreaks of increased disease severity [4,5] and
some have been shown to produce higher levels of toxin in the
laboratory [6]. It has also been suggested that the in vitro rate of
sporulation is greater in BI/NAP1/027 strains of C. difﬁcile [7e9],
although we have recently shown that, in the laboratory, the
‘epidemic’ BI/NAP1/027 isolate R20291 sporulates and germinates
with a lower frequency than the ‘non-epidemic’ C. difﬁcile strain
630Derm [10]. To-date, the literature contains insufﬁcient data to
directly compare the sporulation of different C. difﬁcile types. The
precise role of sporulation in disease incidence and severity, there-
fore, remains unclear. In this study, we use an accurate, reproducible
assay to measure the sporulation characteristics of a variety of C.
difﬁcile types, including several BI/NAP1/027 isolates frombothNorth
America and Europe (Table 1 lists the strains used in this study).
2. Materials and methods
2.1. Bacterial strains and growth conditions
All C. difﬁcile strains were grown at 37 C in an anaerobic
workstation (Don Whitley, United Kingdom) in BHIS (brain heart
infusion supplemented with L-cysteine [0.1%, Sigma, United
Kingdom] and yeast extract [5 mg/ml, Oxoid]) broth or agar [11], in
which C. difﬁcile sporulates efﬁciently.
2.2. Preparation of C. difﬁcile spores
Sporulation of C. difﬁcile was achieved by incubating cultures in
BHIS broth for 5 days. First, C. difﬁcile strains were selected on BHIS
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agar supplemented with cycloserine (250 mg/ml) and cefoxitin
(8 mg/ml). To ensure no spores were present on inoculation of the
sporulation medium, a starter culture was prepared in BHIS broth
with a 1% inoculum of an overnight culture and incubated until an
optical density at 600 nm (OD600) of between 0.2 and 0.5 was
reached. Finally, the sporulation mediumwas then inoculated with
a 1% inoculum of this exponential starter culture.
2.3. Measurement of C. difﬁcile sporulation
In order to measure colony formation, 500 ml samples were
removed from the anaerobic chamber and heated at 60 C for
25 min to kill vegetative cells but not spores. Samples were then
returned to the anaerobic chamber, serially diluted in phosphate-
buffered saline, and plated onto BHIS agar supplemented with the
bile salt taurocholate (0.1%, Sigma, United Kingdom) to induce
germination and enhance recovery of C. difﬁcile spores [11,12]. The
plates were incubated for 24 h before colony forming units (CFU)
were enumerated. Total sporulation after 5 days incubation in BHIS
broth was assayed by counting spores under phase-contrast
microscopy using a Bright-Line haemocytometer (Sigma, United
Kingdom). All statistical analysis was carried out in GraphPad
Prism using Student’s t-test for the comparison of BI/NAP1/027
with non-BI/NAP1/027, and one-way analysis of variance with
Tukey’s post hoc compensation for multiple comparisons of indi-
vidual strains.
3. Results and discussion
First we cultivated all of the C. difﬁcile strains in BHIS broth for
24 h, monitoring growth by the change in OD600. All strains showed
highly similar growth (data not shown), allowing us to exclude
growth differences when interpreting subsequent experiments.
In order to understand the rate at which the selected C. difﬁcile
strains formed spores, we compared the development of heat-
resistant CFU over 5 days (Fig. 1). This appeared to show a large
degree of variation within, but not necessarily among C. difﬁcile
types. The CFU observed for each strain after 24 h and 120 h were
then plotted and compared separately (Fig. 2A). No obvious
difference in heat-resistant CFUwas seen between the BI/NAP1/027
and non-BI/NAP1/027 groups after 24 h suggesting that, under the
conditions of our assay, there is no association between C. difﬁcile
type and sporulation over a 24 h period. However, the BI/NAP1/027
group appeared to form lower levels of heat-resistant CFU after
120 hwhen compared to the non-BI/NAP1/027 group, although this
difference was not quite statistically signiﬁcant (p ¼ 0.054). In
particular, it was noted that VPI 10463 formed signiﬁcantly more
heat-resistant CFU after 120 h than all tested BI/NAP1/027 isolates
(p < 0.05). In order to conﬁrm any sporulation differences, we
counted spores from all strains by phase-contrast microscopy
(Fig. 2B) after 120 h. Spore titres varied signiﬁcantly among the 14
isolates studied (p < 0.05), and although the BI/NAP1/027 group
appeared to form fewer spores than the non-BI/NAP1/027 group,
this difference was not signiﬁcant. These data suggest that, while
spore titres varied greatly between individual strains, there was no
obvious type-associated variation in the spore titres obtained from
the C. difﬁcile strains in this study.
When analysing the sporulation efﬁciencies of these C. difﬁcile
strains, an inconsistency between spore titre and heat-resistant CFU
was observed in some cases. Fig. 3 shows the proportion of micro-
scopically-counted spores of each strain which formed heat-resis-
tant CFU at 120 hwhen germinationwas inducedwith taurocholate
supplement. This colony formation varied signiﬁcantly among the
14 C. difﬁcile isolates tested (p < 0.001), and it was also noted that
spores of a number of non-BI/NAP1/027 strains formed more colo-
nies than the spores of certain BI/NAP1/027 strains. In particular,
a signiﬁcantly higher proportion of VPI 10463 and 630Derm spores
formed colonies than the BI/NAP1/027 strains R20291, R12087, CDC
32 and CDC 38 (p < 0.05). Furthermore, spores of the non-BI/NAP1/
027 isolates Serosubtype A2 and R10459 formed signiﬁcantly more
colonies than R12087 and CDC 38 (p < 0.05). However, it was also
noted that spores of a PCR-ribotype 078 isolate (Wilcox 078) formed
signiﬁcantly fewer colonies in comparison to VPI 10463 (p < 0.05).
Not all BI/NAP1/027 strains formed proportionally fewer colonies
than microscopically-observed spores, as a signiﬁcantly higher
proportion of DH326 spores formed colonies when compared to
R12087 (p < 0.05), while not showing any signiﬁcant differences to
VPI 10463, R10459, Serosubtype A2 or 630Derm (non-BI/NAP1/027).
Additionally, when the BI/NAP1/027 and non-BI/NAP1/027 groups
were directly compared, therewas no signiﬁcant variation observed
in the proportion of spores which formed colonies (p¼ 0.14). Taken
together, thesedata indicate that followingheat treatment, spores of
a number of C. difﬁcile BI/NAP1/027 isolates appear to form colonies
at a lower frequency than certain non-BI/NAP1/027 isolates.
However, a large degree of variation was observed between indi-
vidual C. difﬁcile strains, and the smaller proportion of microscopi-
cally-observed spores forming colonies was not speciﬁc to the
BI/NAP1/027 type. As sporesmust complete germination in order to
Table 1
C. difﬁcile strains used in this study.
Strain Relevant properties Source/reference
BI/NAP1/027
R20291 Stoke Mandeville (2004/2005) isolate Anaerobe Reference Laboratory, Cardiff
CDC 32 Historical USA isolate [13]
CDC 38 USA isolate [13]
M13042 Canada isolate [13]
DH326 Yorkshire and Humberside, Shefﬁeld isolate (2005) Anaerobe Reference Laboratory, Cardiff
DH1329 West Midlands, Coventry isolate (2007/8) Anaerobe Reference Laboratory, Cardiff
R12087 Historical EU isolate (1980s) Institut Pasteur, Paris
Non-BI/NAP1/027
630Derm PCR-ribotype 012
Erythromycin sensitive strain of C. difﬁcile 630
[14]
630Derm spo0A::intron ermB C. difﬁcile sporulation-negative control [15]
GAI 95601 PCR-ribotype 017, Japan [16]
001-3 PCR-ribotype 001 ECDC e Cardiff collection
Serosubtype A2 PCR-ribotype 002 ECDC e Cardiff collection
Wilcox 078 PCR-ribotype 078 Mark Wilcox
R10459 PCR-ribotype 106 ECDC e Cardiff collection
VPI 10463 PCR-ribotype 003
Toxinotype 0 reference strain
[17]
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formcolonies,wehypothesize that the inconsistency between spore
titre and colony formation among these C. difﬁcile strains may be
caused by a difference in the frequency of germination and spore
outgrowth.
Given the recent suggestion that BI/NAP1/027 strains of
C. difﬁcile sporulate at a greater rate than strains of other types
[7e9], the datawe present here is perhaps surprising. A particularly
interesting difference between our study and previous work was
noted with C. difﬁcile VPI 10463. It has been suggested by Akerlund
et al. that VPI 10463 sporulates poorly over a 48 h period [7], but
our data show the opposite. While few heat-resistant CFU were
seen after 24 h (Fig. 2A), we found VPI 10463 to sporulate at least as
well as any other strain tested from 48 h onwards (Figs. 1 and 2B).
Two notable differences between our study and the one by Aker-
lund et al. are the growth conditions employed and the methods of
assaying sporulation. Akerlund et al. used a broth containing
peptone-yeast and without cysteine and glucose [7], while our
strains were cultivated in BHIS broth. Furthermore, Akerlund et al.
expressed sporulation rate as a ratio of spores to vegetative cells
within the population after 48 h, a method previously used to
compare sporulation of C. difﬁcile isolates [8]. However, this relative
measure can be affected by growth differences between strains and
also by the survival of non-sporulating vegetative cells. Addition-
ally, without an actual spore titre it is difﬁcult to accurately quantify
sporulation. We feel it is more appropriate to (i) measure the
change in OD600 to evaluate growth differences; (ii) observe the
development of heat-resistant CFU to assess the rate of sporulation;
and (iii) enumerate spore titres independently of colony formation,
by microscopy, to allow for an accurate measurement of C. difﬁcile
sporulation.
Previous studies of C. difﬁcile sporulation rates have been limited
to a time-course of 48 h [7,9] or 72 h [8]. Interestingly, we observed
that a low level of heat-resistant CFU after 24 h in comparison to
other isolates, such was the case with C. difﬁcile VPI 10463, did not
necessarily correlate to a low level of heat-resistant CFU after 120 h.
To the contrary, it was noted that while VPI 10463 formed few heat-
resistant CFU after 24 h, signiﬁcantly more heat-resistant CFU were
observed after 120 h than all tested BI/NAP1/027 isolates (p< 0.05).
Conversely, when compared to the other individual strains, a high
level of colony formation observed after 24 h, such was the case
with the BI/NAP1/027 isolate C. difﬁcile M13042, did not always
result in high levels of colony formation after 120 hwhen compared
to other strains. This suggests that in a case where a strain initiates
sporulation particularly early, such a strain may not necessarily
form a higher total number of spores than a strain which initiates
sporulation at a later stage. Consequently, by studying C. difﬁcile
sporulation characteristics until a plateau of spores is observed, the
relationship between sporulation rate and total sporulation can be
better described.
The ‘hypervirulence’ associated with BI/NAP1/027 strains of
C. difﬁcile has been largely attributed to an increase in toxin
production [6], although recent studies have argued that BI/NAP1/
027 strains are more proliﬁc in terms of sporulation in vitro, sug-
gesting that sporulation characteristics play a role in disease
Fig. 1. The development of heat-resistant CFU of C. difﬁcile strains over ﬁve days. (A)B, CDC 32;-, M13042;:, R12087;C, R20291;,C. difﬁcile 630Derm spo0A; (B)C, CDC 38;
-, DH326;:, DH1329;,, C. difﬁcile 630Derm spo0A; (C):, R10459;C, 630Derm;-, VPI 10463;,, C. difﬁcile 630Derm spo0A; (D)-, 001-3;:, Serosubtype A2;C, GAI 95601;
B, Wilcox 078;, C. difﬁcile 630Derm spo0A. The data represent the average of three independent experiments and error bars indicate standard errors of the means. The detection
limit for colony counts was 50 CFU/ml.
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incidence and severity [7e9]. On the other hand, both this study and
our previous work [10] would suggest that the in vitro sporulation
rate of C. difﬁcile BI/NAP1/027 strains is not signiﬁcantly higher than
non-BI/NAP1/027 strains, while in some cases the sporulation rate is
lower than other types. The present study also provides evidence of
further BI/NAP1/027 strains whose spores may germinate to form
colonies, in the presence of taurocholate, at a lower frequency than
a number of non-BI/NAP1/027 strains. Overall, our ﬁndings to date
show that the variation in C. difﬁcile sporulation frequency in vitro is
far greater among individual strains than among types. The obvious
Fig. 2. (A) CFU after heat treatment of C. difﬁcile strains after 24 h (open bars) and 120 h (ﬁlled bars), enumerated from the same sporulation cultures as described in Fig. 1;
(B) microscopically-counted spore titres after 120 h. The data represent the average of three independent experiments and error bars indicate the standard errors of the means. The
detection limit for colony counts was 50 CFU/ml and for spore counts 5  103 spores.
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question remains of how the in vitro sporulation characteristics
described in this study relate to sporulation proﬁciency in vivo.
Consequently, until our understanding of in vivo C. difﬁcile sporula-
tion improves, it will be difﬁcult to associate the sporulation char-
acteristics of C. difﬁcile BI/NAP1/027 with the severity of disease
caused by this type. Furthermore, the observed inconsistency
between spore counts and heat-resistant CFU of a number of C.
difﬁcile strains in this study also raises questions about the germi-
nation ratesofdifferentC. difﬁcile strains. If differencesdoexist in the
germination rates of different C. difﬁcile types, future studies ana-
lysing these characteristics may provide a greater understanding of
what factors contribute to the incidence and severity of C. difﬁcile
disease.
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